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ABSTRACT 
This thesis reports the construction of genomic DNA libraries, using 
chromosomal DNA from rodent derived cells which contain chromosomally 
integrated hepatitis B virus DNA sequences. Chromosomal DNA, isolated 
from the eukaryotic tissue cell lines, mouse L/130•41TK154 and 
Rat 2/130•4/TK4, was cloned into the bacteriophage lambda vectors XEMBL4 
and XCh34, and screen by plaque hybridisation for the presence of 
chromosomally integrated hepatitis B virus DNA sequences. 
Five recombinant clones were isolated and the integration patterns of 
the hepatitis B virus DNA analysed. The nucleotide sequences of the 
viral-cellular DNA junctions were determined. Viral DNA integration 
sites were observed at hepatitis B virus nucleotide positions 994, 1655 
and 2300 ± 100. Only one of the clones contained a complete hepatitis 
B viral genome, from nucleotide positions 994-3182/1-1460. The viral-
cellular junction at position 994 is situated between the preSi "TATA" 
box promoter and the putative surface gene promoter. Transfection of 
mammalian tissue culture cells with above clone resulted in expression 
of a 23 kb poly(A) RNA, which hybridised to radioactively labelled 
hepatitis B virus DNA. Examination of the culture medium, from the 
transformed cells by radioiznmunoassay, indicated that immunologically 
reactive HBsAg was expressed. This indicates that the proposed surface 
gene promoter is transcriptionally active in the absence of the preSi 
"TATA" box promoter. 
The results from transient transformation assays, for the expression of 
HBsA8, indicate that the major surface gene promoter is contained 
between hepatitis B virus nucleotide positions 1098 and 1264. No 
upstream distal transcriptional regulatory sequences were identified. 
Therefore, all hepatitis B virus sequences necessary for expression of 
the surface gene are contained between nucleotide positions 1098 and 84. 
Nucleotide comparisons of the sequenced mammalian hepatitis B "like" 
viruses, indicate that, the proposed hepatitis B virus surface promoter 
nucleotide sequence is highly conserved among the mammalian hepadna 
viruses. 
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Chapter One 
Introduction: Molecular Biology of the Hepatitis B virus 
1.1 The Biology of Hepatitis B Infection 
Viral hepatitis B is a contagious infection of man. It has been 
estimated that there are over 200 million carriers of hepatitis B 
worldwide providing a large reservoir of Infection (Szmuness, 1978). The 
disease can be transmitted parenterally, sexually and by inoculation with 
contaminated medical instruments or by blood transfusion thence the term 
"serum hepatitis"). 
The host range of the hepatitis B virus (HBV) is narrow; to date, 
productive experimental Infections have been established only In humans 
and higher primates (Hirschman et al., 1969; Maynard et al., 1972; Barker 
et al., 1973,1975). The virus shows a strong liver tropism, however, 
recently viral DNA sequences have been detected in low copy number in 
cells other than hepatocytes (Blum et al., 1983), most commonly 
associated with blood leukocytes and bone marrow (Romet-Lemonne et al., 
1983a,1983b; Elfassi et al., 1984; Laure et al., 1985; Korba et al., 1986; 
Noonan et al., 1986). These observations indicate that the tissue 
tropism of the virus may be broader than once thought. 
Primary HBV infections in adults are most often acute, a moderately 
severe illness characterised by hepatocellular injury and inflammation. 
Many individuals experience mild or no liver injury despite extensive 
hepatic infection (Redeker, 1975). However, some patients develop 
fulminant disease with extensive hepatic necrosis and high mortality 
(Peters, 1975). Most primary infections are usually self-limited and are 
resolved by the immune system. The host response to infection results 
in the development of antibodies to the virus associated antigens HBsA8, 
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HBcA8 and HBeAg (see below) resulting in the complete clearance of the 
virus and the development of lasting immunity to reinfection (fig. 1.1a). 
However, 5%-10% of immunologically normal adults (Redeker, 1975; 
Hoofnagle et al., 1978) and a much higher proportion of newborn infants 
(Schweitzer et al., 1973; Tong et al., 1981) do not resolve primary 
infections, but develop a persistent hepatic infection which is 
characterised by the persistence of HBsAg in the peripheral blood 
(fig. 1.1b). As with primary infections, such individuals may be 
asymptomatic or experience varying grades of chronic liver injury, with a 
significant number of patients having severe infections that progress to 
cirrhosis (Redeker, 1975; Peters, 1975). Long-standing carriers, mostly 
with cirrhosis, have a predisposition to the development of 
hepatocellular carcinoma (HCC); the incidence of 	HCC among long-term 
chronic HBV carriers is more than 100-fold that of age matched 
noncarriers (Beasley et al., 1981). 
1.2 Taxonomy: The Hepadnaviridae 
The human hepatitis B virus was considered for many years to be a 
unique virus. The identification of the aetiological agent responsible 
for serum hepatitis (viral hepatitis B) followed the discovery of the so-
called "Australia antigen" (hepatitis B surface antigen) (Blumberg et al., 
1965), the association of this antigen with serum hepatitis (Blumberg et 
al., 1968; Prince, 1968) and the subsequent discovery of the Dane 
particle (HBV virion) Dane et al., 1970). Since these early observations 
it has become apparent that viruses with similar ultrastructural, 
molecular and biological features infect other species of animals. 
Robinson, (1980) devised the name Hepadnaviridae (hepatitis-DNA-virus) to 
describe the closely related family of viruses of which HBV is the 
prototype. The Hepadnaviridae at present consists of possibly seven 
viruses: four fully characterised viruses, the human hepatitis B virus 
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Figure 1.1 Serology of HBV infection. The appearance of HBV antigens, 
and antibodies to them, in serum during a) acute and b) chronic 
Infection. There are wide variations In the time at which the various 
serological markers are found In individual Infections; this is indicated 
in part by the broken lines. Figure adapted from Murray, (1987). 
3 
ground squirrel hepatitis virus (GSHV) (Marion et al., 1980a) and the 
duck hepatitis B virus (DHBV) (Mason et al., 1980); the partially 
characterised tree squirrel hepatitis B virus (THBV) Feitelson et al., 
1986a,1986b) and two other possible uncharacterised candidates, the stink 
snake hepatitis virus (SSHV) and the kangaroo hepatitis virus (KHV) 
(Howard, 1986). All the viruses show a strong liver tropism and limited 
host range, usually infecting only one species of animal, and share a 
common pattern of associated diseases. The mammalian members of the 
family also share a limited degree of immunological cross-reactivity 
between their major antigenic determinants (Werner et al., 1979; Gerlich 
et al. 1980; Cote and Germ, 1983; Feitelson et al., 1986a,1986b). 
However, Mason et al., (1980) could not detect any serological cross-
reactivity between the viral surface antigens of the duck hepatitis 
virus and the mammalian hepatitis viruses. Table 1.1 lists the specific 
characteristics of the four characterised hepadnaviruses. The human 
hepatitis B virus was the first to be discovered and Is considered to be 
the type virus of the Hepadnaviridae, the general features of this virus 
are described below. 
The HBV virion (Dane particle) (fig. 1.2a) is a spherical enveloped virus 
with an overall diameter of approximately 42 nm, with an inner electron 
dense spherical core, of 27 nm diameter (Dane et al., 1970). The lipid, 
protein and carbohydrate containing envelope (Burrell et al., 1973; 
Steiner et al., 1974; Gavilanes et al., 1982) bears the hepatitis B 
surface antigen (HBsAg) (Dane et al., 1970; Almeida et al., 1971). The 
inner core particle or nucleocapsid, which can be released from the 
envelope by detergent treatment, bears the hepatitis B core antigen 
(HBcAg) (Almeida et al., 1971). 
Contained within the core particle is the viral genome, which consists of 
a small relaxed circular DNA molecule that is partially single stranded 
(Robinson et al., 1974; Summers et al., 1975; Hruska et al., 1977; Landers 
et al., 1977). Also contained within the core particles is a DNA 
polymerase activity which is capable of "filling in" the single stranded 
region of the genome (Hirchman et al., 1971; Kaplan et al., 1973; Robinson 
and Greenman, 1974). 
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Table adapted from Summers, (1981), Additional information obtained 
from Feitelson et al,, (1982,1983); Stibbe and Gerlich, (1983); Heermann 
et al., (1984); Newbold et al,, (1984); Schaeffer et al, (1986) and Pugh 
et al., (1987), 
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Examination of electron micrographs of fully double stranded DNA 
molecules isolated from Dane particles, indicate that the HBV genome is 
approximately 3200 base pairs in length (Hruska et al., 1977). In 
addition to the DNA polymerase activity, there is also a protein kinase 
activity which phosphorylates the viral core antigen protein (Albin and 
Robinson, 1980). It is presently unclear whether the kinase activity is 
intrinsic to the core antigen protein or is due to an associated protein 
encoded by the virus or derived from the host cell. 
Numerous particles are found in the serum of HBV infected patients in 
many fold excess over the virions, these particles bear HBsAg 
determinants (HBsA8 particles). The HBsA8 particles have two forms, 
small spherical particles of 22 nm diameter and filamentous particles 
22 nm wide with a variable length of up to several hundred nm 
(fig. 1.2b>. The particles have the same biochemical composition as the 
virion envelope being composed of lipid, protein and carbohydrate, 
however, they are devoid of HBcAg and viral DNA and are considered to be 
empty viral envelope material (Bayer et al., 1968; Dane et al., 1970; 
Almeida et al., 1971). The reason for the presence of these particles is 
uncertain, one possibility is that these empty envelope particles may 
serve to adsorb neutralising 	surface antibodies during the 
progression of infection. The HBsAg. present in the viral envelope and 
the HBsAg particles has a major group specific antigenic determinant (a) 
and two sets of generally mutually exclusive subtype determinants (d/y) 
and (r/w), giving rise to the four major antigenic subtypes adr, adw, ayr 
and ayw (LeBouvier, 1971; Bancroft et al., 1972). Additional antigenic 
variation of the w determinant and other minor determinants add to the 
complexity of HBsAg (Courouce-Pauty et al. 1976). Wands et al., (1986) 
have identified isolates of variant human hepatitis B viruses that are 
immunologically distinct from the known subtypes of HBV with respect to 
their major antigens, however, they do share antigenic epitopes with REV 
that are recognised by monoclonal antibodies. The hepatitis B virus 
variants also share complementary DNA sequences to REV. The variants 
and REV were shown not to be cross-protective upon challenge In 
chimpanzees, indicating that their major antigenic determinants are 
immunologically distinct. 
Figure 1.2 A schematic representation of the viral particles and 
components (not to scale). (a) The HBV virion (Dane particle) consists 
of an 42 nm diameter envelope carrying HBsAg and a 27 nm diameter 
nucleocapsid carrying HBcAg (and cryptic HBeAg). The nucleocapsid 
contains a circular DNA molecule and virion associated enzymic 
activities. (b) The HBsAg particles, 22 nm diameter spheres and 
filaments, are empty envelope material carrying HBsAg. (c) The Dane 
particle open circular DNA (3182 nucleotides) showing the single 
stranded region, 5' protein and oligor ibonucleo tide. 
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A third antigenic specificity associated with HBV infection is the 
hepatitis B e antigen (HBeAg) which is found in the serum of Infected 
patients (Magnius and Espmark, 1972). The HBeAg may exist as a free 
polypeptide or in association with IgG molecules (Tedder and Bull, 1979; 
Katz et al., 1980; Blanchy et al., 1980). The HBeAg specificity is also 
associated with the virion nucleocapsid after disruption of core 
particles by detergent treatment (Ohori et al., 1979; Takahashi et al., 
1979). At least two distinct HBeAg (HBeAg/1 and HBeA8/2) epitopes have 
been localized on the HBcAg polypeptide, which are exposed when the 
HBcA8 protein is unfolded 8udkowska et al., 1979; Ohori et al., 1980, 
1984; Ferns and Tedder, 1984). 
The Hepadnaviruses have been reviewed by, Summers, (1981); Marion and 
Robinson, (1983); Tiollais et al., (1981, 1985) and Howard, (1986). 
13 The Viral Genome 
The HBV virion DNA molecule is partially double stranded, thus the DNA 
molecule contains two strands of unequal length, a complete long strand 
which is complementary to the viral mRNAs and by convention is 
designated to be of minus polarity; accordingly, the shorter 
complementary strand is termed the plus strand. The long strand is not 
a covalently closed circle, a "nick" exists at a unique site approximately 
300 bp from the 5' end of the short strand (Summers et al., 1975; 
Sattler and Robinson, 1979; Siddiqui et al., 1979) (fig. 1.2c). The 
circular DNA can be converted to a linear form with single strand 
cohesive ends by heating under the appropriate conditions and 
selectively denaturing the Ca. 300 bp between the 5' ends of the two 
strands (Sattler and Robinson, 1979). The circular conformation of the 
molecule is maintained by hybridisation of cohesive /complementary ends 
at the 5' termini of each strand. The ends of the HBV virion DNA 
strands have recently been mapped on the HBV sequence; the 5' end of the 
minus strand is positioned at nucleotide 3108 with the 3' end probably 
at position 3100 ± 1. Thus the minus strand contains a short terminal 
redundancy Er] of ca. 9 nucleotides at its 5' and 3' ends. The 5' end of 
the DNA plus strand has been mapped to position 2882 ± 1, with the 3' 
end at a variable position (see below) (Will et al., 1987). Therefore the 
cohesive overlap is approximately 220 nucleotides in length from 
nucleotides 2882-3001. 
The single stranded gap present on the HBV virion genome has a highly 
favoured minimum length of 650 to 700 nucleotides with all the 
molecules being double stranded upstream (on the plus strand) of 
position 1420 on the HBV map. Therefore the 3' end of the plus strand 
is at or downstream of position 1420 with a favoured 3' end between 
positions 2180 to 2230 Delius et al., 1983). By contrast, on the genome 
of the duck hepatitis B virus the region of the single strand gap is 
smaller, on average, with many fully double-stranded molecules present 
in DHBV virions (Mason et al., 1981; Summers and Mason, 1982). 
The 5' ends of both strands of DNA appear to be "protected" in a manner 
that prevents phosphoryla1ion by polynucleotide klnase (Gerlich and 
Robinson, 1980). It has been shown that a protein is attached to the 5' 
end of the long strand; the attachment is presumably covalent since 
heating at 90C in detergent or treatment with strong alkali failed to 
remove the attached protein (Gerlich and Robinson, 1980). The chemical 
nature to the blockage to phosporylation of the 5' end of the short 
strand until recently remained an enigma. Lein et al., (1986) have 
demonstrated that the 5' termini of the short strand of the DHBV genome 
contain. a capped oligoribonucleo tide of 18 or 19 bases in length, with 
a possible cap structure (m7GpppAA). Oligoribonucleo tides have also 
been demonstrated to be attached to the 5' ends of the short strands of 
the woodchuck hepatitis virus, the ground squirrel hepatitis virus and 
the human hepatitis B virus (Seeger et al.,1986; Will et el. 1987). If a 
similar capped structure is also present on the oligoribonucleo tide 
attached to the 5' terminus of the HBV short strand, this would prevent 
phosphorylation by polynucleotide kinase, as observed by Gerlich and 
Robinson, (1980). The significance of the protein and RNA covalently 
bound to the 5' ends of the DNA strands is presented below (see section, 
1.6 Viral Replication). 
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In the presence of nucleoside triphosphates the product of the 
endogenously primed DNA polymerase reaction is a fully double stranded 
DNA molecule (Kaplan, et al., 1973; Robinson and Greenman, 1974; Summers 
et al., 1975; Hruska et al., 1977; Landers et al., 1977). These double 
stranded DNA molecules have been cloned into bacterial vectors and their 
nucleotide sequences determined. The sequenced Hepadnaviruses are 
listed in table 1.2. 
Many different nOmenclature systems have been used for the 
Hepadnaviridee. A common system used is that of using a unique Eco Ri 
restriction endonuclease site as position one; this site is present in 
most isolates of HBV (Galibert et al., 1979). However, since this 
restriction site is not present in some isolates of HBV (Burrell et al., 
1979; Gough and Murray, 1982) and does not correspond to a uniform 
origin in the other animal viruses, the numbering system of Pasek et al., 
(1979) has been adopted here. The numbering system of all the hepadna 
viruses have been changed such that position one corresponds to the 
start of the coding sequence for the "mature" HBcAg polypeptide, starting 
at the predicted triplet amino acid translation Met-Asp-lie common to 
all the viruses. This corresponds to the second ATG methionine codon of 
the PreC/C open reading frame for HBV I GSHV and DHBV, or the third 
initiation codon for WHV which corresponds to the second ATG codon of 
HBV and GSHV. The representative genetic maps of each type of virus is 
presented in fig. 1.3 (HBV), fig. 1.4 (WHy), fig. 1.5 (GSHV) and 
fig. 1.6 (DHBV). 
The genetic organisation of the Hepadna virus genomes are similar. 
Analysis of the complete nucleotide sequence of all Hepadnaviruses 
examined shows that only the major open reading frames of the long 
minus strand are conserved, while major reading frames found on the plus 
strand are not conserved among the Hepadnaviridae. Four major open 
reading frames are found in all sequenced mammalian Hepadnavfruses, 
these are termed PreS/Surface, PreC/Core, Polynierase and X (or B). Only 
three open reading frames are found on the DHBV sequence corresponding 
to PreS/Surface, PreC/Core and Polymerase. 
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Table 1.2 List of sequenced Hepadnaviruses. 
Hepadnavirus Nucleotide length Reference 
HBVadyw 
(HBV130) 3182 bp Pugh et al., 	(1986) 
(HBV14) 3188 bp Will et al., 	(1982) 
HBVadr 3188 bp Ono et al., 	(1983) 
HBVadr(2) 3215 bp Kobayashi and Koike, (1984) 
HBVadr4 3214 bp Fujiyama et al., (1983) 
HBVadw 3200 bp Ono et al., (1983) 
HBVadw2 3221 bp Valenzuela et al., (1980) 
HBVayr 3215 bp Okamota et al., (1986) 
HBVayw 3182 bp Galibert at al., 	(1979) 
Bichko et al., 	(1985) 
DHBV 3021 bp Mandart et al., 	(1984) 
GSHV 3311 bp Seeger at al., (1984) 
WHV 3308 bp Galibert et al., 	(1982) 
WHV2 3320 bp Kodama et al., (1985) 
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Figure 1.3 Genetic map of the human hepatitis B virus. 
The map shows the positions of the major open reading frames, the 
mapped transcriptional initiation sites and associated transcriptional 
regulatory signals. Also shown are the positions of the nuclear protein 
binding sites (Ui to U3, E and NF-1) and the direct repeats (DRI and 
DR2). Abbreviations: CR (Core promoter), EN/XP (Enhancer element and X 
promoter), SPI (preSi gene promoter) and SPII (preS2 and Surface gene 
promoter). References: Stibbe and Gerlich, (1983); Heermann et al., 
(1984); Shaul et al., (1985,1986a); Tognoni et al,, (1985); Pugh et al., 
(1986); Shaul and Ben-Levy, (1987); Treinin and Laub, (1987) and Yaginuma 
et al., (1987b). 
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Figure 1.4 Genetic map of the woodchuck hepatitis virus. 
The map shows the positions of the major open reading frames, the 
mapped transcriptional initiation sites and associated transcriptional 
regulatory signals. Also shown are the positions of the direct repeats 
DR1 and DR2). Abbreviations: CP (Core gene promoter), E (enhancer) and 
SP (Surface gene promoter). References: Galibert et al., (1982); Moray et 
al., (1985) and Schaeffer et al., (1986). 
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Figure 1 .5 Genetic map of the ground squirrel hepatitis virus 
The map shows the positions of the major open reading frames, the 
mapped transcriptional initiation sites and associated transcriptional 
regulatory signals. Also shown are the positions of the direct repeats 
DR1 and DR2). Abbreviations: CP (Core gene promoter), E (Enhancer) and 
SP (Surface genbe promoter). References: Seeger et el., (1984); Enders 
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Figure 1.6 Genetic map of the duck hepatitis B virus 
The map shows the positions of the major open reading frames, the 
mapped transcriptional initiation sites and associated transcriptional 
regulatory signals. Also shown are the positions of the direct repeats 
DR1 and DR2). Abbreviations: CP (Core gene promoter), SPI (preS gene 
promoter) and SPII (Surface gene promoter). References: Mandart et al., 
(1984); Buscher et al., (1985) and Pugh et al., (1987). 
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The genetic organisation of the human hepatitis B virus used in this 
discussion is based upon the nucleotide sequence of the HBV genomic DNA 
cloned In the plasmid pHBV130 (Pasek et al., 1979; Gough and Murray, 
1982; Pugh et al., 1986) (see Appendix I). 
1.4 Open Reading Frames and Viral Proteins 
1.4.1 The PreS/Surfpce Gene 
The preS/Surface open reading frame (ORF), position 948-2114, has a 
total coding capacity for a ca. 42,800 dalton protein. The major HBsAg 
proteins isolated from the viral envelope or HBsA8 22 nm particles have 
apparent molecular weights of 25,000 (p25) and 28,000 (gp28) daltons 
(Peterson et al., 1977). Together with the major envelope proteins a 
variable number of minor component proteins with apparent sizes of up 
to 100,000 daltons have been repeatedly observed in HBsAg preparations 
(reviewed by Robinson, 1977). The proteins observed to be greater than 
42,000 daltons are now considered to be aggregates of the HBsA8 
proteins (Koistinen, 1980; Heermann et al., 1984). The assignment of the 
p25/gp28 proteins to the PreS/Surface ORF was possible by comparison of 
the known N-terminal amino acid sequence of the HBsAg protein (Peterson 
et al. 1977), with the predicted amino acid translation of the HBV 
sequence. This positioned the major surface gene starting at the ATG 
methionine codon at position 1437 on the HBV sequence and terminating 
at 2114, giving a coding capacity for a 226 amino acid protein of 
molecular weight ca. 25,400 daltons. 
The surface ORF is preceded by an in-frame ORF with a coding capacity 
for an extra 163 amino acids. This region is termed the preS region 
(948-1436). The preS region is further subdivided into the preSi (948-
1271) and preS2 (1272-1436) regions (fig 1.3). Recently it has been 
shown that proteins are translated from the third ATG (preS2) (or 
fourth, depending upon the subtype) and the first ATG (preSi) methionine 
initiation codons of the preS region, and co-terminating with the major 
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surface proteins. Therefore, the preS2 and preSi proteins contain the 
entire amino acid sequence of the major surface p25 protein with an 
additional 55 and 163 amino acids respectively. The preS translated 
products have apparent molecular weights of 33,000 (gp33) and 36,000 
(gp36) daltons for the preS2 proteins, and 39,000 (p39) and 42,000 
(gp42) daltons for the preSi proteins (Stibbe and Gerlich, 1983; Heermann 
et al., 1984). 
The difference in apparent molecular weight of the major HBsAg proteins 
p25/gp28 is due to the gp28 protein being glycosylated between residues 
121 and 170, most probably a N-linked glycan on the asparagine residue 
at position 146 (Peterson at al., 1977; Peterson, 1981). The preS2 
glycoproteins gp33/gp36 both have a mannose rich g].ycan at asparagine 
residue 4 on their amino acid sequence, 51 amino acid positions upstream 
from the start of p25/gp28. The difference In molecular weight of the 
preS2 proteins is due to an extra glycan group on gp36 in an analogous 
position to gp28 (Stibbe and Gerlich, 1983). Again the size difference 
between the preSi proteins p39 and gp42 is due to the glycan group 
bound to the surface protein part of the molecule. The mannose rich 
glycan of the preS2 proteins is not present on the preSi proteins 
(Heermann at al., 1984). Persing at al., (1987) have recently shown that 
the preSi proteins are acylated, with myristic acid covalently bound to 
the amino terminus. The amino acid motif, methionine-glyclne, is found 
at the amino terminus of the predicted amino acid sequences of the 
preSi proteins of all the Hepadna viruses. It Is proposed that following 
cleavage of the methionine residue, an amide linkage is formed between 
the COOH group of myristic acid and the exposed amino group of glycine 
(Persing at al. 1987). 
The different subtypes of HBV vary in their coding capacity for the 
preSi derived polypeptides. The sequenced subtype HBVayw (Galibert et 
al., 1979) like the HBV sequence cloned in pHBV130, has a preS region of 
a 163 codons, while most of the remaining sequenced subtypes have an 
additional 11 codons at the amino termini of the preSi region. The 
insertion or deletion resulting in this difference of coding capacity is 
bounded by a 7 base direct repeat of GCAI.GG containing the respective 
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methionine initiation codon of the preSi region. It is possible that 
this evolutionary difference could result from insertion or deletion by 
homologous recombination via the direct repeat. It should be noted that 
the sequenced subtype HBVadw (Ono et al., 1983) while having the same 
preSi coding capacity as HBVayw, does however contain DNA sequences 
homologous to the extra sequences found in the other subtypes. The 
furthest upstream ATG initiation codon is absent with the additional 
sequences being only 12 nucleotides in length as opposed to 33 
nucleotides in the other subtypes. In agreement with the nucleotide 
sequence data, p39 and gp42 from isolates of HBVadw, presumably with 
the same coding capacity for preSi as HBVadw2 (Valenzuela et al., 1980), 
are consistently larger than those of HBVayw, with a difference In size 
of Ca. 1000-1500 daltons in apparent molecular weight (Heermann et al., 
1984). This indicates that the coding sequence of p39/gp42 starts with 
the first AUG codon of the preS/Surface ORF, with the first methionine 
codon of the HBVayii and HBVadw preSi genes corresponding to the second 
in-frame methionine of the other subtypes. 
The three morphological forms of the HBsA8; the Dane particle, the 22 nm 
spheres and filaments all contain the above six proteins, however, in 
very different ratios. Heermann et el. (1984) have demonstrated that 
upon silver staining the relative abundance of the proteins differ 
depending upon the morphological form. The relative staining intensities 
suggest that the virion particle (and filaments to a lesser extent) may 
contain up to 20 times more p39 and gp42, as do the 22 nm HBsAg 
particles. Recent reports indicate that the preSi proteins are not 
secreted from the cell, and when artificially over-expressed, inhibit the 
secretion of the smaller preS2 and major surface proteins (Cheng et al., 
1986; Chlsari et al., 1986; Persing et al., 1986; Standring et al., 1986; 
McLachlan et al., 1987; Cu and Rutter, 1987). The preSi proteins are 
only efficiently exported from cells as part of the virion envelope. 
These observations are consistent with the role for the preSi proteins 
in virion assembly. The N-terminal myristic. acid (Persing et al., 1987) 
could be important in anchoring the N-terminus of the preSi protein in 
cellular membranes. It has been observed that the preSi proteins 
accumulate in the Golgi complex and are not secreted (Ou and Rutter, 
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1987). In contrast, the preS2 and major HBsAg proteins are associated 
with the endoplasmic reticulum, from where they are transported to the 
Golgi complex and secreted (Patzer at al., 1986; Cu and Rutter, 1987). 
The presence of the accumulated preSi protein in the Golgi complex could 
cause the smaller preS2 and surface proteins to accumulate and 
therefore, inhibit their secretion. The preSi imposed restriction on the 
transport of NBsAg particles may result from intermolecular association 
of the proteins inhibiting secretion of the 22 nm particles, thus 
favouring the formation of the larger filaments and the HBV virion in 
association with the core particle (Ou and Rutter, 1987). The 
distribution of the surface associated proteins in the 22 nm particles, 
filaments and virion, is consistent with the above hypothesis. The 
expression of the preSi protein is regulated by separate promoter (see 
section, 1.5.3 The Surface mRNAs), and it is conceivable that expression 
of the preSi and other HB5Ag proteins is independently regulated, 
resulting in phasing the formation of the different structures during 
the viral life cycle. 
Binding sites for polymerised human serum albumin (pHSA) have been 
associated with the preS2 protein present in the HBV virion (Machide et 
al., 1983,1984). It is postulated that the attachment of HBV to 
hepatocytes is mediated by species specific pHSA-receptors, present on 
both the cells and the viriori, to pHSA (Imai et al., 1979; Alberti et al,, 
1982). However, the putative role of the pHSA receptors in pathogenesis 
and disease remains controversial. The postulate is based on the 
observation that preS2 proteins bind glutaraldehyde-polymerised NSA (GA-
NSA) in vitro. However, naturally occurring pHSA, unlike GA-NSA, does 
not bind significantly to the HBsAg proteins (Yu et al., 1985) therefore 
casting doubt on the above hypothesis. Although, the possibility that 
pHSAs do mediate viral attachment in vivo can not be totally excluded. 
Neurath et al., 1986) have observed that a synthetic peptide 
corresponding to preSi amino acid residues 10 to 36 (or 21 to 47 for 
the other subtypes) is recognised by both hepatocyte receptors and anti-
11EV antibodies. Neurath et al., (1986) propose that the amino acid 
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sequence present on the preSi protein may facilitate attachment to 
hepatocytes. 
1.4.2 The PreC/Core Gene 
The PreC/Core ORF (3096-3182/1-549) has a coding capacity for a 212 
amino acid protein of molecular weight ca. 24,300 daltons. The core ORF 
was originally defined by early cloning and expression studies conducted 
in Escherichia coil Burrell et ai.,1979; Pasek et al., 1979). 
Immunologically active HBcAg protein was produced in E. coil and was 
found to be translated from the methionine codon at position one. In 
this HBV isolate, the initiation codon was preceded by an in-frame stop 
codon six nucleotides upstream to the initiation codon (Pasek et al., 
1979). Therefore, the core gene (1-549) as defined, could code for a 
polypeptide of 183 amino acids with a molecular weight of ca. 21,000 
daltons. 
Analysis of other sequenced HBV genomes, as well as that contained in 
pHBV130, indicates that the core gene is usually preceded by an in-frame 
29 codons. The isolate used by Burrell et al., (1979) and Pasek et al., 
(1979) was unusual in the fact that it contained a stop codon 
immediately up-stream of the initiation codon for the "mature" core 
gene. This in-frame ORF is termed the preC region, with the 
corresponding preC initiation codon at position 3096 (fig 1.3). The 
other sequenced mammalian Hepadna viruses also contain a preC region in 
an analogous position to that of HBV. It has been suggested that the 
core gene of the duck hepatitis B virus is a fusion of the X and core 
genes to give a single large open reading frame (2893-3021/1-786) 
(Mandart et al., 1984). This assumption was drawn from the observation 
that the 5' end of the duck hepatitis virus "core" gene overlapped the 3' 
end of the polymerase gene, as does the mammalian virus X and 
polymerase genes. However, Mandart et al., (1984) also report that they 
could not detect any significant homology between the amino termini of 
the duck "core" and the mammalian X predicted amino acid sequences. 
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Examination of the amino acid sequence of the preC regions of the 
mammalian viruses indicates that it is rich in hydrophobic residues, with 
the sequence resembling a potential leader signal peptide (Sabatini et 
al., 1982; Ou et al., 1986). The first 43 amino acids of the duck virus 
"core" polypeptide is also rich in hydrophobic residues; and with analogy 
to the mammalian preC region may also represent a leader signal peptide. 
This would position the start of the "mature" DHBcAg ORF at nucleotide 
position one on the DHBV sequence. Therefore, the larger size of the 
duck core gene is possibly due to a larger leader signal peptide coding 
sequence and probably also a longer carboxy terminal region, since this 
region also overlaps the polymerase gene to a greater extent than the 
mammalian core genes. 
The nucleocapsid of HBV is composed essentially of a single protein 
species, the HBcAg protein. The size estimate of the HBcAg protein 
isolated from viral cores is 19,000-21,000 daltons (Budkowska et al., 
1977; Hruska and Robinson, 1977) this is In reasonable agreement with 
the size prediction of the "mature" core protein. It is not known 
whether the primary translated core protein product contains the preC 
region or not. The prec region is not required for expression in 
mammalian cells (Will et al., 1984; Ou et al., 1986). Ou et al., (1986) 
have inserted the core coding sequence, with and without the preC 
region, Into an SV40 early gene replacement vector. Transfection of COS 
cells with the above constructions resulted in the expression of 
immunologically reactive HBcA8 material both with and without the preC 
region. However, when the preC region was present, the core protein was 
found to be associated with the endoplasmic reticulum and Go].gi 
structures, indicating that it is membrane associated, possibly due to 
preC leader signal peptide. The presence of the preC region also 
resulted in the secretion of HBeAg into the culture medium. In contrast, 
when the preC region was absent, the core protein was found to be 
distributed throughout the cytoplasm and no significant HBeAg was 
secreted from the cells. 
The preC region may play a role in the formation of the mature virion. 
The preC amino acid sequence could anchor the preC/Core protein in the 
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membranes containing the surface antigen proteins, such that the carboxy 
terminal portion of the preC/Core faces the cytoplasm. The membrane-
bound preC/Core protein could interact with cytoplasmic "immature" core 
particles, consisting of core proteins lacking the preC region, which 
have been translated from a mRNA initiating downstream of the prec 
initiation codon (see section, 1.5.4 The Core mRNAs). This is consistent 
with the observations of Kamimura et al., (1981) and Yamada et al., 
(1982), that core particles in HBV infected hepatocytes bud into the 
cisternae of the endoplasmic reticulum to form Dane particles (Ou et al., 
1986). 
The HBeAg determinants have been found to be associated with the HBcAg 
protein. The NBcAg determinant is dependent upon the conformation of 
the core particles; when the particles are disrupted and the core protein 
denatured, the antigenic specificity changes from HBcAg to HBeAg 
Budkowska et al., 1979; Ohori et al., 1979,1980; Takahashi et al., 1979). 
Additional evidence that the HBeAg epitope is found on the core protein 
comes from the work of MacKay et al., (1981), when HBcA8 protein 
produced in E. coil is chemically denatured and partially enzymatically 
degraded, the HBcAg specificity is converted to immunologically reactive 
HBeA8. Sequencing of HBeAg protein derived from serum, suggests that 
the conversion of HBcAg to HBeAg may in part arise by proteolytic 
cleavage of 33 to 35 amino acids from the carboxy terminus of the HBcA8 
molecule to give a protein of apparent molecular weight Ca. 15,500 
daltons (Takahashi et al., 1983). 
Pasek et al., (1979) remarked on the protein sequence of the carboxy 
terminal half of the HBcAg (residues 150-183), due to its protamine like 
structure with repeating arginine residues separated by serine and 
proline, suggesting that the C terminal region could bind HBV DNA within 
the Dane particles. Until recently the possible DNA binding properties 
of the core protein were unknown. Petit and Pillot, (1985) using a 
"South-western" technique have demonstrated that the core protein binds 
32 P-labelled DNA. The DNA binding reaction also seems semi-specific, In 
that the affinity for binding HBV DNA was stronger than pBR322 DNA. 
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1.4.3 The Polymerase ORF 
The largest open reading frame on the HBV genome is termed the 
polymerase (pol) gene (407-2902), it has a coding capacity for a 
polypeptide of 832 amino acids with a molecular weight of Ca. 93,500 
daltons. The assignment of the endogenous DNA polymerase to this open 
reading frame was originally based upon purely circumstantial evidence. 
DNA polymerases of bacteria and viruses have molecular weights in the 
same size range as the potential product of the p01 ORF I therefore, the 
hypothesis that this open reading frame codes for the endogenous DNA 
polymerase was proposed (Galibert et al., 1979; Pasek et al., 1979). 
The results of Summers and Mason, (1982) suggest that the life cycle of 
the Hepedna viruses involves replication of the viral DNA via an RNA 
intermediate using a reverse transcription reaction. This also indicates 
that the virus probably encodes a reverse transcriptase, most likely the 
same protein as the endogenous DNA polymerase (see section, 1.6 Viral 
Replication). Evidence supporting this hypothesis comes from the work of 
Toh et al., (1983) and Patarca and Haseltine, (1984), in which the 
predicted amino acid sequence of the pa1 gene was compared to the 
predicted amino acid sequences of retroviral and cauliflower mosaic 
virus reverse transcriptases. The comparisons indicate that the pa1 
gene of HBV contains tracts of amino acid sequence homology with the 
other viral reverse transcriptases, indicating possible functional 
relatedness of the viral proteins. 
Additional evidence that this ORF encodes a DNA polymerase, is that 
fusion proteins produced in E. coil containing the poi gene sequences 
from position 523-1004 fused in frame with E. coil -galactosidase 
exhibit an in vitro DNA polymerase activity. This fusion protein and 
others containing poi gene sequences, have also been found to be 
reactive by "western" blotting to chimpanzee anti-sera following 
challenge by HBV, indicating that the pal gene is expressed during HBV 
infection (McGlynn and Murray, 1987). 
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A fourth open reading frame is conserved in all mammalian Hepadna 
viruses, but as yet no functional or structural aspect of the viral life 
cycle has been associated with the product of this gene. A recent paper 
of Wollershem and Hofschneider, (1987) reports that the X gene product 
may have a trans-activation activity, which suggests a possible 
involvement of the X protein with the transcription of either viral or 
cellular genes during the HBV replication cycle. The X gene (2656-3117) 
has a coding capacity for a protein of 154 amino acids with a molecular 
weight of ca. 16,500 daltons. The X gene has been cloned and various 
fusion proteins have been expressed in E. coil (Kay et al., 1985; 
Moriarty et al., 1985; Elfassi at al., 1986; Meyers et al., 1986; Pugh et 
al., 1986). The above fusion proteins have been used for immuno-
precipitation and "western" blotting analysis to detect antibodies in 
human anti-sera, specifically reactive to the HBV X gene product, 
indicating that the X gene product is expressed in natural infections of 
HBV and constitutes a new HBV serological marker HBxAg. 
Recently Chang et al., (1987a) have identified two proteins that reacted 
by immuno-precipitation with rabbit anti-X-sera, following transfection 
of HuH-7 cells with cloned HBV DNA. The identified proteins have 
apparent molecular weights of 17,000 and 22,000 daltons, with the p17 
protein corresponding to the predicted size of the X protein. It is not 
known whether the p22 protein is a HBV encoded derivative of the X 
protein or a cellular protein co-precipitating with the X protein. 
Another alternative is that p22 could be a HBV-cellular X fusion protein 
bearing HBxA8 epitope(s). Neither protein was observed in immuno-
precipitates of untransfected HuH-7 cell lysates. 
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1 .5 Transcription and Viral Gene Expression 
1..1 The Viral Transcripts 
Only recently has REV been propagated in cell culture (Sureau et al., 
1986). Consequently much of our knowledge of the molecular biology of 
HBV has been drawn from the analysis of viral gene expression of HBV 
infected tissues, hepatoma derived cell lines and transfection of non-
permissive mammalian cells with cloned HBV DNA, 
The REV genome contained within the Dane particle is a relaxed circular, 
partially double-stranded molecule, containing a "nick" at a unique site 
on the long strand. For the viral genome to be transcribed it would be 
expected that the DNA would have to be "repaired" and made a fully 
double-stranded covalently closed molecule. An analysis of nuclear DNA 
from infected tissues, indicates that viral DNA exists as extra-
chromosomal molecules distinct from the Dane particle DNA. The episomal 
REV DNA molecules migrate with apparent molecular sizes of 4.0 kb and 
2.2 kb when separated by agarose gel electrophoresis. The two forms of 
REV DNA can be converted to a single species with an apparent molecular 
size of 3.2 kb, upon digestion with Eco RI. With analogy to bacterial 
plasmids, the 2.2 and 4.0 kb forms represent covalently closed circular 
supercoiled (cccDNA) and "nicked" open circular (ocDNA) molecules 
respectively, which are converted to a linear genomic length molecule 
when digested with Eco RI (Ruiz-Opazo et al., 1982; Elfassi et al., 1984; 
Miller and Robinson, 1984). The covalently closed circular viral DNA is 
found predominantly in the nucleus of infected cells, with approximately 
50 copies per cell, resulting from de novo DNA synthesis via the reverse 
transcriptase pathway in the cytoplasm (Tuttleman et al., 1986). The 
cccDNA is presumed to be the template for transcription of the 
hepadnavirus mRNAs (Miller and Robinson, 1984; Tuttleman et al., 1986) 
Initial studies of REV gene expression were conducted on a human 
hepatocellular carcinoma derived cell line PLCIPRF/5 (Alexander cells) 
(Alexander et al., 1976). The cell line PLC/PRF/5 has been found to 
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secrete HBsA8 22 nm particles Into the culture medium (Marion et al., 
1979; Skelly et al., 1979). Analysis of the integrated HBV DNA shows 
that there are no full length integrated HBV genomes, at least seven HBV 
fragments, some rearranged, are integrated into the PLC/PRF/5 genome 
Brechot et al.,1980; Chakraborty et al., 1980; Edman et al., 1980; Marion 
et al., 1980b; Shaul et al.,1984; Ziemer et al., 1985). The Alexander 
cells produce a poly(A) mRNA of 2,000-2,500 nucleotides that hybridises 
to the surface region of the HBV genome (Chakraborty et al., 1980; Edman 
et al.,1980). This mRNA is approximately the size of the native HBsAg 
mRNA (see below), however, it has recently been shown that this mRNA is 
a hybrid molecule containing HBV sequences co-transcribed at its 3' end 
with human sequences (Freytag von Loringhoven et al., 1985; Ou and 
Rutter, 1985) and it is fortuitous that it is approximately the same size 
as the native HBsA8 mRNA. 
An approach to the study of HBV gene expression was undertaken. It was 
reasoned that since the HBV genome is circular; cloned genomic length 
molecules may not mimic the transcriptional template of HBV. Therefore, 
multimeric forms of HBV genomes were constructed in vitro, containing 
complete tandem copies of HBV DNA cloned into E. coil vectors. These 
constructions could therefore mimic a circular monomeric HBV molecule. 
Pourcel et al., (1982) using a dimeric construction co-transfected, along 
with a plasmid containing the Herpes simplex virus type 1 thymIdine 
klnase (tk) gene as a selectable marker, mouse L cells deficient in 
thymidine kinase (LMtk-). Hypoxanthine (HAT] resistant (tk) 
transformants were found to secrete HBsAg into the medium. Three HBV 
related mRNAs were observed, a major transcript of 2.3 kb which 
hybridised to the surface region of the HBV genome and two minor 
transcripts of 4.3 and 0.9 kb, the nature of the minor transcripts was 
not investigated. 
Gough and Murray, (1982) using a similar technique, however, using a 
construction that contained four "head to tail" copies of HBV 
(pHBV130.4), co-transformed Rat 2 (tk-) and LMtk cells. The HAT 
resistant transformants were found to contain integrated HBV DNA, and to 
express not only }IBsA8 but also HBcAg and ifReAg as Judged by 
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radioimmunoassay. The same transformants were later shown to express 
the HBxAg as assayed by immunofluoresence (Pugh et al., 1986). 
Therefore, these transformants express all the known HBV related 
antigens. Gough (1983) investigated the HBV transcripts produced by 
these cell lines and found four HBV specified mRNAs that hybridise to 
the coding strand (minus strand); a major 2.4 kb mRNA which hybridises 
to the surface and X regions of the genome; a 1.0 kb mRNA which 
hybridises specifically to the X gene and two minor transcripts greater 
than the genomic length of HBV, of 4.4 and 3.9 kb, which hybridise to all 
regions of the HBV genome. No transcripts were observed that hybridised 
to the plus (short) strand or the plasmid vector pBR322. The greater 
than genomic length mRNAs were found in independently isolated cell 
lines that express HBcAg and HBeAg and not in cell lines that express 
only HBsAg. Therefore, the expression of HBcAg/HBeAg probably requires 
the synthesis of at least one of these greater than genomic length 
mRNAs. Synthesis of these transcripts would require read-through from 
one HBV genome to another, therefore mimicking a circular viral genome. 
The production of these transcripts would also require inefficient 
polyadenylation, the transcripts only being polyadenylated upon a second 
(or additional) round of transcription, thus the mRNAs would be 
terminally redundant. 
Cattaneo et al., (1984) isolated RNA from HBV infected chimpanzee liver, 
and by "northern" analysis of the viral transcripts identified two major 
transcripts of 2.3 kb and 3.8 ± 0.3 kb, probably corresponding to the 
2.4 kb surface mRNA and 3.9 kb mRNAs identified by Gough, (1983). The 
greater than genomic length mRNA present in infected hepatocytes was 
found to be much more abundant than in the cell lines constructed by 
Gough and Murray, (1982). The levels of the 3.8 kb and 2.3 kb mRNAs in 
infected liver cells were approximately 20 and 50 copies/cell 
respectively, whereas in the cell lines of Gough and Murray, (1982) the 
2.3 kb transcript is in approximately 50 fold excess over the 3.8 kb 
transcript. This indicates possible differences in the control of viral 
transcription in primate liver and non-permissive rodent cells. Factors 
required for optimal transcription of the core mRNA are possibly only 
present in hepatocytes, allowing optimal expression of the HBcAg/HBeAg 
32 
and viral replication. The 1.0 kb X mRNA was not observed In the 
preparations of poly(A) RNA isolated from infected liver. 
Recently, using the methods of Pourcel et al., (1982) and Gough and 
Murray, (1982) as well as transient expression studies, the human 
hepatitis B virus has been successfully propagated in hepatome derived 
cell lines, indicating the requirement of HBV for hepatocyte cells for 
permissive replication (Sureau et a1.,1986; Chang et al., 1987a; Sells et 
al., 1987; Tsurimoto et al., 1987; Yaginuma et al., 1987b). 
1.5.2 The Polyadenylation Signal 
Pourcel et al., (1982) and Gough, (1983) both propose that the surface 
mRNA is polyadenylated at a variant polyadenylation signal at positions 
16-21 (TATAAA). The sequence AAUAAA is found 10-30 bases upstream of 
the site of addition of the poly(A) tail of most eukaryotic mRNAs 
(Proudfoot and Brownlee, 1976). The sequence at position 16 on the HB'J 
map has only a single mis-match to this sequence and is the preferred 
candidate for the polyadenylation signal for the HBsAg mRNA. The 
results of Gough, (1983) indicate that 3' processing of the X mRNA also 
requires this signal. Cattaneo et al., (1983b), mapped the 3' end of the 
HBsA8 mRNA isolated from infected liver tissue and the cell lines of 
Gough and Murray, (1982). Using Si protection studies, a probe from 
nucleotide 2852 to 430 was protected giving a product of Ca. 370 
nucleotides, corresponding to a 3' polyadenylation addition site at 
nucleotide 40 ± 5. This result was repeated in a later study which 
indicated that the greater than genomic length mRNA Is most likely 
processed at the same polyadenylation signal (Cattaneo et al., 1984) 
Simonsen and Levinson, (1983) using a simian virus 40 (SV40) based 
vector containing the HBsAg gene, as well as 5' and 3' flanking sequences 
(nucleotides 1280 to 84 on the HBV map) positioned behind the SV40 late 
promoter, expressed transcripts In COB cells and identified species of 
mRNA directed by the SV40 late promoter. These transcripts were found 
to terminate within HBV sequences, therefore, utilising HBV 
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transcriptional termination signals. They isolated cDNA clones 
corresponding to the HBV containing transcripts and determined the 
sequence of the 3' ends. The isolated clones contained a poly(A) tract 
inserted 12 to 19 bases downstream of the sequence TATAAA (nucleotides 
16 to 21), with the polyadenylation addition sites between positions 33 
to 41, confirming the speculations of Pourcel et el., (1982); Gough, 
(1983) and Cattaneo, et al., (1983b). The results of Simonsen and 
Levinson, (1983) also indicate that at least 30 nucleotides downstream 
of the polyadenylation signal are required for efficient 3' processing. 
Recent reports suggest that sequences 3' to the polyadenylation signal 
of eukaryotic transcripts are necessary for efficient polyadenylatlon 
(Hart et al., 1985; McDevitt et al., 1986; Gil and Proudfoot, 1987). One 
such sequence motif found downstream of the adenovirus E2A 
polyadenylation site, TT(A/G)TTTTT (U-rich element) (Hart et al., 1985; 
McDevitt et al.,1986) shares nucleotide homology to a sequence 28 bases 
downstream of the HBV polyadenylation signal (TcGTTTTT, position 49 to 
56) (unpublished observations). Evidence that this sequence could be 
involved in the polyadenylation of the HBV transcripts comes from the 
above results of Simonsen and Levinson, (1983). Three prime deletion 
mutants, with different lengths of sequence downstream of the 
polyadenylation signal were tested for their efficiency of 
polyadenylation. One such deletion derivative, pHBVterm 13, deleted for 
sequences downstream to position 52 contains the polyadenylation signal 
with the deletion point within the U-rich sequence defined above. 
Transcripts directed by this construction in COS cells were inefficiently 
polyadenylated. A similar construction, pHBVterm 14, deleted for 
sequences downstream to position 67, contains both the polyadenylation 
signal and the U-rich element. This deletion derivative directed the 
synthesis of mRNA of the same size and efficiency as their standard 
construction (pDL RI), which contains HBV sequences from the Eco RI site 
(position 1280) downstream to the Bgl II site (position 84). This 
strongly suggests that this U-rich element could be involved in 3' 
processing of the HBV transcripts. Related sequences are found 
downstream of the polyadenylation signals of the other Hepadnaviruses, 
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Indicating possible conservation of a functionally important DNA/RNA 
sequence. 
The single mis-matches between the HBV polyadenylation signal, the 
U-rich element and the consensus sequences, may permit read through 
transcription of the polyadenylation signals, due to a relatively less 
specific interaction with the polyadenylation machinery. Therefore 
allowing the synthesis of the greater than genomic length mRNAs 
observed by Gough, (1983) and Cattaneo et al., (1984). Saito et al., 
(1986) using an Adenovirus type 5 based vector, containing an HBV Bgl II 
fragment (523-84), transfected HeLa cells and expressed HBV transcripts. 
Two-thirds of the viral transcripts failed to terminate at the HBV 
polyadenylation signal and proceeded into vector sequences Indicating 
that the HBV polyadenylation signals are functionally "leaky". 
1.5.3 The Surface mRNAs 
The HBV surface mRNA has an apparent molecular size of ca. 2,300 
nucleotides as determined by "northern" hybridisation (Pourcel et al., 
1982; Gough, 1983; Cattaneo et al.,1984). Both Pourcel et al., (1982) and 
Gough, (1983), by inference to the length of the viral transcripts and on 
the basis of hybridisation studies postulated, that the surface antigen 
promoter is contained upstream to the preS region. A "TATA"-like 
sequence at position 876 (TATATAAA) has been proposed to be the 
promoter, implying the start of the transcript at around 900-910 
(Pourcel et al., 1982). Gough, (1983), however, observed hybridisation of 
the transcript to a probe extending from 523-900, and therefore proposed 
that the surface promoter may be at position 790 (TATTAAA) or 845 
(TATTTA), with initiation sites 815-825 or 870-880 respectively. 
The original studies conducted to investigate the transcriptional 
promoter signals of the preS/surface gene were those of Rall et al., 
(1983). These studies involved the generation of in vitro run off 
transcripts using HeLa whole cell extracts. Rall et al., (1983) 
identified an RNA polymerase II dependent surface transcript initiating 
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at position 907 ± 10 on the HBV map, 25 nucleotides downstream of a 
potential "TATA"-like sequence TATATAA (876-882), in agreement with the 
site postulated by Pourcel et al., (1982). 
Cattarteo et al., (1983b) isolated surface mRNA from HBV infected 
chimpanzee liver and the Rat2/130.4/TK4 cell line of Gough and Murray, 
(1982). Using an Si protection procedure, with a probe covering 
sequences 533-1409, the 5' end of the HBsAg mRNA was mapped to position 
1255 on the HBV map, 185 nucleotides upstream of the S gene coding 
sequence. The same site was mapped when the RNA/DNA hybrids were 
digested with Exo VII or analysed by primer extension experiments, 
indicating that this site does not represent a splice site and no large 
i.ntron exists in the 5' end of the surface transcript. This result was 
unexpected considering the In vitro transcription results of Rall et al., 
(1983) and the hybridisation results of Gough, (1983) which map the 5' 
end of the surface mRNA upstream of the preS region. The 5' initiation 
site mapped by Cattaneo et al., (1983b) is 17 nucleotides upstream from 
the initiation codon for the preS2 open reading frame and could 
therefore code for both the preS2 and surface proteins. 
No TATA box promoter is found In the expected position 20-30 
nucleotides upstream to position 1255. A sequence found 30 nucleotides 
upstream of the SV40 late mRNA initiation site has been defined as being 
important in regulation of transcription of the SV40 late mRNA (Brady et 
al., 1982). Cattaneo et al., (1983b) observed that a sequence upstream 
of the surface mRNA initiation site shares extensive homology to the 
sequence defined by Brady et al., (1982). A second sequence motif with 
homology to the SV40 origin of replication, which has also been shown to 
be involved in the regulation of SV40 late transcription (Contreras et 
al., 1982; Cattaneo et al,, 1983a), is found 60 nucleotides upstream of 
the surface mRNA start site (Cattaneo et al., 1983b). It should be noted 
that an additional consensus sequence for the binding site of the 
transcription factor CTF (CCAAT), which Is a common element of many 
eukaryotic promoters (Benoist et al., 1980; Efstratiadis et al., 1980), is 
found between the homology to the SV40 origin and late promoter 
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regions, 51 nucleotides upstream of the surface mRNA start site 
(unpublished observation) (fig 1.7). 
Since the above studies were reported, the expression of HBsAggene and 
its mRNA have been studied in a variety of expression systems. These 
expression systems include the study of stably transformed rodent cells 
and hepatoma cell lines containing integrated HBV DNA, HBV infected 
human and chimpanzee liver tissue and transient expression systems using 
viral based vectors containing the HB5Ag gene. The results of some of 
these experiments are presented in table 1.3. Summation of these 
results indicates that the major surface mRNAs exist as a closely 
related set of RNA species with heterogeneous 5' ends. Probably only 
three major species of surface mRNA exist with initiation sites between 
positions 1250-1260, 1274-1280 and 1284-1290. The most 5' initiation 
site maps upstream of the preS2 initiation codon with the two smaller 
mRNA initiating 3' to the preS2 ATG codon, 145-165 nucleotides upstream 
of the surface ATG initiation codon. The transcriptional initiation site, 
position 907,observed in vitro (Rail et al., 1983), is utilised in mouse 
fibroblasts, infected liver and in hepatoma derived cell lines, however, 
at a very low efficiency. The relative abundance of this preSi mRNA 
produced in the cell line PLC/PRF/5 has been estimated at only 2% of the 
total surface mRNA (Ou and Rutter, 1985). Another low abundance preSt 
mRNA is expressed in the cell line L/130.4/TK154, constructed by Gough 
and Murray, (1982); Cattaneo et al., (1984) observed the mRNA initiating 
at position 851±20, in the mouse L cell derived cell line. The existence 
of this mRNA would account for the hybridisation results of Gough (1983) 
in which surface mRNA was found to hybridise to probes extending from 
523 to 900. 
The surface mRNAs are probably directed by two separate promoters, the 
preSi "TATA" box promoter (SPI) at position 876 to 882 and the 
preS2/surface "SV4O-late-like" (SPIt) promoter situated between positions 
1188 and 1260. The downstream Initiation sites could be derived by 
some form of 5' processing, however, no introns are present In the 5' end 
of the major transcripts (Cattaneo et al.,1983b; Standring et al.,1984). 
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CCGCCTCG-GCCTC SV40 on 
++++.++ +++++ 	 ***1260 
CCGCCTCCTGCCTCTACCAATCGCCAGTCAGGACGGCAGCCTACCCCGCTGTCTCCACCTCTGAGAACCACTC HBV 
1188 	 +++ ++ ++ + ++++ ++ 	++ +++ ++ + +++ 	+ 
CCTCA-GAAGGTA-CCTAACC--AAGT-TCC--TCTTTCAGAGGTTATT SV40 
	
266 	 *372 
1261 	*** 	**** 1330 
ATCCTCAGGCCAICAGTGGAACTCCACAACCTTCCACCAAACTCTGCAA8ATCCCAGAGTGA6AGGCCT 	HBV 
preS2 
Figure 1.7 Alignment of nucleotides from the HBV major surface promoter 
(HBV130 sequence; Pugh et al., 1986) (middle), the SV40 late promoter 
region (bottom) and the SV40 origin (top). The sequence important in 
positioning the SV40 major late transcript (Brady et al., 1982) is 
underlined. The 4-bp deletion in the SV40 origin strongly reducing SV40 
late transcription (Contreras et al., 1982) is overlined. A putative CTF 
binding site (CCAAT) is underlined on the HBV sequence. The major 
initiation of transcription sites are indicated with a *, homologous 
nucleotides between the SV40 and HBV sequences are indicated with a +. 
Figure adapted from Cattaneo et al., (1983b). 
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Cell type method sites Reference 
In vitro Run off trans. 907±10 Rail et al., 	(1983) 
COS SI 
Chimpanzee SI,ExoVII,PE 1255 Cattaneo et al., 
liver (1983b) 
Rat2/ 130. 4/TK4 
In vitro 
Chimpanzee SI,ExoVII 851±20 Cattaneo et al., 
liver 901±20 (1984) 
L/130. 4/TK154 1256 
1301 
1396 
Mouse L SI,PE 1254/5/6 Standring et al., 
1274/5/6 (1984) 
1285/7 
PLC/PRF/5 PE 907±4 (2%) Cu and 'Rutter, 	(1985) 
1255,1260 	(59%) 
1276,1278 	(24%) 
1288, 1289 	(15%) 




Rat SI,PE 885-890 Siddiqui 	et al., 
fibroblast 1266 (1986) 
1285 
1297 








Chimpanzee SI,PE 910±20 will 	et al., 	(1987) 
Liver 
§ Run off trans.=in vitro run off transcription; 
SI, ExoVII=SI, ExoVil digestion mapping, PE=primer extension 
mapping 
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The identity of the preS2/surface promoter has been confirmed by cloning 
fragments of HBV DNA devoid of the SPI promoter and expressing HBsAg in 
mammalian cells under the control of the SPII promoter of HBV (Standring 
et al., 1984; Siddiqul et al., 1986). Slddiqul et al., (1986) using a 
heterologous system with the surface promoter (SPII) directing the 
expression of bacterial chioramphenicol acetyltransferase (CAT) in CV-1 
cells, defined the major HBsAg promoter as being between nucleotides 993 
and 1310 on the HBV map. A recent report of Shaul et al., (1986a) using 
a heterologous system similar to Siddiqul et al., (1986), indicates that 
the proximal promoter elements defined by Cattaneo et al., (1983b) are 
possibly dependent on at least one upstream distal element for maximal 
expression. Shaul et al., (1986a) identified a binding site for nuclear 
factor 1 (NF-1), TGG N GCCAA, at positions 1068 to 1081. The 
expression of 5' deletion mutants in HeLa cells indicate that deletions 
extending to position 1069 on the HBV map resulted in a 5 fold 
reduction in CAT expression. Therefore, Shaul et al., (1986a) propose 
that NF-1 is a transcriptional regulatory factor for the major surface 
promoter. 
Three separate proteins are translated from the preS/surface ORF. It 
was originally proposed that the entire open reading frame was 
translated to give a precursor polypeptide which was subsequently 
processed to the major surface proteins (p25/gp28) and the preS 
proteins. However, this idea was refuted when Persing et al., (1985) 
introduced a +1 frame shift mutation at the Eco Ri site (1280) between 
the start of the coding sequences for the preS2 and surface proteins. 
Mouse L cells transfected with this construction secreted HBsAg 22 nm 
particles. Analysis of the protein composition indicated that the 22 nm 
particles were devoid of the preS derived proteins and contained only 
the smaller major surface proteins. These results indicate that the 
surface protein is translated independently of the preS proteins and is 
not derived from cleavage of a precursor protein. A more plausible 
explanation for the translation of the HSsAg polypeptides is that each 
protein is translated from separate species of mRNA. The preSi protein 
is translated from an mRNA, initiating at position 907, which is directed 
by the SPI promoter. While the preS2 and major surface proteins are 
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translated from mRNAs directed by the SPII promoter. The preS2 protein 
is probably translated from a mRNA which initiates between positions 
1250-1260, while the major surface protein is translated from two 
alternative mRNAs initiating between positions 1274-1280 and 1284-1290 
(fig 1.8). 
15.4 The Core rnRNAs 
The core mRNA (greater than genomic length mRNA) has not been as well 
characterised as the surface mRNA due to its low abundance in most 
expression systems. The core mRNA isolated from infected liver has an 
apparent size of ca. 3,800 ± 300 nucleotides (Cattaneo et al., 1984). 
The major 5' end of liver derived core mRNA has been mapped to position 
3100 ± 2 on the HBV map; minor transcripts initiating upstream to 
position 3100 were also observed (Will et al., 1987). The same 
initiation site was mapped by Saito et al., (1986) using an Adenovirus 
vector system although the 5' end appeared to be heterogeneous. Zelent 
et al., (1987) using a head to tail dimer of HBV, transfected mouse 3T3 
cells and expressed HBV transcripts. The major core transcripts 
appeared to have 5' ends at positions 3027 ± 5 and 2902 ± 5 with minor 
mRNAs initiating at approximate positions 3040, 3060, 3070 and 3097. 
Yaginuma et al., (1987b) have used a transient assay system to produce 
Dane particles in hepatocellular carcinoma derived cell lines. The core 
mRNAs produced in these studies had 5' initiation sites at positions 
3063/4, 3072 ± 1 and 3099 ± 1 in agreement with both the major core 
mRNA of Will et al., (1987) and the minor transcripts of Zelent et al., 
(1987) (fig 1.8). The above difference in the map positions of the 5' 
ends is possibly due to different transcriptional affinities of 
hepatocyte derived and non-permissive mammalian cells, as reflected by 
the greater abundance of the core mRNA in infected liver tissue 
(Cattaneo et al., 1984). The 5' ends of the core mRNAs of DHSV, GSHV and 
WHV have been mapped to approximately the same positions as the HBV 
core mRNAs on their respective maps Buscher et al., 1985; Enders et 
al.,1985; Moroy et al., 1985). No promoter sequences have been mapped 
immediately upstream of the initiation sites of the HBV core mRNAs and 
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Figure 1.8 Diagram of the HBV transcriptional regulatory region. The 
transcriptional regulatory signals (top) are shown in relation to the 
start of the viral open reading frames. Open arrows indicate the 
transcriptional start sites, positions of the transcriptional start sites 
are taken from Yaginuma et al., (1987b) and Treinin and Laub, (1987). 
The positions of the protein binding sites (NF-1, U1-U3, E) are Indicated 
above the line. The start and stop codon positions for the open reading 
frames are shown below. 
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no "TATA" consensus is found 20 to 30 bases upstream of the mapped 5' 
ends, and like the major surface promoter the core promoter probably 
represents non-TATA promoter. 
The major 5' end of the core mRNA (position 3100 ± 2) mapped by Will et 
al., (1987), initiates 5 nucleotides downstream of the prec ATG initiation 
codon, therefore, the mRNA could only code for the "mature" core protein. 
The preC region could be translated from the mRNA species initiating 
upstream to the preC ATG codon at positions 3063/4, 3072 ± 1 (Yaginuma 
at al., 1987b) (fig 1.8). Such mRNAs have also been observed in GSHV, 
and WHV infected liver (Enders et al., 1985; Moroy et al., 1985). 
No HBV mRNA has been observed to initiate immediately upstream of the 
polymerase gene; it is proposed that the core mRNA also encodes for this 
protein. Translation of the polymerase protein would require that the 
mRNA be polycistronic, with the polymerase protein being synthesised by 
internal initiation of translation (reviewed by Kozak, 1986). 
Alternatively the core mRNA could be spliced to give minor transcripts 
In which the poi initiation codon is the first available AUG on the mRNA, 
thus allowing synthesis of the polymerase protein. However, no spliced 
HBV transcripts have been observed, although this may be due to the low 
abundance of these mRNAs. An alternative hypothesis has been proposed 
by Will et al., (1986). The arrangement of the HBV core and polymerase 
genes is similar to the arrangement of the analogous retroviral gag and 
pal genes. Therefore, the HBV polymerase/reverse transcriptase could be 
synthesised via a HBcA8-Pol (c-pol) fusion protein reminiscent of the 
retroviral gag-pol polyprotein produced by ribosomal frameshifting 
during translation (Jacks and Varmus, 1985). However, it should be noted 
that the HBV p01 gene is in the +1 frame relative to the core gene, 
whereas most retroviral p01 genes are in the -1 frame relative to the 
gag gene. 
In support of their hypothesis Will at al., (1986) have observed c-pol 
fusion proteins in liver samples from patients with primary liver cancer. 
The tumours contained integrated HBV DNA, with no evidence of active HBV 
replication. It is possible that these fusion proteins could result from 
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rearrangement of the integrated HBV DNA, with the resultant 
transcription/translation of fused core and polymerase genes. Will et 
el., (1986) argue against this possibility, since they observed that 
separate isolates of the tumours expressed a 35,000 dalton fusion 
protein, indicating that the separate tumours synthesise either the same 
or similar protein which would not be expected if the fusions were due 
to aberrant re-arrangement of the integrated HBV DNA. Will et al., 
(1986) suggest that the sizes of the observed c-pol fusion proteins 
could result from incomplete synthesis or processing of the HBV reverse 
transcriptase in the non-HBV-replicating cells. It remains to be 
conclusively shown whether these c-pal fusions are produced during 
natural HBV infection. Detection of the native polymerase protein should 
answer this question. 
Miller, (1987) has observed that the predicted amino acid sequence of 
the core protein contains a stretch of amino acids with homology to 
protease active site sequences of cellular and viral proteases. Miller, 
(1987) proposes that the HBV putative protease-like sequence (amino acid 
residues 27-37 of the "mature" core protein) could act by proteolytic 
self-cleavage of the core protein to generate the serum HBeAg. Two 
possible pathways could determine the fate of the core protein. In the 
first pathway the protease is in an inactive form and no cleavage takes 
place. After translation the core protein remains intact and is 
incorporated into the nucleocapsid of the virus. In the second pathway 
the protease becomes activated (possibly by post-translational 
modification), and the core protein is cleaved to remove the carboxy 
terminal 33-35 amino acids (Takahashi et al., 1983). This reaction would 
generate HBeAg (from the amino terminus) and a small protein containing 
the pro tamine-like region (from the carboxy terminus) of the core 
protein. The HBeAg is then secreted from the infected cell where it is 
found as a free protein in the serum. Miller (1987) also proposes that 
the protease activity of the HBV core protein may be necessary for post-
translational modification of the putative c-pol polyprotein to form an 
active polymerase similar to the proteolytic cleavage of the retrovfral 
gag-pal polyprotein. Therefore, the generation of the HBeAg protein 
could possibly be a by-product of the HBV replication system. If this is 
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the case, and depending upon where the translational ribosomal frame 
shifting occurs, it is possible that an active polymerase derived from 
the putative c-pol fusion protein could contain the protamine-like amino 
acid sequence at its amino terminus and therefore may have nucleic acid 
binding properties. 
J .5.5 The HBV Enhancer Element 
Sequences have been found on the HBV genome which can effect the 
expression of the core mRNA. Shaul et al., (1985) inserted a fragment of 
HBV (2243-2964) upstream of the CAT gene in a SV40 based vector. 
Significant CAT expression was observed In transfected Alexander cells 
when the core promoter region was Inserted in the sense orientation to 
the CAT gene. When a sub-fragment (2682-2964) of this region was 
inserted in sense to the CAT gene, no expression was observed which 
indicates that sequences between 2243 and 2682 influence the expression 
of the core promoter. Shaul et al., (1985) propose that the sequences 
2243 to 2682 contain an enhancer element. When the enhancer fragment 
was inverted with respect to , the core promoter fragment, significant CAT 
expression was also observed, indicating that the enhancer element is 
independent of orientation. The HBV enhancer was also tested In a 
heterologous system; when an HBV fragment (2015-2519) was inserted 
upstream of the SV40 early promoter and used to direct CAT gene 
expression in COS cells, the CAT expression was induced 105 fold above 
the expression level of the vector containing no enhancer. Using a 
series of deletions, the HBV enhancer activity (although at a reduced 
efficiency) was found to reside between nucleotides 2360 to 2519. 
Insertion of the enhancer region 3' to the CAT gene also resulted in 
increased expression from the SV40 early promoter. The activity of the 
HBV enhancer also appears to be semi-tissue specific, in that the effect 
of the HBV enhancer upon the HBV core promoter expression of the CAT 
gene was 50-fold higher in PLC/PRF/5 cells as compared to expression in 
CV-1 cells. This tissue specific enhancer activity may explain the low 
expression level of the core mRNA In non-permissive mammalian cells and 
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the relatively high expression levels in HBV infected liver (Gough, 1983; 
Cattaneo et al., 1984). 
It should be noted that the core promoter DNA fragments used by Shaul 
at al., (1985) only contain sequences upstream of position 2964; the 
mapped core mRNA initiation sites are positioned 99-136 bases 
downstream of this site. It is possible that the constructions used by 
Shaul et al., (1985) may not contain the complete core promoter 
sequences, although they do contain the RNA polymerase II "TATA" 
promoter (position 2933-3939) found to be weakly active in vitro, with 
the probable transcriptional initiation site at 2961/2 (Rail et al., 
1983). However this promoter and mRNA initiation site are probably not 
utilised in vivo (Will et al., 1987; Yaginuina at al., 1987b). 
Tognoni at al., (1985) have also identified the enhancer element between 
nucleotides 2400-2600. The exact nucleotide sequence of the HBV 
enhancer element is not known. Tognoni et al., (1985) could not detect 
any perfect matches to consensus sequences of other enhancer elements, 
although they do report a run of alternating purines and pyrimidines 
between positions 2513 and 2523, and suggest that these sequences could 
be involved in enhancer activity. 
Shaul and Ben-Levy, (1987) using protein-DNA binding filter assays, have 
identified DNA protein binding sites between nucleotides 2107 and 2655 
on the HBV map. The protein binding sites were further analysed by 
DNase I footprinting studies. Multiple binding sites were observed at 
positions 2161-2180 (UE3); 2252-2271 (UE2); 2309-2328 (UEI) and 2460-
2486 (E). The protein binding sites UE1, UE2 and UE3 map upstream of 
the defined enhancer element (2400-2600). Factors that bind to these 
three sites were only found in nuclear extracts of fully differentiated 
hepatocyte derived cells and not in non-hepatocyte cells (eg. Wish cells 
or HeLa cells). Evidence that these binding sites could be involved In 
enhancer expression comes from the results of Shaul et al., (1985); 
deletion of the sequences from 2015-2360 resulted in a reduction of the 
enhancer activity, suggesting that the factors that bind to the upstream 
sites could act in a synergistic manner with the defined enhancer 
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region. If these binding proteins act in such a way, this may explain 
the semi-tissue specificity of the HBV enhancer element. The E binding 
site maps within the enhancer region. The E binding factor was found 
not only in hepatocyte derived cells but also in HeLe cells. Shaul and 
Ben-Levy, (1987) observed a DNase I hypersensitive site at the 5' end of 
the E region, when using nuclear extracts from hepatocyte derived cells 
in their DNase I footprinting studies. When using HeLa cell extracts the 
E region was protected indicating the presence of the E binding factor, 
however, the DNase I hypersensitive site was not observed. Shaul and 
Ben-Levy, (1987) suggest that the E factor of HeLa cells may be related, 
but not identical to that found in liver cells. It remains to be 
determined whether these protein binding sequences are involved in 
enhancer function. Mutation and expression studies need to be conducted 
in order to confirm this. 
The HBV enhancer region is situated about 1150 nucleotides downstream 
of the major initiation site for the surface mRNA; and 500 nucleotides 
upstream of the major initiation sites for the core mRNA. Since 
enhancer elements are known to have an effect when positioned 
downstream of a gene, and the HBV enhancer fulfils this requirement 
(Shaul et al., 1985), it is conceivable that the enhancer may also 
augment expression from the surface promoter. Indications for this come 
from the studies of Chang et al., (1987b). They used a heterologous 
expression system with the surface promoter region (523-1280) upstream 
of the CAT gene and the HBV enhancer region (2243-2682) inserted 
upstream to the surface promoter. Chang et al., (1987b) demonstrated 
that CAT expression was increased 20 fold in the hepatoma cell line 
HuH-7, as compared to expression using constructions lacking the HBV 
enhancer but still retaining the surface promoter. Although the system 
of Chang et el., (1987b) was artificial in respect to the native 
positions of the surface promoter and the enhancer, their results 
demonstrate that the enhancer can interact with the surface promoter 
and augment expression. However, it remains to be determined whether 
the preSi or the major surface promoter, or both, are stimulated by the 
effect of the enhancer when the elements are in their native 
conformation. 
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A glucocorticoid-responsive element has also been identified on the HBV 
genome. Tur-Kaspa at al., (1986) have shown, using a heterologous 
expression system containing the SV40 early promoter, the CAT gene and 
fragments of HBV containing the HBV enhancer and upstream sequences, 
that expression of the CAT gene In hepatoma derived and non hepatic 
derived cell lines can be enhanced above the level due to the effect of 
the enhancer by the addition of dexamethasone (Dex) to the culture 
medium. Dex augmentation of CAT expression, is due to a glucocorticoid-
responsive element which was shown to be distinct from the previously 
mapped enhancer. The glucocorticoid-responsive element was found to 
reside between nucleotides 1310 and 2016, possibly the sequence 
CCAACTTGTCCT (1635-1646) which has homology to the consensus sequence 
GNNACAANNTGTYCT found in the human growth hormone gene which functions 
as a specific glucocorticoid receptor binding site (Moore et al., 1985; 
Tur-Kaspa et al., 1986). It is not known whether the hormone-responsive 
element of the HBV genome has enhancer activity independent of the HBV 
enhancer defined above, or, whether the effect is mediated via the known 
enhancer (Tur-Kaspa at al., 1986). 
1.5.6 The X mRNA 
An X specific mRNA has been observed to be expressed in non-permissive 
mammalian cells transformed with HBV DNA. The size estimates of this 
message range from 700 to 1,000 nucleotides (Gough, 1983; Saito, et al., 
1986; Zelent et al,, 1987). The 5' ends of this mRNA were determined by 
Saito at al., (1986), at least 10 discrete 5' ends were observed 
initiating between positions 2530 and 2580. This result is unexpected, 
considering the results of Gough, (1983) who observed that a probe from 
2271-2512 hybridised to the X mRNA. On the basis of these 
hybridisation studies and size estimates of the X mRNA, Gough, (1983) 
proposed that the X mRNA promoter could be around position 2300. It is 
possible that Gough, (1983) was detecting the presence of minor X 
transcripts as with the case of the preS/surface mRNA, or that the 
different expression systems direct the synthesis of different X mRNAs. 
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The HBV enhancer region is positioned 5' to the X gene and could 
therefore also control the expression of the X mRNA. Evidence for this 
comes from a recent report of Treinin and Laub, (1987); using a 
heterologous system with the HBV sequences 2244-2635, bearing the 
enhancer element and sequences upstream of the X gene, inserted in the 
they 
A sense orientation upstream of the CAT gene, observed CAT expression in 
transfected HepSK cells. The 5' ends of the X promoter directed 
transcripts were mapped by primer extension experiments. The 5' ends 
appear to be heterologous with three major transcripts and possibly four 
minor transcripts having multiple start sites spanning nucleotides 2530 
to 2630, in agreement with Saito et al., (1986). The three major 
initiation sites were mapped to nucleotide positions 2590 ± 5, 2613 ± 5 
and 2620 ± 5 on the HBV map (fig 1.8). Deletion of HBV sequences 2250-
2396 resulted in a 12-fold reduction of CAT expression in Alexander 
cells; deletion of part of the enhancer region, from nucleotides 2244-
2497 abolished CAT expression (Treinin and Laub, 1987). The above 
experiments have been repeated using similar constructions expressed in 
HepG2 cells (Siddiqui et al., 1987). The major X mRNA 5' ends were 
mapped to positions 2535, 2560,2580 and 2590, a slight difference to the 
5' ends mapped by Treinin and Laub, (1987) possibly reflecting the large 
number of heterogeneous initiation sites directed by this promoter. 
Deletion of sequences upstream to the defined enhancer region resulted 
in a decrease of X promoter directed CAT expression (see above). The 
results of Shaul et al., (1985) indicate that the maximal enhancer effect 
is also observed when sequences upstream of position 2360 are present. 
Siddiqui et al., (1987), have shown that expression of the X promoter in 
HeLa cells was less than 10% as efficient as in HepG2 cells, Indicating a 
tissue-specific character. The above results indicate that the X gene 
promoter requires the activity of the enhancer for its function, however 
the possibility that the X promoter and the enhancer are the same 
element, or two independent overlapping elements, remains to be 
determined 
The X mRNA has only been observed by expression of HBV DNA in non-
permissive mammalian cells; it has not been observed in HBV infected 
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liver (Cattaneo et al., 1984; Will et al., 1987) nor in GSHV or WHV 
infected liver tissues (Enders et el., 1985; Moroy et al., 1985). It is 
possible that expression of this message is an artifact of the 
expression systems used, however, the results of Treinin and Laub, (1987) 
and Siddiqui et al., (1987) indicate that the X promoter/enhancer is 
active in hepatoma derived cell lines. Therefore, the X mRNA has the 
potential to be expressed in HBV infected hepatocytes. Failure to detect 
the X mRNA in infected tissues could possibly be due to the X mRNA 
being a low abundance message or that it is transiently expressed during 
HBV infection, Serological evidence indicates that the X protein is 
expressed during infection (Kay et al., 1985; Moriarty et al., 1985; 
Elfassi et al., 1986; Meyers et al., 1986), supporting the possibility of 
the X mRNA being transcribed, assuming that the S mRNA or other HBV 
mRNAs do not function as polycistronic messages with regard to the 
translation of the X protein. 
1.6 Viral ReDlication 
The direct study of HBV DNA replication has been limited due to, until 
recently, the inability to propagate the virus in tissue culture and the 
limited availability of infected tissue samples. Much of our knowledge 
of hepadnaviral replication has been drawn from the studies of the 
animal virus models. The results of these studies have been 
extrapolated to include HBV by analysis of the structural features of 
the HBV transcripts and virion DNA. 
The first insight into the replication mechanisms of the hepatitis B 
viruses came from the work of Summers and Mason, (1982). Isolated 
"immature" core particles from DHBV infected liver were shown to have 
two DNA polymerase activities; in contrast to the mature virion particles 
both plus and minus strands appeared to be labelled in vitro, in the 
presence of 32 P-dNTPs. The synthesis of the viral DNA strands was found 
to be asymmetric; the minus strand being synthesised via a reverse 
transcription activity utilising an RNA template, with the RNA being 
degraded by an RNAase H activity as it is reverse transcribed into DNA. 
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Electrophoresis and "Southern" blot analysis of total DNA from 
Hepadnavirus infected cells has shown the presence of a heterogeneous 
population of rapidly migrating species of DNA. Hybridisation with 
strand-specific probes has shown that the heterogeneous species are 
predominantly single-stranded minus strands, shorter than, and equal to, 
unit length viral DNA. These species represent intermediates and end 
products of the reverse transcription reaction, with little or no 
associated plus strand DNA (Mason et a1,,1982; Molnar-Kimber et al., 1983; 
Weiser at el., 1983; Blum et al., 1984). Summers and Mason (1982) also 
demonstrated that plus strand synthesis utilises the viral minus strand 
as a template, with the plus strand being fully annealed to its minus 
strand complement. 
The most likely candidate for the RNA pregenome is the greater than 
genomic length mRNA observed in poly(A) fractions of infected liver 
tissue (Cattaneo et al.,1984; Buscher et al., 1985; Enders at al., 1985; 
Moroy et al., 1985). The 5' ends of the pregenome/core mRNA appear to 
be heterogeneous in GSHV and WHV infected liver (Enders et al.,1985; 
Moroy at al., 1985) and possibly also in HBV infected cells (Will et al., 
1987; Yaginuma, et al., 1987b). Enders et al., (1987) have analysed GSHV 
RNAs in cytoplasmic lysates, they observed that the 2.3 kb surface mRNA 
and the two largest core mRNAs (initiating at positions 3205 ± 4 and 
3198 ± 4) appear to be associated with polyribosomes, indicating that 
they were being translated to yield the surface and the preC/core 
proteins. In contrast most of the shortest pregenomic mRNA (initiating 
at position 3227 ± 3) was found to be primarily associated with viral 
core particles. The ratio of this RNA to other viral RNAs was 100 to 1 
within the core particle, therefore, this shortest pregenomic mRNA is 
preferential packaged within the particles. The 5' end of the packaged 
pregenomic RNA of GSI{V corresponds to the major 5' ends of the 
pregenomic mRNAs observed in HBV, WHV and DHBV infected liver (Will et 
al., 1987; Moroy et al., 1985; Buscher at al., 1985). 
The smallest detectable nascent minus DNA strand (ca. 30 bases) has been 
shown to have a covalently attached protein at its 5' end, which possibly 
acts as a primer for minus strand synthesis (Molnar-Kimber et al., 1983). 
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Priming of the Hepadnavfrus minus strand synthesis has been shown to 
occur within a sequence termed DR1 (Direct Repeat 1) (fig. 1.9) present 
within the terminal redundancy ER], found on both the 5' and 3' ends of 
the pregenomic RNA (HBV sequences 3100 ± 2 to 40 ± 5) (Molnar-Kimber 
et al., 1983; Seeger et al., 1986; Will et al., 1987). The 5' end of the 
HBV minus strand has been mapped to position 3108 (Will et al., 1987), 
three nucleotides from the 5' boundary of the DR1 sequence (3106-3116). 
Termination of the minus strand synthesis could occur In response to 
some internal signal, or by exhaustion of the pregenomic template. The 
3' end of the GSHV minus strand has been mapped to position 3227, 
corresponding to the 5' end of the shortest major pregenomic RNA (Seeger 
et al., 1986). This result, if taken in conjunction with those of Enders 
et al., (1987), indicates that the reverse transcription reaction most 
likely proceeds to the end of the pregenomic RNA. Placement of the GSHV 
minus strand 5' end at 3235 and the 3' end at position 3227, would mean 
that the minus strand of the virion DNA is greater than genomic length 
with a short terminal redundancy Er] of 9 nucleotides. By analogy to the 
GSHV the minus strand of HBV would also have a terminal redundancy Er] 
of 9 nucleotides (positions 3100-3108) (Will et al., 1987). 
The 5' end of the virion plus strand appears to be homogeneous and 
probably reflects the priming site for the second strand synthesis. An 
oligoribonucleotide (17-19 mer) has been found to be attached to the 5' 
end of the Hepadnavirus plus strands. This RNA molecule most likely 
serves as a primer for plus strand synthesis, with the plus strand DNA 
sequence beginning at the 3' boundary of the viral DR2 sequence (Direct 
repeat 2) (fig. 1.9) (Lien et al., 1986; Seeger et al., 1986; Will et al., 
1987). The HBV plus strand contains a RNA primer of Ca. 17 bases, with 
the plus strand DNA sequence beginning at position 2882 ± 1, at the 3' 
end of the DR2 sequence (2872-2882) on the HBV map (Will et al., 1987). 
Lien et al., (1986) and Seeger et al., (1986) have investigated the origin 
of the RNA primer; their RNA sequencing results indicate that the 
oligoribonucleo tide is derived from the DR1 sequence, which is transposed 
to the DR2 position. The RNA primer could be derived from either DR1 
sequence represented within the 5' and 3' ER] regions of the pregenome 
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a) DR1 Sequences 
DR1 
AACTTTTTCACCTGTGC }iBV (3106-3116) 
ATCTTTTTCACCTTGC GSHV (3232-3242) 
ATCTTTTTCACCTGTG WHV (3230-3239) 
AGAATTACACCCCTCTC DHBV (2910-2921) 
I 	r 	I 
b) DR2 Sequence 
DR2 
TTCACCTCTGC HBV (2872-2882) 
TTCACCTGTGC GSRV (3010-3020) 
TCACCTGTGC WHy (3008-3017) 
TACACCCCTCTC DHBV (2852-2873) 
Figure 1.9 Nucleotide sequence (plus strand) of the hepadnavirus direct 
repeats (DR1 and DR2) showing their respective nucleotide positions. 
The DR1 sequence (underlined) showing the upstream terminal 
redundancy Cr] found on the 5' and 3' end of the minus strand DNA. 
The DR2 sequence. 
54 
RNA, however, evidence suggests that the RNA primer is derived from the 
5' end of the pregenomic RNA. Lien at al., (1986) observed that the DHBV 
RNA primer is capped, and that the 5' end of the packaged pregenomic RNA 
corresponds to the 5' end of the RNA primer (Lien at al., 1986; Seeger at 
al., 1986; Enders at al., 1987). 
A model for Hepadnavirus replication (fig. 1.10) has been proposed based 
on the above experiments (Summers and Mason, 1982; Molnar-Klmber et al., 
1983; Buscher et al., 1985; Lien at al., 1986; Seeger at al., 1986; Will et 
al., 1987). For simplicity HBV is used as an example here. Upon entry 
to a susceptible cell the virion DNA is made a fully double stranded 
covalently closed circle and transported to the nucleus of the cell 
where it is transcribed to give the viral mRNAs. The mRNAs are 
translated in the cytoplasm to generate the core, polymerase and 
possibly the surface and X proteins. In the cytoplasm the pregenome RNA 
is packaged within immature core particle along with the HBV polymerase 
protein (reverse transcriptase). Priming of the minus strand occurs in 
the terminal redundancy [R] within the sequence DR1, presumably by the 
uncharacterised protein attached to the 5' end of the minus strand. 
Initiation of the minus strand could occur at either the 5' or 3' (R] of 
the RNA template; if priming occurs at the 5' (RI, elongation of the 
minus strand would require a template switch to the 3' end of the 
pregenomic RNA. Therefore, for simplicity, priming at the 3' [R] sequence 
is shown in fig. 1.10. Initiation of reverse transcription occurs at 
position 3108 and proceeds to the end of the RNA template terminating 
at position 3100, generating a short terminal redundancy (ri of 9 
nucleotides at the 5' and 3' ends of the minus DNA strand. The RNA 
template is probably degraded by an RNAase H activity behind the growing 
point of the nascent minus strand. 
The second strand synthesis is primed by an approximately 17-base RNA 
oligomer containing the DR1 sequence and flanking upstream sequences 
extending to position 3100 ± 2 which is released from the 5' end of the 
viral RNA and transported by undefined mechanisms to the position of the 
DR2 sequence on the newly synthesised minus strand. Synthesis of the 
plus strand is initiated at position 2882 ± 1 and proceeds to the 5' end 
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of the minus strand containing the Er] sequence, with the template being 
exhausted shortly after initiation resulting in a strong stop plus 
phenomenon as observed in retrovirus replication (Smith et al., 1984; 
Champoux et al., 1984). Evidence for a strong stop plus phenomenon for 
Hepadnaviruses comes from the results of Molnar-Kimber et al., (1983), 
who have shown the existence of an actinoinycin D sensitive DNA product 
of ca. 68 nucleotides present in DHBV liver derived core particles. The 
size of this species of DNA corresponds to the size of the DHBV cohesive 
overlap, strongly suggesting that it represents a strong stop plus 
product of DHBV. Further extension of plus strand synthesis would 
require a template switch to the 3' end of the minus strand template. 
This would require the dissociation of the 9 base Er] sequence and base-
pairing of the plus strand Er'] sequence to the Er] sequence present on 
the 3' end of the minus strand, thus allowing the continued synthesis of 
the plus strand, resulting In the formation of the open circular DNA 
structure present in the Dane particle. Features that may facilitate the 
dissociation of the Er/r'] duplex, could be the presence of the 5' bound 
protein on the minus strand destabilising the DNA duplex and the high 
A+T content (hence low Tm) of the Er] sequence, a feature present in all 
the Hepadnaviral [r] sequences (fig 1.9). Conservation of the A+T rich 
sequence would be consistent with the requirement for the transfer of 
the second strand by a mechanism dependent upon local melting and 
duplex formation. 
The newly synthesised virion DNA could either be transported to the 
nucleus to complement the pool of covalently closed supercoiled 
molecules used for transcription of the viral mRNA (Tuttleman et al., 
1986), or remain within the core particles and form mature virions 
surrounded by the surface envelope. 
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Figure 1.10 Proposed model of Hepadnavirus DNA replication. 
After entry of the virus into the cell, the partially single stranded 
virion DNA is repaired, resulting in a double-stranded covalently closed 
DNA molecule present in the nucleus. The covalently closed DNA is 
transcribed to give the viral transcripts, which are then translated in 
the cytoplasm to generate the viral polypeptides. The terminally 
redundant (R), greater than genomic length pregenomic RNA is packaged 
into immature core particles containing the reverse transcriptase. The 
minus strand DNA is primed within the DR1 sequence by a protein of 
unknown origin. The minus strand DNA is elongated by reverse 
transcription with the RNA template being degraded behind the growing 
point of the minus strand DNA. Minus strand synthesis continues to the 
end of the RNA template generating a complete minus strand sequence 
with a 9 base terminal redundancy Er]. Plus strand synthesis is 
initiated from a RNA primer, probably derived from the 5' end of the 
pregenomic RNA, hybridised via the homologous DR1 (RNA plus sequence) 
and DR2 (DNA minus sequence). Initiation of plus strand DNA synthesis 
begins at the 3' boundary of the DR2 sequence and proceeds to the 5' end 
of the minus strand. The terminal redundancy Er] probably facilitates an 
intramolecular template switch which allows the plus strand to be 
elongated generating the virion open circular DNA. Before completion of 
the DNA plus strand, the immature core particle associates with the 
surface antigen envelope and is exported from the cell. Alternatively, 
the newly synthesised DNA is made fully double stranded and transported 
to the nucleus to supplement the pool of nuclear supercoiled DNA used 
for viral transcription. 
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1.7 Viral Infection and Hepatocellular Carcinoma 
Many independent lines of evidence have related the occurrence of 
hepatocellular carcinoma (HCC) to chronic hepatitis B virus infection. 
These include (1) the close geographical correlation between the 
prevalence of HBV infection and the incidence of HCC (Szmuness, 1978), 
the establishment of HCC derived cell lines containing integrated 
REV DNA (Alexander et al.,1976; Aden at al., 1979; Koike at al., 1983), 
the epidemiological study of Beasley et al., (1981) which has shown 
that there is a very strong correlation between chronic REV infection 
and the development of primary liver carcinoma and (iv) the occurrence 
of HCC in association with chronic infection of the GSHV, WHy, and DHBV 
and integrated DNA in their respective hosts (Summers at al., 1978; 
Ogston et al., 1982; Marion et al., 1984,1986; Rogler and Summers, 1984; 
Yokosuka et al., 1985; Popper et al., 1987) 
Integration of HBV DNA Into the cellular genome, while not essential for 
replication, may be an inevitable consequence of long-term infections. 
Integrated HBV DNA has been observed in acute hepatitis, asymptomatic 
carrier hepatitis, chronic hepatitis, cirrhosis and HCC (Shafritz et al., 
1981; Brechot et al., 1981,1982; Chen at al., 1982; Kam et al., 1982). In 
geographical areas, with a high prevalence of both HBsAg carriers and 
HCC, at least 80% of tumours from HBsAg-positive patients contain 
integrated HBV DNA sequences (Hino at al., 1984; Chen et al.,1986). It is 
clear that in the case of HBV-associated HCC, integrated REV DNA is 
present in a large proportion of tumours, however, it remains to be 
determined whether REV infection and integration play a direct or causal 
role in the development of neoplasia. 
The most studied hepatoma derived cell line PLC/PRFIS (Alexander et al., 
1976) has been shown to contain integrated REV DNA (Brechot et al., 
1980; Chakraborty et al., 1980; Edman et al.,1980; Marion et al., 1980b; 
Twist et al., 1981). The integrated HBV sequences have been cloned and 
analysed (Dejean at al., 1983; Koch at al., 1984b; Shaul et al., 1984; 
Ziemer et al., 1985). The studies show that at least seven fragments of 
the REV genome are integrated in PLC/PRF/5 cells. Analysis of the cloned 
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viral integrations leads to the conclusion that the viral sequences have 
been rearranged showing deletion, Inversion and duplication of the viral 
sequences following the integration event (s). There appears to be no 
pattern of site preference for integration within the viral sequences; 
with the sites of integration-recombination dispersed over the entire 
viral genome, with some preference for integration within the double 
stranded portion of the genome (Ziemer et al., 1985). This is in 
contrast to an earlier report which suggests that the integration events 
occurred within the single stranded region of the genome (Koshy et al., 
1983). The only intact HBV open reading frame is the surface gene 
(Shaul et al., 1984; Ziemer et al., 1985), which is expressed, with the 
cells secreting 22 nm HBsAg particles (MacNab et al., 1976; Marion et al., 
1979; Skelly et al., 1979). Similar results were obtained for the 
integrated HBV sequences of the cell line huSP, in which the integrated 
HBV sequences were found to rearranged, showing an inverted duplication 
of both viral and cellular sequences at the viral host junctions 
(Mizusawa et al,, 1985). 
Analysis of integrated HBV DNA from solid tumour tissue has also shown 
that integration of viral DNA tends to be random, however, there is 
evidence that a semi-specific integration may occur in the cohesive 
overlap region at the DR1 and DR2 sequences (Dejean et al., 1984; Hino et 
al., 1986; Fowler et al., 1986; Yaginuma et al., 1987a). Evidence for this 
comes from the results of Yaginuma et al., (1987a) in which one of their 
clones, isolated from a liver tumour, contained a terminal redundancy at 
both viral-host junctions, corresponding to the terminal redundancy Er] 
the 
found on the virion minus strand. This indicates thatAHBV DNA 
integration event probably occurred by recombination via the free ends 
of the viral minus strand. 
Although HBV may integrate via a specific viral site(s), the available 
evidence suggests that integration into the cellular genome occurs at 
random, In some cases associated with deletion, inversion and 
translocation of the cellular sequences (Mizusawa et al., 1985; Rogler et 
al., 1985; Yaginuma et al., 1985,1987a; Hino et al., 1986). Recent reports 
suggest that integration into the cellular sequences may not be totally 
random; highly repetitive sequences have been noted in the cellular 
flanking regions of the Integrations. It has been proposed that 
chromosomal satellite and mini-satellite repetitive sequences may be 
"hot spots" for the integration of 11EV DNA (Shaul et el., 1984,1986b; 
Fowler et al., 1986; Berger and Shaul, 1987). 
The mechanism by which HBV may Induce the development of malignant 
transformation is not known. One mechanism by which some retroviruses 
cause neoplastic changes is the expression of viral oncogenes, originally 
of cellular origin, which disrupt the normal regulation of cell growth. 
Could a similar mechanism be applied to 11EV? Gough and Murray, (1982) 
transfected Rat2 cells with cloned HBV DNA; the resultant can line 
Rat2/130.4/TK4 contains complete integrated copies of the 11EV genome, 
with all the known viral genes transcribed and expressed (Gough and 
Murray, 1982; Gough 1983; Pugh et al., 1986). Gough and Murray, (1982) 
could not detect any phenotypic transformation of the cell line 
Rat2/130.4/TK4, favouring the notion that HBV does not encode an 
oncogene. However, the results of the above studies should be viewed 
with caution since the Rat2 cell line is fibroblastoid; the oncogenic 
functions of HBV may be tissue specific and only be active in infected 
hepa tocy tes. 
the 
No function of the viral life cycle has been associated with 'product of 
the X gene. Therefore, could the product of the X gene have oncogenic 
functions? Miller and Robinson, (1986) have evaluated the codon usage 
preference of the hepadnaviral genes. Like retroviral oncogenes, the X 
gene codon usage preference is similar to that of the genes of 
eukaryotic cells, with the eukaryotic cellular codon usage preference 
extending upstream of the viral enhancer. Conversely, the other HBV 
genes clearly share the codon preference of viral genes. Therefore, 
Miller and Robinson, (1986) propose that both the HBV enhancer and X 
gene have been acquired from a cellular origin. Miller and Robinson, 
(1986) could not detect any significant amino acid homology between the 
REV X gene predicted amino acid sequence, and known retroviral oncogenes 
or cellular proteins. They propose that the REV X gene could be 
analogous to the trans-activating proteins of some retroviruses. 
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Expression of the trans-activating proteins could result in cellular 
transformation by activation of cellular genes, with tumour formation 
after a long latent period. The recent results of Wollersheim and 
Hofschneider, (1987) suggest that the HBV X protein may indeed have 
trans-activation  properties, supporting the proposal of Miller and 
Robinson, (1986), However, it has not been shown that the trans-
activation properties of the HBV X protein are capable of directing the 
development of malignant transformation. 
A second mechanism, whereby viruses cause neoplastic transformation, is 
"insertional mutagenesis". Disruption of normal transcriptional control 
may result from deletion, chromosomal translocation or integration of 
the viral genome, resulting in the introduction of a promoter or 
enhancer sequence near cellular proto-oncogenes, as has been show for 
other viruses (Hayward et al., 1981; Klein, 1983). Analysis of cellular 
flanking sequences of integrated HBV DNA derived from cell lines and 
human tumour tissues has in most cases failed to detect the presence of 
any closely linked cellular oncogenes (Dejean et al., 1983; Koch et al., 
1984a; Mizusawa et al., 1985). Only in one report has an oncogene-like 
sequence been found in the cellular flanking sequences. De.jean et al., 
(1986) report an HBV integration event that has occurred within a human 
sequence that shares a degree of amino acid homology to the oncogene 
v-erb-A. Dejean et al., (1986) propose that expression from the HBV 
surface promoter could result in the synthesis of a preS-v-erb-A "like" 
fusion protein possibly causing cell transformation. The general absence 
of oncogenes in close proximity to the integrated HBV DNA does not 
exclude the possibility of integrated viral sequences activating or 
augmenting expression of proto-oncogenes placed more distally due to the 
effect of the HBV enhancer element. 
Translocation and deletion of cellular sequences, due to HBV integration 
(Rogler et al., 1985; Hino et al., 1986), has not been directly shown to 
result in malignant transformation. However, using one of the HBV-like 
animal models Moroy et al., (1986) have shown that integrated woodchuck 
hepatitis virus DNA was associated with enhanced expression and allelic 
alterations of the c-myc oncogene in three woodchuck hepetocellular 
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carcinomas. The cloning and analysis of the break-point region of the 
altered c-myc gene has shown that the c-myc gene was truncated and 
joined to cellular sequences of unknown function. WHV DNA was not 
Integrated near the c-myc coding exons, excluding the direct role of 
virus promoters (or possible enhancer) in c-myc activation suggesting 
that chromosomal translocation has resulted in activation of c-myc 
expression. 
The aetiology of the development of HCC could be multifactorial and 
REV infection and integration may play only a casual role in the 
development of 11CC. If the development of HCC is multifactorial, REV 
infected cells, or cells containing integrated REV DNA may be "partially" 
transformed and have an increased probability of progressing to 
malignant transformation in association with other environmental factors. 
Integrated HBV DNA in MCCs may represent merely a "snap-shot" of a 
previous integration event, which has become detectable through the 
clonal expansion of the subsequently transformed cell. Whatever the 
molecular basis of the involvement of HB%J in the development of primary 
liver cancer, it is clear that a period of persistent viral infection, 
along with chronic liver disease, predisposes to the development of 
neoplasia, 
1,8 The Aims of this Thesis 
When this project was initiated in October 1982 very little was known 
about the molecular biology of the hepatitis B virus. Evidence that REV 
to 
infection predisposes   the development of hepatocellular carcinoma was 
available (Szmuness, 1978; Beasley et al,, 1981). The epidemiological 
studies of Beasley et al., (1981) indicated a correlation between chronic 
hepatitis B virus infection and the development of hepatocellular 
carcinoma. At this time, at least two hepatoma derived cell lines were 
known to contain integrated REV DNA and express the HBsAg (Aden et al., 
1979; MacNab et al., 1976). In addition, the study of REV infected liver 
samples indicated that long-term infection with REV is associated with 
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integration of virus specific sequences into cellular DNA (Brechot et al., 
1981; Shafritzt et al., 1981; Chen et al., 1982; Kern et al., 1982). The 
above studies indicate that there is a strong correlation between 
persistent viral infection, HBV associated cirrhosis, viral DNA 
integration and the development of hepatocellular carcinoma. 
From the studies of Gough and Murray, (1982), In which they constructed 
a series of rodent cell lines containing integrated HBV DNA, we knew 
that cells, other than infected hepatocytes, could express the known 
viral antigens. A later study of Gough, (1983) reported that the 
transfected rodent cells expressed four viral specific transcripts. The 
availability of the cell lines of Gough and MurrayI (1982) offered the 
opportunity to investigate if the HBV genomic DNA required specific virat 
or cellular sequences for integration. The aim of this project was to 
generate genomic libraries, using the chromosomal DNA of the transfected 
rodent cells of Gough and Murray, (1982). The chromosomal DNA was 
cloned into bacteriophage lambda vectors, and clones containing 
Integrated HBV DNA sequences were isolated. The structure of the 
integrated HBV sequences was determined and the integration sites 
mapped. 
Many of the aims of this thesis have been superseded by the publication 
of detailed analyses of the natural integration patterns of HBV 
sequences, found in hepatocellular carcinoma derived tissue culture cells 
and solid tumour tissues CZiemer et al., 1985; Mizusewa et al., 1985; 
Dejean et al., 1984,1986; Rogler et al., 1985; Nina et al., 1986). The 
above studies Indicate that HBV DNA integration into the host 
chromosomes is essentially random, with respect to both viral and 
by 
cellular sequences. The results obtained studying the HBV integration 
pattern of the transfected rodent cells, is, also consistent with random 
integration of HBV sequences with the integration sites being dispersed 
over the HBV genome. 
Over the last five years considerable advances have been made concerning 
our understanding of the molecular biology of HBV. The nucleot 
and 
sequencesof all the major subtypes of HBV have been determined, this has 
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allowed the identification of the arrangement of the gene sequences and 
the tentative identification of potential control signals for 
transcription. The initiation and polyadenylation sites of the major 
viral transcripts have been mapped, however, apart from the putative 
promoter sequence proposed by Cattaneo et al., (1983b), no detailed 
examination of the viral promoters has been reported. 
As an extension to the study oF the HBV integration pattern, the 
isolated genomic clones were examined for their ability to act as 
templates for the viral specific transcripts observed by Gough, (1983). 
One of the genomic clones was examined for its ability to act as a 
template for transcription of the major surface mRNA. The results 
obtained for in vivo expression of HBsAg indicate that the promoter 
sequences postulated by Cattaneo et al., (1983b), are transcriptionally 
active in the absence of the preSi "TATA" box promoter (Rail et al., 
1983). The nucleotide sequence of the major surface antigen promoter 
was found to be contained, at or between, the HBV130 nucleotide 
positions 1098 to 1264. The major surface antigen promoter sequences 
correspond to a region of highly conserved nucleotide sequences, found 
in the surface antigen promoter regions of all the mammalian 
Hepadnaviruses. The results of transient HBsAg expression assays 
also suggest: 	that the NF-1 binding site observed by Shaul et al., 
(1986a) is not essenf,L( 	for expression of the native MSV 
surface antigen mRNA. 
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Chapter Two 
Materials and Methods 
2.1 Bacterial Strains 
All Escherlchla coil strains used are listed below: 
5K 	hsoR derivative of C600. F, thu 1 thri, ieuB6, sup€44, 
tonA21, iacYl, hscR(rk ,mk 4 ) (Hubacek and Glover, 1970) 
5K/R245 	5K containing the plasmid R245 encoding Tcr, Eco Ru. 
This study 
BHB2688 	N205 recA (Ximm434 , clts, L, red3, Eam4, Sam7)/X 
(Hohn, 1979) 
BHB2690 	N205 recA (X1mm434 , clts, b2, red3, DamlS, Sam7)/X 
(Hohn, 1979) 
ED8654 	sujE44, supF58, hs&514, trpR55, iacYl (Barck et al., 1976) 
GM48 	F, dam3, dcm6, gal, ar-a, lac, thr-, leu, thi, tonA, tsx 
(Marinus, 1973) 
HB101 	F, hsS20(r9 ,m9 ), recA13, ara14, proA2, lacYl, gaiK2, 
rp.20, xylS, mtil, sup€44,>c 
(Boyer and Roulland-Dussoix, 1969) 
JM83 	ar-a, £(lac proA,B), rp, 80, ladZ AM15 
(Vieira and Messing, 1982) 
NM145 	R245,Tc', Eco Ru 	N. E. Murray, personal communication) 
NM514 	hs&, lyc7 (Arber et al., 1983) 
NM522 	hsd5 derivative of 71-18. hsdA5, L(iac pro) 
IF' iacZ AM15, 	(Gough and Murray, 1983) 
Q359 	P2 lysogen derivative of Q358. hs(rk,mk'), sujF, cp8O', 
(P2). (Karn et al., 1980) 
2.2 Plasrnids and Bacteriophages 
E. coil plasmids and bacteriophages used are listed below: 
pDWM1 	Contains the mouse hypoxanthine phosphoribosyltransf erase 
(HPRT) mini-gene cloned In pUC8 
(Melton et al., 1986) 
pHBV130 Tcr This plasmid contains a greater than genomic length HBV 
genome, approximately 38 kb (Ca. nucleotides 850±50 to 
1460±501 inserted into the Pst I site of pBR322 by oligo 
dG-dC tailing. (Gough and Murray, 1982) 
pHBV1304 Tc' 	This plasmid contains four tandem copies of unit 
length }{BV DNA cloned between two copies of the vector 
pBR322. (Gough and Murray, 1982) 
pUC8 	E. coil cloning vehicle containing a portion of the lac Z gene 
(-galactosidase) and multiple cloning sites. (Vieira and 
Messing, 1982) 
XEMBL4 	X b189, 'sbIX3(R ,B ,S- red,ganv,PL , trçE-S,B ,R]sbIX4', KH54, chi, 
n1n5 	Frischauf et al., 1983) 
XCh34 	X 'srIXliacCR,Ss,Xb,H,B-E. coil stuffer 34 (16•2 kb) 
-B,H,Xb,Ss,R1srIX3', gam, A WL113, KH54, n1ri5 
(Loenen and Blattner, 1983) 
)J1M1149 	b538, 1mm 43 ' (Eco RI, Hind III) (Murray, 1983) 
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X,. 	v2, vi, v3 (Ordal and Kaiser, 1973) 
M13mp18/ E. coil M13 based vectors used for DNA sequencing templates, 
M13mp19 these vectors contain a portion of the lac Z gene 
(-galac tosidase) and multiple cloning sites 
Norrander et al., 1983; Yanisch-Perron et al., 1985). 
2.3 Suppliers of Laboratory Reagents 
Restriction eridonucleases were purchased from Amersham International 
Ltd., Boehringer Mannheim GmbH Biochemica, Bethesda Research Laboratories 
Inc., New England Biolabs Inc. and Pharmacia Fine Chemicals AB. E. coli 
DNA polymerase I (holoenzyme and Kienow fragment) were purchased from 
Boehringer Mannheim GmbH Blochemica. All enzymic reactions were 
performed in accordance with the specifications of the manufacturer, 
except where otherwise noted. 
Deoxnucleo tide triphosphates were purchased from Bethesda Research 
Laboratories Inc. Dideoxynucleo tide triphosphates were purchased from PL 
Biochemicals Inc. All radiocheinicals were purchased from Amersham 
International Ltd. 
Standard laboratory reagents were purchased from BDH Chemicals Ltd., 
Boehringer Mannheim GmbH Biochemica, Fisons Chemicals and Sigma Chemical 
Co., except where otherwise noted. 
2.4 Bacteriological Media 
All media used was sterilised by autoclaving. Where appropriate, 
antibiotics were added to molten agar and liquid media to final 
concentrations: Ampicillin 100 g/ml, Tetracycline 25 j&g/ml. 
L broth: 
Difco Bacto Tryptone, 10 g; Difco Bacto yeast extract, 5 g; NaCl, 5 g; per 
litre adjusted to pH 7-2. 
L agar: 
Difco Bacto Tryptone, 10 g; Difco Bacto yeast extract, 5 g; NaCl, 10 g; 
Difco agar, 15 g; per litre adjusted to pH 72. 
BBL agar: 
Baltimore Biological Laboratories trypticase, 10 g; NaCl, 5 g; Difco agar, 
10 g; per litre (pH unaltered). 
BBL top agar: 
As for BBL agar, but only 65 g Difco agar per litre. 
BBL top agarose: 
As for BBL agar, but containing 65 g agarose (Miles) per litre replacing 
the Difco agar. 
Spizizen salts (50: 
NH4)SO4 , 2 g; K2HPO4, 14 g; KH2HP0II , 6 g; tn-sodium citrate, 1 g; 
M8SO4 , 0•2 g; per litre. 
Minimal medium: 
Difco Bacto agar, 15 g; 200 ml Spizizen salts (50; 10 ml 20% (w/v) 
glucose; 0125 ml 5 mg/nil Vitamin Bi; per litre. 
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Phage buffer: 
KH,PO4 , 3 g; Na2HPO4 (anhydrous), 7 g; NaCl, 5 8; 10 ml 01 L!I M8SO4 ; 
10 ml 0•01 M CaCi; 1 ml 1% (w/v) gelatin solution; per litre. 
2.5 Isolation of Plasmid and Bacteriophage Lambda DNA 
2.5.1 Large Scale Isolation of Plasmid DNA 
The method used to isolate piasmid DNA was a modification of the method 
described by Clewell and Helinski, (1972). An overnight culture of a 
plasmid carrying E. coil strain was diluted 100-fold into 500 ml of 
L broth (containing 1% glucose and antibiotics as required) and shaken 
at 37°C to an optical density at 650 nm of 0'8-1•0, at which time solid 
chloramphenicol was added to a final concentration of 150 j&g/ml and the 
culture shaken for a further 12 hours at 37°C. The cells were harvested 
by centrifugation and resuspended in 5 ml sucrose mix 125% (w/v) 
sucrose, 50 mM Tris-HC1 pH 86, 10 mi EDTA]. After incubation for 5 
minutes on ice with 5 mg lysozyme, 1 •0 ml of 0'5 M EDTA was added and 
the cells incubated for a further 10 minutes on ice. After this 
incubation, 13 ml of lytic mix 11% (v/v) Triton X-100, 50 mM Tris-HC1 
pH 8•0, 62.5 mM EDTA] was added slowly and the suspension mixed by 
gentle swirling. The lysed cell suspension was left on ice for 10 
minutes and then centrifuged at 15,000 rpm for 10 minutes at 4°C in a 
Sorvall ss34 fixed angle rotor. The cleared supernatant was recovered 
and the volume measured. The volume of the supernatant was adjusted to 
25 ml; 2375 g CsCl and 25 ml of 5 mg/ml ethidium bromide were added 
to the solution. The plasmid DNA was banded by equilibrium 
centrifugation using a Sorvail Ti50 rotor at 38,000 rpm for 48-72 hours 
at 20°C. The CsCi gradient thus formed was viewed under long 
wavelength UV light and the plasmid DNA removed through the side of the 
tube using a 21 gauge syringe. The ethidium bromide was removed by 
extraction with ice-cold butan-1-ol and the aqueous phase dialysed 
overnight against 10 mM Tris-HC1 pH 80, 1 mfj EDTA to remove the CsC1 
salt. 
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2.5.2 Alkaline-SDS Preparation of Plasmid DNA 
The method used was essentially that of Birnhoim and Doly, (1979). An 
overnight culture of E. coil was used to fill a 1-5 ml microcentrifuge 
tube. The cells were recovered by centrifugation for 5 minutes and the 
supernatant discarded. The cell pellet was resuspended in 100 jil of 
lysis solution 12 mg/ml lysozyme, 25 mM Tris-HC1 pH 80, 10 mM EDTA, 
1% (w/v) glucose] and left on Ice for 5 minutes. To the suspension was 
added 200 il of alkaline-SDS solution 10-2 N NaOH, 1% (w/v) sodium 
dodecyl sulphate] and the suspension left on ice for 5 minutes. To the 
lysed cell suspension was added 200 pl of 3 L sodium acetate pH 52, 
the suspension was mixed and left on ice for 30 minutes. The lysed 
cells were centrifuged for 10 minutes at 4C and the supernatant 
transferred to a fresh microcentrifuge tube. The tube was then filled 
with room temperature ethanol, mixed and centrifuged for 5 minutes at 
room temperature. The supernatant was discarded and the pellet 
resuspended in 100 il of 0.1 M sodium acetate pH 5•2, followed by the 
addition of 250 jil cold ethanol; the solution was mixed and left 
at -70C for 15 minutes. The solution was then centrifuged for 10 
minutes at 4C and the supernatant discarded, the pellet dried under 
vacuum and redissolved in 50 pJ. 10 mM Tris-HC1 pH 80, 1 mj EDTA. The 
plasmid DNA recovered can be digested with most restriction 
endonucleases, half of this material (ca. 0•5 pg DNA) can be visualised 
on an agarose gel by ethidium bromide staining. 
2.5.3 Preparation of Bacteriophage Lambda DNA 
The method used to isolate bacteriophage lambda DNA was a modification 
of the methods described by Thomas and Abelson (1966) and Yamamoto et 
al., (1970). A fresh overnight culture of E. coil was diluted ten-fold 
into 200 ml of L broth, supplemented with 10 mK MgS0 1., in a 2 litre 
flask and shaken at 37C. When the cells had grown to 0D 660 of 05, 
bacteriophage X was added to the culture at 4-6x10'° phage plaque 
forming units and the cells again shaken at 37C. The optical density 
of the culture increased to ca. 0D60 2•0 then decreased to Ca. 05. 
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When the optical density reached a minimum value, 0•5 ml of chloroform 
was added and the cells shaken for a further 10 minutes. At this time 
8 g NaCl, DNAase and RNAase (to a final concentration of 1 jig/ml) were 
added. The culture was then left for 1 hour at room temperature. The 
cell., debris was removed by centrifugation for 10 minutes at 10,000 rpm 
In a Sorvall GSA rotor, and the supernatant recovered. Next 20 g of 
polyethylene glycol 6000 (PEG 6000) was dissolved in the phage 
suspension, and the suspension left at 4°C overnight. The phage-PEG 
pellet was collected by centrifugation in a Sorvall GSA rotor for 
10 minutes at 10,000 rpm. The supernatant was discarded and the phage 
pellet resuspended in 5 ml of phage buffer. An equal volume of CHC1 3 
was added to the phage suspension in a centrifuge tube and mixed 
thoroughly to form a white emulsion. The PEG-CHCl was separated from 
the phage suspension by centrifugation for 15 minutes at 5,000 rpm in a 
Sorvall ss34 rotor and the cleared aqueous phase recovered. 
The bacteriophage suspension was carefully layered onto a preformed 
cesium chloride step gradient, which consisted of 15 ml of 17 g/ml, 
2 ml of 1-5 g/ml and 2 ml of 1-3 g/ml cesium chloride made up in phage 
buffer, in a 14 ml MSE ultracentrifuge tube. The phage particles were 
banded in the gradient by centrifugation at 38,000 rpm for 2 hours at 
20°C in a MSE 6x14 ml swing out rotor. The bluish band of phage 
particles present between the 1-3 and 1-5 g/inl cesium chloride steps was 
removed by withdrawal through the side of the tube using a 21 gauge needle. 
The recovered phage suspension was then mixed with enough 
1-5 g/ml cesium chloride to fill a 5 ml MSE ultracentrifuge tube. The 
page suspension was re-centrifuged at 33,000 rpm for 24 hours at 4°C in 
a MSE 6x5 ml swing out rotor. The phage band was removed as described 
above. The cesium chloride was removed from the phage particles by 
dialysis at 4°C for 1 hour against a 1000-fold volume of 10 mM Tris-HC1 
pH 80, 1 mj EDTA (TE). The dialysis buffer was replaced and dialysis 
continued for an additional hour. The phage suspension was extracted 
twice with an equal volume of phenol, equilibrated in TE. A third 
extraction was performed using an equal volume of equilibrated 
phenol:chloroform (1:1 ratio). The- phage DNA solution was further 
dialysed against TE to remove the organic solvents, using several 
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changes of TE over a 24 hour period. The concentration of the phage 
DNA was measured at 0D 60 . with OD,,., of 10 being equivalent to 
50US/MI. 
2.6 General Nucleic Acid Manipulation Methods 
2.6.1 Phenol Extraction of Nucleic Acid Solutions 
Proteins present in DNA and RNA solutions were removed by extraction 
with phenol (re-distilled and equilibrated with 1 M Tris-HCI pH 80). An 
equal volume of phenol was mixed with the nucleic acid solution, and the 
two phases mixed by gentle inversion. The phases were separated by 
centrifugation in either a microcentrifuge or in an MSE bench centrifuge 
at 3,000 rpm for 5 minutes, depending upon the volume. The upper 
aqueous phase was recovered and re-extracted with an equal volume of 
phenol:chloro form: isoamyl alcohol (50:50:1). The phases were separated by 
centrifugation and the aqueous phase recovered. Trace amounts of the 
organic solvents present in the aqueous phase were removed by either 
1) extraction with an equal volume of ice-cold ether, followed by 
precipitation of nucleic acids with ethanol (see below), or ii) dialysis 
of the aqueous phase against several changes of a 1000-fold volume of 
10 mfj Tris-HC1 pH 75, 1 mM EDTA. 
2.6.2 Precipitation of Nucleic Acids 
a) Ethanol precipitation 
Nucleic acids were precipitated from aqueous solutions by the addition 
of one tenth volume of 3 M sodium acetate pH 52, and 2•5 volumes of 
absolute ethanol. After incubation at -70C for 15 minutes or -20C 
overnight, nucleic acids were sedimented by centrifugation in a 
microcentrifuge for 10 minutes or a Sorvall ss34 or HB4 rotor at 4C for 
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10 minutes at 10,000 rpm. The supernatant was discarded, the pellet 
dried under vacuum and redissolved in 10 mM Tris-HC1 pH 75, 1 mM EDTA. 
b) Isopropanol precipitation 
Nucleic acids were precipitated from aqueous solutions by the addition 
of one tenth volume of 3 M sodium acetate pH 60, and 06 volumes of 
isopropanol. After incubation at 0C for 15 minutes the nucleic acids 
were sedimented by centrifugation in a microcentrifuge for 10 minutes. 
The supernatant was discarded, the pellet dried under vacuum and 
redissolved in 10 mM Tris-HC1 pH 75, 1 mM EDTA. 
2.6.3 In Vitro Enzymic Reactions 
Digestion of DNA with restriction endonucleases 
DNA was digested with three to ten fold excess of restriction 
endonuclease in 1-5 ml inicrocentrifuge tubes for 1 hour using conditions 
recommended by the manufacturer. Digestions were terminated by heating 
at 65C for 10 minutes and/or extraction with an equal volume of 
equilibrated phenol. 
Modification of recessed 34  termini of DNA 
The 3' recessed termini created by digestion of DNA with some 
restriction enzymes, were rendered blunt ended by the action of E. coli 
DNA polymerase I (Klenow fragment). The reactions were carried out 
using 1-10 j&g of DNA, with 1 unit of Kienow enzyme per 1 p.g DNA, in 
10 mM Tris-HC1 pH 80, 10 mM MgCl, and 0'25 mM each of dATP, dCTP, dGTP 
and dTTP at room temperature for 1 hour. 
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C) In vitro recombination of DNA fragments 
1) DNA fragments with 5' or 3' cohesive ends 
The DNA fragments were ligated using T4 DNA ligase under the following 
conditions; linearised vector and insert DNA were mixed in a molar ratio 
of 1:3 to a final concentration of 5-30jig/ml. The DNA fragments were 
covalently joined by the action of T4 DNA ligase at 1 unit ligase per 
1 jg DNA, in a buffer consisting of 066 M Tris-HC1 pH 72, 10 mM EDTA, 
0.1 M MgC].2 , 0.1 ( dithiothreitol, 1 mM ATP; at 10-15C for 12 hours. 
ii) DNA fragments with blunt ends 
Reactions were carried out in a similar fashion to those with DNA 
fragments bearing cohesive ends, however, higher concentrations of DNA 
(200-500 jig/ml), T4 DNA ligase (Ca. 10 units/)Lg) and ATP (10 mM) were 
used. 
2.7 Sucrose Gradient Fractionation of DNA Fragments 
Restriction endonuclease generated DNA fragments were fractionated on 
pre-formed continuous 12 ml sucrose gradients 110% (w/v) to 40 % (w/v) 
sucrose, dissolved in 20 mM Tris-HC1 pH 80, 5 mM EDTA] prepared in 
14 ml MSE ultracentrifuge tubes. The DNA samples (dissolved in 10 mM 
Tris-HC1 pH 8•0, 1 mM EDTA) were carefully layered onto the surface of 
the sucrose gradients and centrifuged at 30,000 rpm for 16 hours in a 
6 x 14 ml MSE swing-out rotor. Five drop fractions were collected in 
microcentrifuge tubes by puncturing the bottom of the ultracentrifuge 
tubes. Fractions were analysed by agarose gel electrophoresis (see 
below). Fractions containing the desired DNA fragments were pooled and 
dialysed against several changes of 10 mM Tris-HC1 pH 80, 1 mm EDTA. 
The DNA was recovered by ethanol precipitation and resuspended in 10 mM 
Tris-HC1 pH 80, 1 mM EDTA. 
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2.8 Gel Electrophoresis of Nucleic Acids 
2.8.1 Agarose Gel Electrophoresis of DNA 
DNA was size fractionated on submerged horizontal agarose slab gels. 
The agarose gels consisted of 0•7% to 1.0% (w/v) agarose (Miles), 
containing 0•5 jig/ml ethidium bromide in Tris-borate buffer (TBE) 189 mM 
Tris borate p11 8'2, 89 mM HOBO,,, 2 mM EDTA]. Prior to loading the DNA 
samples, 0•25 volumes of DNA sample buffer (5x) ( 12.5% (w/v) Ficoll, 
50 mM.  EDTA, 0125% (w/v) bromophenol blue, 0125% (w/v) xylfne cyanol FF; 
in (50 TBE] were added and the samples heated to 65C for 10 minutes. 
Electrophoresis was carried out in TBE buffer, between 5-20 volts/cm 
until the required separation was achieved. Migration of DNA fragments 
was monitored by the use of a hand held UV-illuminator (254 rim) and 
observing the migration of the DNA bands due to the fluorescence of the 
ethidium bromide stain. DNA size standards used were restriction 
digests of Xc1857, 1 kb and 123 base pair ladders (Bethesda Research 
Laboratories). 
2.8.2 Gel Photography 
Nucleic acids were visualised in ethidium bromide stained gels using a 
Cromato-vue UV-transilluminator (302 rim wavelength). Photographs of 
gels were taken on a Kodak specialist 3 camera containing a red (Al) 
filter at f/45 for 20 seconds using Ilford HP5 film (5x4 inch sheet 
film). The photographic films were developed at room temperature in 
Ilford microphen developer (5 minutes), transferred to 3% acetic acid 
(30 seconds), fixed in Hypam fixer (5 minutes), washed in cold water for 
15 to 20 minutes and air dried. Relative mobility of DNA fragments were 
measured directly from the negatives and the sizes of the DNA fragments 
determined relative to size standards, using the relationship of the 
log10 molecular size verses the relative mobility. 
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2.8.3 Electrophoresis of RNA on Agarose Gels 
RNA was size fractionated by electrophoresis through gels containing 
formaldehyde (Lehrach et al., 1977). Agarose gels were prepared as 
follows: 1-3% (w/v) agarose gels were prepared by melting the required 
amount of agarose (Miles) in distilled H0 and cooling the solution to 
60C. One tenth the volume of 1OxMOPS buffer 10.2 M 3-(N-Morpholino) 
propane-sulphonic acid (MOPS), 50 mM sodium acetate pH 70, 10 mj EDTA] 
was added followed by formaldehyde stock solution (123 j) to a final 
concentration of 2-2 M. The molten solution was then poured into the 
gel formers. The RNA samples were prepared in dH 20; an equal volume of 
sample buffer [2xMOPS buffer, 50% (v/v) formamlde, 35 j formaldehyde] 
was added and the samples denatured by heating at 65 'C for 5 minutes, 
then chilled on Ice. Next 025 volumes of loading buffer 130% FIcoll 
type 400, 0.1 j EDTA, 0.1 mg/ml bromophenol blue] were added and the 
samples Immediately loaded onto the prepared gel. The gels were run 
submerged In IxMOPS buffer at 5-20 volts/cm until the desired migration 
was achieved. Under these conditions the bromophenol blue dye migrated 
slightly slower than tRNA. Molecular weight standards used were as for 
DNA agarose gels, except the standard samples were treated in the same 
fashion as the RNA samples. Mouse 28S rRNA and 18S rRNA were also used 
as molecular weight standards. 
2.8.4 Electrophoresis of RNA on Polyacrylamide Gels 
Small RNAs were separated using agarose/acrylamide composite gels 
containing 2-2 ?.( formaldehyde. These gels consisted of 35% (w/v) to 
5% (w/v) polyacrylamide and 1-0% (w/v) agarose for textile strength', 
using the buffer conditions described above. Acrylamide stock solution 
was 30% (w/v) acrylamide 128•5% <w/v) acrylamide, 1-5% (w/v) NN'-
methylene bisacrylamide]. Gels were prepared in vertical gel plates 
using, for 100 ml gel volume: 10 g agarose (Miles) in 1120 (to a final 
volume of 100 ml) boiled and then cooled to 60'C, acrylamide stock 
solution to desired final concentration, 179 ml of 12•3 M formaldehyde, 
10 ml 1OxMOPS buffer, 21 ml of 30% (w/v) ammonium persulphate and 
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30 l TEMED (N,NNS.NL tetramethyle thylenediamine). Electrophoresis was 
carried out in MOPS buffer as described above. 
2.8.5 Staining of Nucleic Acids Separated In Gels Containing Formaldehyde 
After electrophoresis tracks containing standard marker nucleic acids 
were removed and stained in either of the following ways: 
a) Ethidium bromide staining 
Gels were stained with ethidium bromide (5 g/ml) in 0'1 M ammonium 
acetate at room temperature for 1 hour and destained for 2 hours in 
01 M ammonium acetate. Stained nucleic acids were visualised and 
photographed as described above for DNA agarose gels. 
ID.) Silver staining of nucleic acids 
The method used to silver stain nucleic acids was a modification of the 
method of Herring et al., (1982). Gels were equilibrated in 0•025 M 
sodium phosphate pH 65, for 1 hour. The nucleic acids were fixed in 
the gel by immersion in 10% (v/v) ethanol, 05% (v/v) acetic acid for 15 
minutes. The gels were impregnated with silver nitrate by immersion in 
11-2 mM AgNO3  for 20 minutes with gentle agitation and then rinsed in 
dHO. The gels were immersed in 0•75 M NaOH, 90 mM formaldehyde and 
the stained nucleic acids allowed to develop for 10 minutes. The 
reaction was stopped by immersing the gel in 70 mM Na 2CO3 for 30 
minutes. The silver stained gels were stored in sealed plastic bags in 
the dark. 
2.8.6 Recovery of DNA from Low Melting-Temperature Agarose Gels 
DNA fragments were recovered from low melting-temperature agarose gels 
essentially as described by Wieslander, (1979). DNA fragments were 
separated by electrophoresis in agarose gels as described above. 
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However, low melting-temperature agarose (Sea Plaque agarose, FMC 
BioProducts) was used, replacing the normal agarose and the 
electrophoresis carried out at 4C. The ethidium bromide stained DNA 
was visualised using a hand held UV-lamp (254 nm). The desired DNA 
band(s) was excised from the gel using a sterile scalpel and placed in a 
1-5 ml microcentrifuge tube or a 50 ml screw cap Falcon tube, depending 
upon the volume of gel recovered. An equal volume of 10 mj Tris-HC1 
pH 7.5, 1 mM EDTA was added to the gel and the tube placed at 65C 
until the agarose melted. An equal volume of room temperature 
equilibrated phenol was added to the DNA solution and the phases mixed 
by gentle inversion to form a white emulsion. The phases were separated 
by centrifugation for 10 minutes, either in a microcentrifuge or in a 
MSE bench centrifuge, at 3000 rpm; a dense white layer of agarose 
formed at the interface. The upper aqueous phase was recovered and re-
extracted with phenol and then extracted with phenol:chloroform:isoamyl 
alcohol (50:50:1). The aqueous phase was recovered and extracted with 
butan-1-ol to reduce the volume to ca. 100 to 200 jil (and to remove 
trace amounts of phenol). The DNA was recovered by ethanol 
precipitation, the pellet was dried under vacuum and resuspended In 
10 mM Tris-HC1 pH 7•5, 1 mM EDTA to the desired concentration. DNA 
prepared in this manner can be used for digestion with restriction 
endonucleases, ligation and radio-active labelling. 
2.9 Radio-active Labelling of DNA 
2.9.1 Nick Translation 
The method of nick translation (Maniatis et al., 1975; Rigby et al., 1977) 
was used to label DNA with [cx- 2 P]dNTP. A typical reaction contained 0.5 
to 1.0 pg DNA in a volume of 20 p1. The DNA was labelled using 
2x10 pg DNAase I and 0'5 units of E. coil DNA polymerase I in a 
solution of 50 mM Tris-HC1 pH 7.5, 10 mM MgCl2 , 80 J41 dATP, 80 pM dGTP, 
80 p[j dTTP, 35 mM -mercaptoethanol, 5 pg/mi bovine serum albumin and 
10 to 50 pCi of [a- 32 P]dCTP (10 mCi/ml; 3,000 Ci/mmol; Amersham). The 
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labelling reaction was carried out at 15°C for 90 minutes. The reaction 
was terminated by increasing the volume to 200 p.1 with 20 mM NaCl, 
20 m!j Tris-HC1 pH 7•5, 2 mM EDTA, 025% (w/v) sodium dodecyl sulphate, 
containing 50 p.g/ml tRNA and then extracted with equilibrated phenol. 
The products of the reaction were separated from unincorporated 
[a- 3 2 P]dCTP by Sephadex G-50 column chromatography. 
2.9.2 Random Priming Using Hexadeoxyribonucleo tide Primers 
Random hexadeoxyribonucleo tide primers (PL Biochemicals) were used to 
radio-label DNA according to the method of Feinberg and Vogelstein 
(1983, 1984). Plasmid or bacteriophage DNA was cleaved with appropriate 
restriction endonucleases and the fragments electrophoretically separated 
on a 1-0% low gelling temperature agarose gel (Sea Plaque agarose, FMC 
BloProducts) containing 5 jig/ml ethidium bromide, In TBE buffer. After 
electrophoresis the desired DNA bands were cleanly excised using a 
scalpel and placed into a pre-weighed 1-5 ml microcentrifuge tube. 
Sterile distilled water was added to a ratio of 3 ml H0/g of gel. The 
tube was then placed at 95-100°C for 10 minutes to melt the gel and 
denature the DNA. The DNA/gel was stored at -20°C in small aliquots. 
Prior to labelling, an aliquot was re-boiled for 5 minutes and stored at 
37°C for 15 minutes. 
The labelling reaction was carried out at room temperature by addition 
of the following reagents in the stated order: H0 (to a final volume of 
50 jil), 10 p.1 of oligo-labelling buffer (see below), 2 p.1 of 10 mg/ml 
bovine serum albumin, DNA in agarose (10-50 ng of DNA In up to 32'5 p.1 
of molten gel), 5 p.1 of [a- 32 P]dCTP (3000-4000 Ci/mmol, 10 p.C1/111) and 
2 to 5 units of E. coli DNA polymerase I (Klenow fragment). The 
reaction was allowed to proceed for 4 to 6 hours. The reaction was 
stopped by addition of 200 p.1 of a solution containing 20 mM NaCl, 
20 mj Tris-HC1 pH 7.5, 2 mu EDTA, 025% sodium dodecyl sulphate, 1 PM 
dCTP. Purification of labelled DNA from unincorporated [a-s 2 P]dCTP was 
not usually necessary prior to hybridisation since 80-100% of the label 
was routinely incorporated into the DNA. 
PX 
Oligo-labelling buffer was prepared as follows: 
Solution 0: 125 M Tris-HC1 pH 8'0, 0125 fi M8C1 2 . 
Solution A: 1•0 ml of solution 0, 18 ji of -mercaptoethanol (14 i), 
5 ji of 0•1 M dATP, 5 ii of 0•1 j dGTP, 5 &l of 01 M dTTP. 
Solution B: 2.0 K HEPES (N-2-hydroxyethyipiperazlne-N'-2-
ethanesuiphonic acid), adjusted to pH 66 with 4 M NaOH. 
Solution C: Hexadeoxyribonuc leo tides (PL Biochemicals) suspended at 
90 OD units/ml. 
Oligo-labelling buffer was prepared by mixing the solution A:B:C at a 
ratio of 2:5:3. The buffer was stored in 10 .il aliquots at -20C. 
2.9.3 5' DNA Terminus Labelling 
T4 polynucleotide kinase was used to label the free 5' ends of DNA by a 
phosphate exchange reaction similar to the method of Berkner and Folk, 
(1977). Excess ADP was used to drive the exchange reaction, causing 
polynucleotide kinase to transfer the terminal 5' phosphate from DNA to 
ADP. The DNA was re-phosphorylated by transfer of the labelled 
,y-phosphate of [y- 32 P]ATP. The reactions were carried out in a total 
volume of 25 l containing ca. 10 pmoles 5' ends of DNA in a solution of 
50 mM Imidazole-HC1 pH 6•3, 12 mM MgC1m, 15 mM -mercaptoethanol, 
0•3 mM ADP, 05 	ATP, 01 mg/ml bovine serum albumin, plus 50 pCi of 
[y- 32 P]ATP (10 Ci/1il, ca. 6000 Ci/mmol) and 5 to 10 units of T4 
polynucleotide kinase. The reaction was incubated at 37C for 30 
minutes. The unincorporated (y- 32 PIATP was separated from the products 
of the reaction by Sephadex G-50 column chromatography. 
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2.9.4 Measurement of Radioactivity in Nucleic Acids 
Precipitation with Trichioroacetic Acid 
Five microlitres of the products of a labelling reaction to be assayed 
were spotted onto two Whatman GF/C glass fibre filter disks. The 
filters were air dried. One of the filters was placed in ice-cold 
10% (w/v) trichloroacetic acid (TCA) for 15 minutes then washed three 
times with 20 ml of ice-cold 10% (w/v) TCA followed by 10 ml of ice-
cold absolute ethanol. The filters were dried under a heat lamp, and 
the relative incorporation determined by counting in a toluene-based 
scintillation fluid 16g/litre butyl-PBD in toluene). 
Absorbtion to DE81 paper 
Five microlitres of the products of the labelling reaction to be assayed 
were spotted onto two pieces of Whatman DE81 paper. One pieces of 
paper was air dried and then washed six times for 5 minutes per wash in 
0.5 ( N82HPO4. The piece of paper was then washed twice in water for 
one minute per wash and once in absolute ethanol for 2 minutes. Both 
pieces of paper were dried under a heat lamp and the relative 
incorporation determined by counting in a toluene-based scintillation 
fluid 16g/litre butyl-PBD in toluene]. 
2.9.5 Sephadex Gel Filtration 
Sephadex G-50 (Pharmacia) was prepared as follows: dry Sephadex G-50 
(medium) was added to 10 mM Tris-HC1 pH 75, 1 mt( EDTA, and the powder 
allowed to absorb the aqueous solution overnight at 4C. Sephadex G-50 
columns were prepared in 10 ml plastic disposable .pipettes, plugged with 
glass wool, and washed with several changes of 10 mM Tris-HC1 pH 75, 
1 inj EDTA; The labelled DNA samples were applied to the top of the 
column in ca. 200 il volume, with a reservoir of 10 mM Tris-HC1 pH 7.5, 
1 mM EDTA connected to the top of the column. The passage of radio- 
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active DNA and free nucleotides was monitored using a mini-monitor 
Geiger counter. The first radio-active peak to pass through the column 
was collected. The total incorporated label was determined by either 
TCA precipitation or absorbtion to DE81 paper as described above. 
2.10 Transformation of Escherichia coil 
The methods used were essentially those of Mandel and Higa, (1970) and 
Lederberg and Cohen, (1974). An overnight culture of Escherlchia coil 
was diluted 50-fold into 50 ml of L broth; the cells were grown at 37C 
to an 0D660 of 0'2-0'4. The culture was then placed on ice for 20 
minutes; the cells were then recovered by centrifugation and resuspended 
in 25 ml of ice-cold 0'1 M MgCl.,. The cells were immediately repelleted 
and resuspended in 2'5 ml of ice-cold 10 mtj  CaCl2 . The cells were then 
stored on ice for at least 30 minutes. The transforming DNA (up to 
50 ng) was mixed with 200 il of the competent cell preparation and left 
on ice for 30 minutes, The cell-DNA mixture was placed In a water bath 
at 42 *C for 2 minutes and then returned to ice for a further 30 minutes. 
For bacteriophage transfections of E. coil, 10-fold dilutions of the 
DNA/recipient cell mixture were made prior to plating. For bacteriophage 
X transfections a 0'1 ml aliquot of transformed-cell dilution was mixed 
with 0'1 ml of freshly grown E. coil cells in 2'5 ml of molten BBL top 
agar supplemented with 10 mfI  MgSO4 , and plated onto BBL agar plates. 
For M13-iacZ based vectors, the transformed-cell dilutions were mixed 
with 0'1 ml of plating cells in 2'5 ml molten BBL top agar containing, 
30 jl of 20 mg/nil XG (5-bromo-4-chloro-3-iridoly--D-galactiside 
dissolved in dime thy lformamide) and 20 jil of 20 mg/ml IPTG (isopropyl-
thio--D-galactoside dissolved in dime thy lformamide) and plated onto 
either BBL or minimal agar plates. 
For plasmid transformation of E. coil, the DNA/competent cell mixture was 
diluted Into 1.0 ml of L broth and incubated at 37C for 1 hour. The 
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cells were then diluted In L broth and plated onto selective L agar 
media. 
2.11 In Vitro Packaging of Bacteriophage Lambda DNA 
The method used for the preparation of in vitro packaging mixes was a 
modification of those described by Becker and Gold, (1975) and Hohn and 
Murray, (1977). Using this procedure efficiencies of in vitro packaging 
of uncut Xc1857 DNA were ca. lx 108 plaque forming units/pg (pfu/JLg). 
The packaging mix consisted of four components: 
1) Buffer A 
20 mM Tris-HC1 pH 8•0, 3 mM MgCl, 10 mM -mercaptoethonol, 
1 mM EDTA pH 70 
Buffer MI. 
Constituents added in the following order: 
110 l H20, 1 l -mercaptoethonol, 6 JLl 05 M Tris-HC1 pH 74, 300 jd of 
a mixture of 50 mM spermidine and 100 mM putresclne adjusted to pH 70 
with Tris base, 9 l 1 M MgC12 75 l 100 mM ATP. 
Freeze-thaw lysate (FTL) 
Four lawns of E. coli strain BHB2688 were grown on L agar plates, three 
of which were incubated overnight at 30C while the fourth was incubated 
overnight at 42C. The plate grown at 42C was checked for no growth 
of bacterial colonies, indicating induction of the lambda lysogen. 
The cells from the plates grown at 30C were resuspended in 10 ml of 
L broth and used to inoculate three 500 ml volumes of L broth in 
2 litre flasks to an 0D600 of 008 to 01. The cultures were aerated at 
30C until the optical density rose to Wcoc of 03, at which time the 
contents of the three flasks were combined in a single 5 litre flask. 
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The culture was induced by slowly shaking in a 45 C water bath for 15 
minutes. The induced culture was then grown at 37C for three hours 
with vigorous aeration. The culture was checked for induction by adding 
2 drops of CHC1 to a 1 ml sample of the culture; if induced, the cell 
suspension cleared within a few minutes. 
After induction the culture was chilled in Ice-water and the cells 
recovered by centrifugation, with 200 ml of culture per centrifuge 
bottle. The supernatant was discarded and the bottles inverted, on ice, 
to allow the remaining media to drain from the cells, which was then 
removed with a pasteur pipette. The cells were kept on Ice while 
resuspending the pellet from each bottle in 03 ml of ice-cold 10% (w/v) 
sucrose, 50 mM.  TrIs-HC1 pH 7•4. The semi-liquid cell paste was then 
dispensed into ice-cold 5 ml centrifuge tubes, with approximately 05 ml 
per tube. To each tube was added 30 jul of fresh lysozyme solution 
(2 mg/ml In 0•25 M Tris-HC1 pH 74), followed by gentle mixing and 
immediate freezing in liquid nitrogen. The cells were allowed to thaw 
slowly on ice until semi-liquid and viscous; 125 p.1 of buffer Ml was 
added to each tube, followed by gentle mixing. The samples were 
Immediately centrifuged at 35,000 rpm for 25 minutes at 2 C using an 
MSE 6x14 ml swing-out rotor. The supernatant was recovered and 
dispensed in 100 pl aliquots into pre-cooled microcentrifuge tubes, which 
were immediately frozen in liquid nitrogen and stored at -70C. 
Iv) Sonicated extract (SE) 
Two lawns of E. coil strain BHB2690 were prepared, one incubated 
overnight at 30C and the other at 42C. As with the E. coil BHB2688 
the plate grown at 42C should show no growth. 
The cells were grown and induced as with preparation of the FTL. 
However, only one 500 ml culture was inoculated and incubation after 
induction was for 90 minutes. The cells were pelleted, as for FTL, and 
resuspended in a total of 46 ml buffer A and then lysed by sonication, 
without foaming, until the suspension was no longer viscous. The cell 
debris was pelleted by centrifugation for 6 minutes at 6,000 rpm using a 
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Sorvall ss34 rotor. The supernatant was recovered and dispensed in 
50 jil aliquots into pre-cooled microcentrifuge tubes which were then 
frozen in liquid nitrogen and stored at -70C. 
The packaging reactions were carried out by the addition of the reagents 
in the following order: 
7 pl buffer A 
a maximum of 200 ng of ).. DNA suspended in 1-2 p.]. 
1 p.1 buffer Ml 
6 p.1 SE 
10 p.1 FTL. 
The mixture was incubated at 25C for 60 minutes and the reaction 
terminated by the addition of 0.5 ml of phage buffer. Appropriate 
dilutions of the packaged X DNA were made in phage buffer and mixed 
with 01 ml of freshly grown plating cells and 2•5 ml of molten BBL top 
agar (or BBL agarose), supplemented with 10 mM MgSO4 , and plated onto 
BBL agar plates. 
2.12 Nucleic Acid Hybridisation 
2.12.1 Plaaue Detection •bv Blott 
The method used to detect recombinant clones using bacteriophage 
vectors was that of Benton and Davis, (1977). Bacteriophages were 
plated onto E. coli lawns using BBL top agarose onto dry BBL agar in 
Petri dishes and grown overnight at 37C. The Petri dishes were placed 
at 4C for 1 hour to promote greater adhesion of the agarose top layer 
to the agar base. Nitrocellulose (Schleicher and Schuell) filter disks 
were cut to the same dimensions as the Petri dishes. The nitrocellulose 
disks were carefully placed over the surface of the plates and allowed 
to become wet. After 1 minute the disks were removed and placed, plaque 
side up,on a pad of blotting paper saturated with 0•5 M NaOH, 15 M 
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NaCl, to denature the DNA, and left for 2-5 minutes. The disks were 
placed in 200 ml of 05 M Tris-HC1 pH 7•4, 3 M NaCl for 1 minute, then 
rinsed in 2xSSC (0.3 M NaCl, 003 ( tn-sodium citrate], dried at 37C on 
blotting paper and baked in a vacuum oven at 80C for 90 minutes. The 
disks were then used for DNA hybridisation (see below). 
2.12.2 Transfer of DNA to Membranes (Southern blotting) 
The method used to transfer DNA from agarose gels to nitrocellulose or 
nylon membranes was essentially that of Southern, (1975). After 
electrophoresis and photography the agarose gels were trimmed of excess 
agarose to minimise the amount of membrane required for transfer. The 
gel was placed in 5-10 volumes of 0•25 M HCl for 15 minutes to 
partially depurinate the DNA (Wahl et @1., 1979). The gel was then 
rinsed in distilled H 20 and placed in 5-10 volumes denaturing solution 
11•5 M NaCl, 05 M NaOH] with gentle agitation for 30 minutes. The gel 
was rinsed In dH2O and then placed in 5-10 volumes of neutralising 
solution 115 M NaCl, 0•5 M Tris-HC1 pH 72, 1 mM EDTA] with gentle 
agitation for 30 minutes. 
The gel was placed on a sheet of blotting paper (resting on a solid 
support) saturated with 20xSSC (3 M NaCl, 03 M tri-sodium citrate], with 
the ends of the blotting paper overhanging the solid support such that 
they are dipping in a reservoir of 20xSSC, so that they act as wicks. 
The gel was surrounded with strips of Parafilm, flush with the edges of 
the gel. A piece of nitrocellulose (0•45 pm pore size) (Schleicher and 
Schuell) or nylon Hybond-N membrane (Amersham), was cut to the same 
dimensions as the gel. The membrane was soaked in 2xSSC and carefully 
placed on the surface of the gel making sure that it did not overhang 
the edges of the gel and that no air bubbles were trapped between the 
gel and the membrane. Two sheets of blotting paper (the same dimension 
as the gel) were soaked in 2xSSC and placed on top of the membrane. A 
stack of dry blotting paper (5-10 cm high) was placed on top of the 
wetted blotting paper. A glass plate was placed on top and weighted 
with a 1-1-5 kg weight to compress the whole sandwich. DNA transfer 
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was allowed to proceed for 16 hours. The blotting paper was removed 
and the membrane washed in 2xSSC to remove any adhering agarose; the 
membrane was then dried at 37C. Nitrocellulose membranes were then 
baked in a vacuum oven at 80C for 90-120 minutes. Hybond-N membranes 
were wrapped in cling-film and placed, DNA side down, on a 
UV-transilluminator for 2-5 minutes. 
2.12.3 Transfer of RNA to Membranes (Northern blotting) 
The method used to transfer RNA from agarose gels containing 
formaldehyde to solid support membranes was essentially the same as the 
transfer of DNA (Thomas, 1980). However, the gels were not treated with 
acid, denaturing solution or neutralising solution prior to transfer. 
After electrophoresis the gels were placed directly on the transfer 
apparatus containing 2OxSSPE E36 M NaCl, 0'2 j sodium phosphate pH 77, 
20 mj EDTA], replacing the 20xSSC. The transfer allowed to proceed for 
at least 12 hours and the membranes treated as above. However, the 
filters were not rinsed in 2xSSC before the RNA was bound to the 
membranes. 
2.12.4 DNA Blot Hybridisation 
After DNA has been transferred to nitrocellulose or nylon membranes, 
using either plaque or Southern blotting, the membranes were pre-
hybridised by treating in hybridisation solution, with ca. 5 ml of 
solution per 100 cm 2 of membrane. Hybridisation solution consisted of 
50% formamide, 6xSSC, 0.5% (w/v) sodium dodecyl sulphate (SDS), 
SxDenhardt's solution [lxDenhardt's solution: 0•02% (w/v) bovine serum 
albumin, 002% (w/v) Ficoll (mol. wt. 400,000), 002% (w/v) polyvinyl 
pyrollidone (mol. wt. 360,000)) Denhardt, 1966). Denatured non-
homologous DNA was prepared; 05 ml of 1 mg/ml sonicated salmon sperm 
DNA was heated at 95-100'C for 10 minutes and added to the 
pre-hybridisation solution. Pre-hybridisation was carried out with 
shaking, in heat-sealed plastic bags, for at least 1 hour at 37C. 
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Hybridisation was carried out by replacing the pre-hybridisation solution 
with fresh hybridisation solution. Denatured non-homologous DNA was 
prepared as above, however, also containing a denatured radio-actively 
labelled DNA probe (Ix10 6 _1x10 8 cpm/ig). Hybridisation was performed 
with shaking for at least 12 hours at 37C. 
Filters were washed for 15 minutes at room temperature in two changes 
of 200 ml of 2xSSC, 0•5% (w/v) SDS. The wash solution was replaced with 
500 ml of 1xSSC, 0•1% (w/v) SDS and the filters washed at 37C for 1 
hour. A high stringency wash was performed by incubating the filters in 
500 ml of 01xSSC, 0•1% (w/v) SDS at 65C for 10-30 minutes. The washed 
filters were blotted to remove excess fluid, however, the filters were 
not allowed to dry completely. The filters were then sealed in plastic 
bags and exposed to X-ray film. 
2.12.5 RNA Blot Hybridisation 
After RNA had been transferred from agarose gels containing 
formaldehyde, the nitrocellulose or nylon membranes were treated with 
RNA hybridisation solution with ca. 5 ml of solution per 100 cm 2 of 
membrane. RNA hybridisation solution consisted of 50% (v/v) formamide, 
5xSSPE, SxDenhardt's solution, 10% (w/v) dextran sulphate. Denatured 
non-homologous DNA was added as described above. Pre-hybridisation was 
carried out with shaking in heat sealed plastic bags for 4 hours at 
42C. 
The pre-hybridisation solution was replaced with fresh hybridisation 
solution containing denatured heterologous DNA plus denatured radio-
actively labelled complementary DNA probe. Hybridisation was performed 
with shaking for at least 12 hours at 42 C. The membranes were washed-
with two changes of 5xSSPE for 15 minutes at 42C. The washing buffer 
was replaced with 1 xSSPE, 0•1% (w/v) SDS and the membranes incubated for 
30 minutes at 42C. A high stringency wash was performed by incubating 
the membranes in 0•1xSSPE, 01% (w/v) SDS for 15 minutes at room 
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temperature. The membranes were blotted to remove excess fluid, sealed 
in plastic bags and exposed to X-ray film. 
2.12.6 Autoradiography 
Autoradiography was performed using Cronex 4 or Kodak XAR-5 X-ray films 
in cassettes. For 32 or 1251 labels, the Cronex 4 X-ray films were 
pre-flashed and exposed at -70C using intensifying screens (Dupont 
Cronex Lightning Plus). Kodak XAR-5 X-ray films were exposed directly 
at -70C using intensifying screens without pre-flashing. For 35 S 
labelled DNA sequencing gels, the gels were dried and the X-ray film 
exposed at room temperature. For 35S  labelled proteins, the gels were 
impregnated with a scintiliator (sodium salicylate) and dried, the X-ray 
films were pre-flashed and exposed at -70C. The X-ray films were 
developed using an automatic film processor. 
2.13 Electron Microscopy of DNA Heteroduplexes 
The method used for preparation of heteroduplexes was a modification of 
the method of Davis et al., (1971). The two DNAs, at equal concentration 
(about 3 jg/ml), were denatured in 50 .il of 0.1 j NaOH, 20 mM EDTA and 
incubated at 27C for 10 minutes. The solution was neutralised by the 
addition of 5-6 pl of 20 fj Tris base, 1-6 M HC1. Renaturation was 
achieved by adding 50 jl of deionised formamide (9%) such that final 
concentration of the solution was 01 fj Tris pH 85, 001 M EDTA, 
50% (v/v) formamide. The DNA was renatured by incubating the solution 
at 27C for 2 hours to allow approximately 50% renaturation. The 
renatured DNA solution (10 .i1) was diluted 20-fold into spreading 
solution (hyperphase solution) with final concentrations of 01 f.i, Tris 
pH 8•5, 10 mM EDTA, 50% (vfv) formamide, 0•1 mg/ml of cytochrome c and 
015 jg/ml of DNA. The hyperphase solution was spread onto the surface 
of the hypophase solution (10 mM Tris-HC1 pH 85, 1 mM EDTA, 15% (v/v) 
formamide) by slowly pouring the hyperphase solution down a silica ramp 
(pre-wetted with hypophase solution). The film of hyperphase solution 
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was allowed to stand for 1 minute before being picked up. The film was 
picked up onto a 400 mesh copper grid by touching a parlodion coated 
grid onto the surface of the film at a distance of about 1 grid width 
from the ramp-solution boundary. The grid was stained by immersion in 
uranyl stain 150 LK uranyl acetate, 50 	HC1 in 90% (v/v) ethanol] for 
30 seconds with gentle agitation and then allowed to dry on filter 
paper. The grids were rotary shadowed with platinum and coated with a 
thin layer of carbon. The parlodion was removed by immersion in 
absolute ethanol for 60 seconds. 
The grids were viewed and electron micrographs prepared using a Siemens 
1A electron microscope at 60 to 80 kV accelerating voltage. The contour 
lengths of the heteroduplexes were measured by projecting an image of 
the electron micrograph onto a white surface and measured using a 
Keuffel and Esser No. 62 0300 map measurer connected to a digitiser 
Ferranti Cetec Graphics) and programmable calculator (British Olivetti 
Ltd.). The map lengths of the heteroduplexes were measured by 
comparison to molecular size standards spread with the heteroduplexes 
(double stranded standard: pAT153, 3657 base pairs; single stranded 
standard: wild type M13 bacteriophage DNA, 6407 nucleotides). 
2.14 DNA Sequencing 
The method used to sequence DNA was based upon the methods of Sanger 
et al., (1977,1980). 
2.14.1 Preparation of M13 Replicative Forms 
Double stranded M13 vector DNA (RF DNA) was prepared as follows: 
Appropriate dilutions of the M13 vector bacteriophages were plated on 
lawns of E. coil NM522, prepared in 2•5 ml of molten BBL top agar, 
containing 30 p.1 of 20 mg/ml XG (5-bromo-4-chloro-3-indoiy--D-
galactiside dissolved in dimethylformamide) and 20 p.1 of 20 mg/mi IPTG 
(isopropyl- thio--D-ga1ac toside dissolved in dime thylformamide) on 
minimal agar plates supplemented with vitamin Bi. A single blue plaque 
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was picked with a sterile tooth pick and transferred into 2•5 ml L broth 
and shaken at 37C for 6 hours. After the incubation, 10 ml of the 
phage/cell culture was added to 2x250 ml cultures of E. coil NM522 at 
0D580=0 25 and grown for a further 5 hours at 37C with constant 
agitation. The M13 infected cells were recovered by centrifugation at 
10,000 rpm for 10 minutes in a Sorvall GSA rotor. The cells were lysed 
and the double-stranded covalently closed circular replicative forms of 
the M13 vectors were isolated as described for large scale isolation of 
H. coil plasmids. 
2.14.2 Cloning into the M13 Vectors 
The M13-based vectors used were mpl8 and mp19. M13 vector RF DNA and 
the DNA to be cloned were digested with appropriate restriction 
endonucleases and ligated in vitro. The ligated DNA mixture was used to 
transform E. coil NM522; 01 ml of 10-fold serial dilutions (in L broth) 
of the transformed cells were mixed with 01 ml of freshly grown plating 
cells and 25 ml of molten BBL top agar supplemented with 30 &l of 
20 mg/ml XG and 20 pl of 20 mg/ml IPTG and plated onto minimal agar 
containing vitamin Bi and grown at 37C overnight. The recombinant 
clear ("white" non-blue) plaques were picked and transferred in a grid 
formation onto two duplicate minimal agar plates freshly overlaid with a 
lawn of E. coil NM522, and incubated at 37C overnight. One of the 
replica plates was used for plaque blotting and hybridisation as 
described above. Plaques giving positive signals were picked from the 
remaining duplicate plate, diluted In phage buffer and titrated on 
E. coil as described above; the plates were incubated at 37C overnight 
and then stored at 4C. Recombinant M13 bacteriophages were also stored 
in suspension by picking a isolated "white" plaque into 50 jil of 20 mM 
Tris-HC1 pH 79, 20 mM NaCl, 1 mM EDTA and stored at 4C. 
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2.14.3 Preparation of Single-Strand Template DNA 
Single-stranded template DNA was prepared by picking an isolated "white" 
plaque into a 1-5 ml culture of E. coil NM522 (an overnight culture 
freshly diluted 1/100 in L-broth). The inoculated culture was grown at 
37C with vigorous agitation for 4-5 hours. The bacteriophage particles 
were isolated as follows: the 1-5 ml culture was transferred to a 
microcentrifuge tube and the cells removed by centrifugation for 10 
minutes. The supernatant was transferred to a fresh microcentrifuge 
tube and the bacteriophage particles precipitated by the addition of 
200 p.1 of 25 M NaCl, 20% (w/v) polyethylene glycol 6000 (PEG 6000). 
The contents of the tube were mixed by inversion and the tube left at 
room temperature for 30 minutes. The bacteriophage/PEG precipitate was 
isolated from the solution by centrifugation for 5 minutes; the 
supernatant was discarded and the tubes inverted onto absorbent paper 
to allow the remaining medium to drain away. Any remaining solution 
was removed using a drawn out Pasteur pipette. The pellet was 
resuspended in 100 p.1 of sequencing TE 110 mM Tris-HC1 pH 7•4, 0.1 mM 
EDTA]. The bacteriophage suspension was extracted with 50 p.1 of 
equilibrated phenol and the phases were mixed vigorously for 10 seconds; 
the tubes were allowed to stand for 10 minutes at room temperature and 
then re-mixed. The phases were separated by centrifugation for 5 
minutes and the aqueous phase recovered, being careful not to take any 
phenol. The single-strand DNA was precipitated by the addition of 10 p.1 
of 3 M sodium acetate pH 52 and 250 p.1 of absolute ethanol, mixed and 
then placed at -70C for 15 minutes. The DNA was recovered by 
centrifugation for 10 minutes at 4C and the supernatant discarded. The 
pellet was rinsed by adding 1 ml of 95% (v/v) ethanol (-20C), 
re-centrifuged for 5 minutes. The pellet was dried under vacuum and 
resuspended in 40 p.1 of sequencing TE and stored at -20C. 
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2.14.4 DNA Sequencing Reactions 
1) Annealing reaction 
Single-stranded template was annealed to a synthetic M13 sequencing 
primer (-20, 17 mer; New England Biolabs, M13 sequencing primer #1211). 
Annealing reactions were performed in 1-5 ml microcentrifuge tubes; 8 il 
of single stranded template preparation (see above) was mixed with 1 ii 
of TM buffer 101 mM Tris-HC1 pH 7.5, 0.1 mj MgC12] plus 1 j&i of primer 
(0.5 pmol/j&l). The mixture was heated to 60C for 1 hour and then 
cooled to room temperature. 
ii) Synthesis reaction 
DNA sequencing reactions were carried out in 1-5 ml un-capped 
microcentrifuge tubes as follows: 2 p.1 aliquots of the annealing mixture 
were dispensed into 4 separate microcentrifuge tubes followed by 2 p.1 of 
one of the nucleotide mixes (G° or A or T or C . , see below). Finally 
2 p.1 of enzyme/label mix 110 mi Tris-HC1 pH 7•5, 0.5 p.Ci/p.l [a- 35 S]dATP 
(400 Ci/mmol; Amersham), 0•25 units/p.l Klenow fragment, 10 mM 
dithiothreitol] was added to each tube; the solutions were mixed by 
centrifugation for 5 seconds and left at room temperature for 25 
minutes. After the initial incubation, 2 p.1 of chase mix 1025 mM each 
of dAT?, dCTP, dGTP, dTTP] were added to each tube, mixed and incubated 
at room temperature for a further 20 minutes. Prior to polyacrylamide 
gel electrophoresis, 2 p.1 of forinamide-dye mix 120 mM EDTA, 0.5% (w/v) 
bromophenol blue, 0•5% (w/v) xylene cyanol FF dissolved in deionised 




Nucleotide mixes were prepared as follows and stored at -20C: 
G: 2•5 1 of 50 ma dTTP; 2•5 j&1 of 50 mM dCTP; 125 l of 05 mM dGTP; 
15 pl of 1 mM ddGTP; 0'5 ml of sequencing TE; 05 ml H.O. 
A: 25 1 of 50 mM dTTP; 2•5 p.1 of 50 mM dCTP; 25 p.1 of 50 mM dGTP; 
75 j.d of 1 mM ddATP; 05 ml of sequencing TE; 05 ml of H20. 
T: 25 il of 50 mM dCTP; 25 .&l of 50 mM dGTP; 125 41 of 0•5 mM dTTP; 
30 41 of 10 mM ddTTP; 05 ml sequencing TE; 05 ml H20. 
C: 25 pl of 50 mM dTTP; 2•5 p.1 of 50 mM dGTP; 12•5 p.1 of 0•5 mM dCTP; 
75 p.1 of 10 mM ddCTP; 05 ml sequencing TE; 05 ml H 20. 
2.14.5 Polyacrylamide Gel Electrophoresis 
Separation of the products of the DNA sequencing reactions were 
performed on vertical gel apparatus with 6% (w/v) acrylamide, 7 M urea 
gels (dimensions 40cmx20cmx03mm), cast between two glass plates, with 
the notched plate coated in a layer of silicon water repellent 
(Repelcote; Hopkin and Williams Ltd.). Gels were prepared as follows: H 20 
to final volume of 40 ml, 6 ml of 40% acrylamide (38% (wfv) acrylamide, 
2% <w/v) NMI-methylene bisacrylamide, delonised using an ion-exchange 
resin and stored at 4C], 17 g urea, 4 ml sequencing TBE (lOx) 
[sequencing TBE (lx): ogo M Tris borate pH 83, o•go M H3B04 , 25 mM 
EDTA], 250 p.1 of 10% (w/v) ammonium persulphate and 40 p.1 of TEMED. 
The solution was poured between the glass plates and allowed to 
polymerise with the well comb in place. 
Prior to loading the DNA sequencing reactions/formamide-dye mixture, the 
samples were boiled for 5 minutes. Approximately 2p.l of each sample 
was loaded onto the gel using a drawn-out capillary tube. The DNA 
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sequencing products were separated by electrophoresis in sequencing IRE 
(lx), at constant power of 25-30 watts (Ca. 20-30 mA, 1•1-15 kV). 
Electrophoresis was continued until the required fragment separation was 
achieved (bromophenol blue migrates with DNA fragments of about 25-30 
nucleotides, the xylene cyanol FF migrates with DNA fragments 75-80 
nucleotides). After electrophoresis the glass plates were prised apart 
making sure that the gel remained attached to one of the glass plates. 
The gel was immersed in 10% (v/v) acetic acid, 10% (v/v) methanol fixing 
solution. After 15 minutes in the fixing solution, the gel (still on the 
glass plate) was removed and the acetic acid/methanol solution was 
allowed to drain off. The gel was transferred to a sheet of blotting 
paper, covered in cling-film and dried on a gel slab drier. Once dry the 
cling-film was removed and the dried gel exposed to X-ray film. 
2.15 In Vitro Transcription of Eukaryotic Genes 
The method used for In vitro transcription experiments was that of 
Manley et al., (1980). The in vitro eukaryotic transcription system was 
purchased from Bethesda Research Laboratories; 25 il reactions were 
carried out according to Manley et al., (1980). 
A typical reaction (25 J.Ll) consisted of the following reagents: 15 P1 of 
HeLa cell extract (BRL); 0-2-1-5 jig of linear template DNA; 0•5 mM each 
of ATP, CTP, TTP; 005 mM GTP; 014 mM EDTA; 1 mM creatine phosphate; 
5 pCi [a- 32 P]GTP (10 pCi/pu, 410 Ci/mmol; Amersham); sterile H2O to final 
volume of 251il. The incubation was carried out at 30C for 90 minutes. 
The reaction was terminated by the addition of 250 p1 of 7•5 fj urea, 
0•5% (w/v) SDS, 10 mM Tris-HC1 pH 8•0. An equal volume (275 j.Ll) of 
phenol:chloroform:isoamyl alcohol (20:20:1) was added and the phases 
mixed. The phases were separated in a microcentrifuge for 5 minutes. 
The aqueous phase (first aqueous phase) was transferred to a fresh 
microcentrifuge tube, leaving the organic phase plus lnterphase. To the 
organic phase was added 150 p1 of 7 ii. urea, 035 M NaCl, 1% (w/v) SDS, 
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10 mM. EDTA, 10 mM.  Tris-HC1 pH 80 plus 25 &g of yeast tRNA. The phases 
were mixed by vortexing and then separated in a microcentrifuge for 20 
seconds. A very dense protein precipitate formed at the interphase, 
therefore, the organic phase was removed leaving the interphase. The 
interphase plus second aqueous phase were re-extracted with 200 pl of 
chloroform; after vortexing and centrifugation (20 seconds) the second 
aqueous phase was recovered and combined with the first aqueous phase. 
The combined aqueous phases were extracted with an equal volume of 
phenol:chloroform:isoamyl alcohol and the phases separated by 
centrifugation for 5 minutes and the aqueous phase recovered. The 
aqueous phase was re-extracted twice with an equal volume of 
chloroform. The nucleic acids precipitated from the aqueous phase by 
adding 1 ml of ethanol, mixing and incubating in a dry-ice ethanol bath 
for 5 minutes. The nucleic acids were recovered by centrifugation for 
10 minutes at 4C. The supernatant was discarded and the pellet 
resuspended in 200 .il of 02% (w/v) SDS and 200 l of 2 M ammonium 
acetate and then precipitated with ethanol as described above. The 
resuspension and precipitation was repeated and the nucleic acid pellet 
dried under vacuum, and dissolved in sterile distilled H 20. 
The labelled RNA samples were separated by electrophoresis on either an 
agarose or polyacrylamide/agarose composite gels containing 2 2 !i 
formaldehyde in MOPS buffer as described previously. Upon completion of 
electrophoresis, the gels were dried using a slab gel drier and 
autoradiographed at -70°C in contact with Kodak XAR-5 X-ray film and an 
intensifying screen. Molecular weight standards used were 32 P-labelled 
DNA fragments visualised by autoradiography. Mouse (28S, 18S, 5•8S and 
5S) and E. coil (5S) ribosomal RNAs were also used and visualised either 
by ethidium bromide staining or silver staining of non-dried portions of 
the gels. 
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2.16 Eukeryotic Cell Culture 
2,16.1 Cell Lines and Growth Conditions 
Tissue culture cells lines used were: Rat2 (tk, derivative of the rat 
fibroblastoid cell line Rati) (Topp, 1981), Mouse LMtk cells (Kit et al., 
1963), the HPRT-deficient Chinese hamster cell line RJK88 (Fuscoe et al., 
1983) and derivatives of the above cell lines (Gough and Murray, 1982). 
Cells were grown in DMEM (Dulbecco's modified Eagles' medium; Gibco) 
supplemented with 7% (v/v) foetal bovine serum (Flow laboratories) at 
37C in a CO2 incubator. After transformation (see below) tk and HPRT 
cells were maintained in HAT medium (DMEM containing 15 pg/ml 
hypoxanthine, 0•2 ig/ml aminopterin and 5 pg/ml thymidine). 
2.16.2 Transformation of Mammalian Cells with Cloned DNA 
a) Calcium phosphate precipitation 
The procedure used was a modification of the methods of Graham and van 
der Eb, (1973) and Wigler et al., (1978). DNA was co-precipitated with 
calcium phosphate and introduced to tissue culture cells using the 
following procedure. A known amount of sterile DNA, ethanol precipitated 
and resuspended in 1 mM Tris-HC1 pH 7.8, 0.05 mj EDTA, was added to 
1.0 ml HBS (0'14 M NaCl, 5 mM KC1, 0'7 mM Na2HPO4 , 56 mljj D-glucose, 
20 mM HEPES pH 711. To this mixture was then added 62 l of 2 M 
CaCl2 , slowly to the DNA solution with gentle mixing. The solution was 
then left at room temperature for forty-five minutes to allow a 
precipitate to form and then added to an aspirated cell culture (at 
ca. 10-20% confluence in a 100 mm diameter Petri dish). The cell 
cultures were then left for 20 minutes with frequent gentle mixing. 
After the incubation, 10 ml of DMEM was added and the cells incubated 
for four hours at 37C in a CO 2  incubator. After incubation the medium 
was removed and the cells exposed to 2 ml of 15% (v/v) glycerol in HBS 
and incubated for 3'5 minutes. The cells were then washed and incubated 
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overnight in 15 ml of fresh DMEM. Twenty-four hours after the addition 
of the DNA the medium was replaced with appropriate selective medium. 
b) Transient Assay Procedure 
The method used for transient assay transformation was a combination of 
the methods of Sompayrac and Danna, (1981) and Luthman and Magnusson, 
(1983). DEAE-dextran and chioroquine were used as facilitators for DNA 
uptake In a modification of the method of McCutchan and Pagano (1968). 
Tissue culture cells were plated onto 10 cm diameter Petri dishes 
(2'5x10' cells per dish) and allowed to grow at 37°C in a CO2 incubator 
to be subconfluent at the time of transformation. DEAE-dextran (mol. wt. 
5x10 5 ; Sigma) was dissolved in serum-free DMEM, 50 mM Tris-HC1 pH 7•3, 
to final concentration of 200 ig/ml and filter sterilised. The cells 
were washed twice with serum-free DMEM and incubated with 5 ml DEAE-
dextranfDMEM/Tris containing approximately 5 pg of DNA at 37C in a CO2 
Incubator for 6 hours. After the initial incubation the transfection 
medium was supplemented with chloroquine to a final concentration of 
100 4j chioroquine diphosphate (Sigma) and incubated for a further 2 
hours at 37C in a CO2 incubator. After the incubation the cells were 
washed once in serum-free DMEM and incubated with DMEM supplemented 
with 7% (w/v) fetal bovine serum for the required expression time. For 
HBsAg expression, the cells were allowed to grow to confluence and the 
medium and cells harvested. 
2.16.3 Preparation of Eukaryotic DNA from Tissue Culture Cells 
The method used to isolate chromosomal DNA from tissue culture cells 
was a modification of the method of Gross-Bellard et al., (1973) as 
described by Gough and Murray (1982). Tissue culture cells were grown 
to confluent monolayers in 10 cm Petri dishes. The cells were removed 
from the Petri dishes by treatment with trypsin/EDTA (Gibco), washed 
with sterile phosphate-buffered saline (PBS) (Dulbeccos phosphate 
buffered saline; Flow laboratories) and resuspended in 50 ml of 10 mM 
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Tris-HC1 pH 75, 10 mj EDTA, 100 mM. NaCl per 10 Petri dishes. The cells 
were lysed by the addition of 250 pl of 10% (w/v) sodium dodecyl 
sulphate. The lysed cells were incubated with 500 pl of 10 mg/ml 
proteinase K (Sigma) and 50 j&l of 10 mg/ml heat-treated ribonuclease A 
(Sigma) at room temperature for 16 hours with gentle agitation. The DNA 
was isolated by extraction, once with phenoi:chloroformdsoamyl alcohol 
(50:50:1) and once with chioroform:isoamyl alcohol (50:1). The aqueous 
phase was then dialysed for 2 hours against several changes of 10 mM 
Tris-HC1 pH 80, 1 mj EDTA. The concentration of DNA was measured by 
absorbance at 260 nm. 
2.16.4 Preparation of Eukaryotic RNA from Tissue Culture Cells 
The method used to isolate RNA from tissue culture cells was a 
modification of the method of Feramisco at al., (1982). Cells, grown to 
confluent monolayers in 10 cm Petri dishes, were washed with 10 ml of 
sterile PBS per dish and the cells scraped off each plate using a rubber 
policeman (in 2 ml of PBS). Using a wide-mouthed pipette the cells were 
transferred to 50 ml screw cap Falcon tubes. The cells were harvested 
by centrifugation at 1200 rpm for 5 minutes in a MSE bench centrifuge 
and resuspended In 2 ml/dish of guanidinium lysis solution 
14 M guanidinium thiocyanate (sigma), 50 mM Tris-HC1 pH 7•5, 10 mM. EDTA, 
2% (w/v) Sarkosy]., 0-14 M -mercaptoethanol]. The cells were lysed and 
the mixture heated to 60C. While maintaining temperature, the 
suspension was drawn through a 18-gauge needle fitted to a 10 ml 
syringe and the suspension forcefully ejected back into the tube. This 
step was repeated until the viscosity of the suspension was reduced by 
shearing of the chromosomal DNA. An equal volume of equilibrated phenol 
(pre-heated to 60 C) was added to the lysed cells and the emulsion was 
drawn through the syringe a number of times. A half volume of 01 M. 
sodium acetate pH 52, 10 mM Tris-HC1 pH 74, 1 mM EDTA was added to 
the phenol cell emulsion followed by an equal volume of a 24:1 solution 
of chloroform:isoamyl alcohol. The suspension was shaken vigorously, 
while maintaining the temperature at 60C, for 10-15 minutes. The 
suspension was cooled on ice and the phases separated by centrifugation 
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at 3,000 rpm for 10 minutes in a MSE bench centrifuge. The aqueous 
phase was recovered and extracted once phenol:chloroform (1:1) and twice 
with chloroform at room temperature. The aqueous phase was recovered 
and transferred to sterile corex tubas. The nucleic acids were 
precipitated by adding two volumes of ethanol and storing at -20C for 
at least 2 hours. The nucleic acids were recovered by centrifugation at 
10,000 rpm for 20 minutes in a Sorvall ss34 rotor at 4C. The pellet 
was dissolved in the original starting volume of 01 M Tris-HC1 pH 74, 
50 mM. NaCl, 10 mM EDTA, 0•2% (w/v) SDS. Protelnase K was added to a 
final concentration of 1 mg/ml and the solution incubated for 1-2 hours 
at 37C. The nucleic acid solution was extracted once with 
phenol:chloroform:isoamyi alcohol (25:25:1), once with phenol:chloroform 
(1:1) and twice with chloroform at room temperature. The nucleic acid 
was precipitated by adding one tenth of the volume of 3 f!I sodium 
acetate and 2•5 volumes of ethanol and placing at -70°C for 15 to 30 
minutes. The nucleic acids were recovered by centrifugation at 
10,000 rpm for 20 minutes at 4°C in a Sorvali ss34 rotor. The pellet 
was rinsed with 70% (v/v) ethanol (-20°C), dried under vacuum and 
resuspended in distilled H 20. 
To select poly (A)-'- RNA (mRNA), the nucleic acids prepared as above were 
fractionated by chromatography on an oligo- (dT)-cellulose column. 
Oligo- (dT)-cellulose (Type 7; Pharmacie) was equilibrated in sterile 
loading buffer (20 mM Tris-HC1 pH 76, 05 M NaCl, 1 mM EDTA, 01% (w/v) 
SDS). A 1 ml column was poured in a disposable column and washed with 
three column volumes of 1) sterile H20; ii) 01 11 NaOH, 5 mj EDTA; 
iii) sterile H20. The pH of the effluent was checked to be less than 8. 
The column was then washed with 5 column volumes of loading buffer. 
The RNA samples (from above) were mixed with an equal volume of 
(20loading buffer and heated to 65C for 5 minutes, cooled and applied 
to the column. The flow-through was collected, heated to 65 C, cooled 
and re-applied to the column. The column was washed with 10 volumes of 
loading buffer followed by 10 column volumes of 20 mM Tris-HC1 pH 76, 
0•1 Ij NaCl, 1 mM EDTA, 0.1% (w/v) SDS. The poly(A)'- RNA was eluted from 
the column using 3 column volumes of 10 mM Tris-HC1 pH 75, 1 mM. EDTA, 
005% (w/v) SDS. The poly (A)° RNA was precipitated with ethanol and the 
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pellet rinsed with 70% (v/v) ethanol (-200, dried under vacuum and 
dissolved in sterile dH20. 
The column was regenerated by sequential washings with H20 and NaOH as 
described above. 
2.16.5 Isolation of Total Nucleic Acids from Tissue Culture Cells 
The method used to isolate total nucleic acid from tissue culture cells 
was a modification of the method to isolate cellular RNA. The above 
procedure was followed, however, the syringe shearing steps were omitted 
and all extractions were performed at room temperature. The poly (A) 
RNA was not purified from the non-p6lyadenylated nucleic acids. 
Tissue culture cells were grown to slightly sub-confluence on 10 cm 
diameter dishes in DMEM medium. The cell were washed twice in PBS and 
the medium replaced with 10 ml of MEM (minimum essential medium (Eagle) 
without L-methionfrie and L-glutamine; Gibco # 041-1900) supplemented 
with L-glutamine (586 mg/mi) and 250 iCi of L-( 35 S]methionine 
0800 Ci/mmol: Amersham #SL204). The cells were then incubated at 37C 
In a CO2 incubator for 24 hours. The medium was removed and retained 
at -20C. 
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2,17.1 Determination of Protein Concentration 
Protein concentrations were determined as described by Lowry et al., 
(1951). 
Reagents used were as follows: 
Solution A: 2% (w/v) NaC0 (anhydrous) in 0'1 M NaOH. 
Solution B: 0'5% (w/v) CuSO4 .5H0 In 1% (w/v) sodium citrate. 
Solution C: 1 ml of solution B plus 50 ml of solution A. 
Solution D: Folin and Coicalteau's phenol reagent diluted 1:1 in distilled 
H20. 
Standards used for protein concentration estimations were bovine serum 
albumin (BSA) solutions ranging from 0-400 jig/ml BSA In distilled M 2 O. 
Protein samples were diluted to 1:50, 1:100, 1:200 and 1:400. Each 
protein sample (400 l) was mixed with 2 ml of solution C in a glass 
5 ml test tube and Incubated for 10 minutes at room temperature; 0'2 ml 
of solution D was added and the mixture Incubated for a further 30 
minutes at room temperature. The optical absorbtion of the standards 
and samples was measured at a wavelength of 550 nm in a 
spec tropho tome ter. The absorbtion of the samples was related to protein 
concentration using a standard curve constructed from the absorbtion 
values of the known standards. 
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2.17.2 Radioactive Labelling of Proteins Using lodogen 
1) Preparation of lodogen coated tubes 
lodogen (Fraker and Speck, 1978) coated 1-5 ml microcentrifuge tubes 
were prepared as follows: 1 mg of lodogen (Pierce Chemical Company, 
# 28600) was dissolved in 25 ml of dichioromethane and distributed into 
50 pl aliquots In microcentrifuge tubes. The dichioromethane was 
evaporated under a stream of nitrogen gas, the tubes were "filled" with 
N 2 gas, capped and then stored at -70C. 
ii) Iodination reaction 
To each tube was added 5 jl of 0.1 M phosphate buffer pH 7'5, 10 P1 of 
protein solution (50-100 g) and 5 j&l of 125 lodide (100 mCi/mi; 
Amersham, # IMS.30). The tubes were incubated at room temperature for 
10 minutes with vigorous shaking. The reaction was terminated by 
transfer of the solution to a fresh 1-5 ml microcentrifuge tube. 
The products of the iodination reaction were separated from 
non-incorporated 1 2 51 by separation through a Sephadex G-25M column, 
A PD-to column (Sephadex G-25M; Pharmecia) was equilibrated with 
phosphate buffered saline (PBS) containing 1% (w/v) bovine serum albumin. 
Then 05 ml of PBS/0'1% BSA (saturated with potassium iodide) was added 
to the top of the column. The 20 jil reaction mixture was added to the 
0'5 ml of PBS/0 '1% BSA/sat. KI and the sample allowed to enter the gel 
bed. The labelled proteins were then eluted with PBS/1% BSA. Ten to 
twelve drop fractions (ca. 05 ml) were collected and the level of 
radioactivity present in the fractions determined by counting 5 P1 
aliquots using a LKB mini-gamma-counter. The fractions corresponding to 
the first peak eluted from the column were pooled. 
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2.17.3 Separation of Proteins by Polyacry].amide Gel Electrophoresis 
The polyacrylamide gel electrophoresis system used to separate proteins 
was a sodium dodecyl sulphate-polyacrylamide gel electrophoresis system 
(SDS-PAGE) using a discontinuous buffer. Polyacry].amide gels were 
formed between two glass plates with gel dimensions 170mmxl5Ommxl 5mm. 
The resolving gel (10% polyacrylamide) was prepared by adding the 
following constituents: 13•24 ml of 302% acrylamide solution (30% (w/v) 
acrylamide, 0•2% (w/v) bis-acrylamide], 5 ml of 3 M Tris-HC1 pH 88, 
0•4 ml of 10% (w/v) SDS, H0 to a final volume of 40 ml, 02 ml of 10% 
(w/v) ammonium persulphate and 20 pl of TEMED. The solution was poured 
between the glass plates, leaving a 2-3 cm space for the stacking gel, 
overlaid with a thin layer of butan-1-ol, to allow a smooth surface to 
form and left to polymerise for approximately 2 hours. When the 
resolving gel had polymerised the butan-1-ol was removed and the top 
edge of the gel washed extensively with distilled water and then allowed 
to drain. The stacking gel (375% polyacrylamide) was prepared by 
addition of the following constituents: 3q75 ml of 302% acrylamide 
solution, 375 ml of 1 M Tris-HC1 pH 6•8, 03 ml of 10% (w/v) SDS, 14 20 to 
a final volume of 30 ml, 0•2 ml of 10% (w/v) ammonium persuiphate and 
20 il of TEMED. The stacking gel solution was poured on top of the 
resolving gel and the gel comb positioned in place. The stacking gel 
was allowed to polymerise for approximately 30 minutes. Prior to 
loading the protein samples, an equal volume of sample buffer 1012 M 
Tris-HC1 pH 6•8, 20% (v/v) glycerol, 4% <w/v) SDS] was added to each 
sample dithiothreitol (DTT) was added to a final concentration of 60 mj 
DTT. The samples were boiled for 10 minutes before loading onto the 
gel. Electrophoresis was carried out using protein gel buffer (25 mm 
Tris, 0192 fj glycine, 0.1% (w/v) SDS, (pH 8•3)] at a constant current of 
5-7 mA for 12-16 hours or 25 mA for 5-6 hours until the desired 
separation was achieved. 
Protein molecular weight markers used were low molecular weight markers 
(Pharmacia) containing: phosphorylase b (94 kd), bovine serum albumin 
(67 kd), ova].bumin (43 kd), carbonic anhydrase (30 kd), trypsin inhibitor 
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(20•1 kd) and a-lactalbumin (14•4 kd). A standard curve of log10 
molecular weight verses distance migrated was constructed using data 
from the standard polypeptide molecular weight markers. 
2.17.4 Staining of Protein Separated on Polyacrylamide Gels 
After electrophoresis on polyacrylamide gels, the proteins were stained 
for 30 minutes in a solution of 0-2% (w/v) Coomassie brilliant blue R 
(Sigma), 45% (v/v) methanol, 10% (v/v) glacial acetic acid. The gels were 
destained with gentle agitation in 45% (v/v) methanol, 10% (v/v) glacial 
acetic acid, until the background staining was reduced to an acceptable 
level. The gels were stored for short periods in sealed plastic bags or 
permanently dried onto blotting paper using a slab gel drier. 
2,17.5 Western Blotting 
Proteins were electrophoretically transferred from non-coomassie blue 
stained SDS-PAGE gels to nitrocellulose filters (Towbin et al., 1979). 
The electrotransfer of proteins was accomplished using a Biorad electra-
transfer apparatus. A cassette was constructed containing the layered 
components in the following order: a Scotchbrite pad, 3 sheets of 
blotting paper cut to the same dimensions as the gel, the gel, a sheet 
of nitrocellulose (0'45 m; Schleicher and Schull) the same size as the 
gel, 3 more sheets of blotting paper and finally another Scotchbrite pad. 
The cassette was closed and placed in the Biorad elec tro- transfer tank 
with the nitrocellulose sheet towards the anode. The electro-transfer 
was conducted in a buffer of 0'025 M Tris-HC1 pH 83, 0'15 M glycine, 
20% (v/v) methanol, 01% (w/v) SDS. Proteins were transferred at a 
constant current of 0'3-0'5 amperes for 5 hours. 
After electra-blotting the nitrocellulose filter was incubated in a 
solution of 10 mj Tris-HC1 pH 8•1, 0.15 j NaCl, 3% (w/v) bovine serum 
albumin (TS/BSA) for 1 hour, with gentle agitation, to reduce non- 
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specific binding of protein probes to the membrane. Immunological 
probing was carried out by gentle agitation at room temperature with 
the antibody diluted in TS/BSA (5-10 ml solution per 100 cm 2 of 
membrane) for 12-16 hours. The filter was washed in 5 changes of 
10 ma Tris-HC1 pH 8•1, 015 M NaCl, 01% (v/v) Tween20, over a 60 minute 
period. After washing the filter was incubated with 5-10 ml, per 
100 cm 2 , of 10 mM Tris-HC1 pH 8•1, 0•15 M. NaCl containing 05 iCi/ml of 
125 1-labelled protein A (>30mCi/mg; Amersham, #IM.144) for 90 minutes at 
room temperature. After incubation the filter was washed as above, 
wrapped in cling-film and exposed at -70C using two intensifying 
screens and pre-flashed X-ray film. 
2.17.6 Radloimmunoassays 
Radloimmunoassays for the presence of hepatitis B virus surface antigen 
were performed using an AUSRIA 11-125 kit (Abbot laboratories). The 
method used was procedure B as recommended by the manufacturer. 
Protein samples (200 il) were added to wells containing beads coated in 
guinea pig antibody to the hepatitis B surface antigen. The samples and 
beads were incubated at room temperature for 16 ± 4 hours. The liquid 
was removed by aspiration and the beads washed by filling the wells 15 
times with distilled H0. To each well was added 200 pl of 
1 25 I-antj-s (human) and the beads incubated for 1 hour at 45 C. The 
liquid was removed by aspiration and the beads washed as described 
above. The beads were then transferred to counting vials and counted 
for 1 minute in a LKB mini-gamma-counter. 
2.17.7 Double Antibody. Immunoprecipitation 
Antisera wer?. diluted 1:5 or 1:10 in RIP buffer [phosphate buffered saline 
(flow laboratories), 0.5% (w/v) bovine serum albumin]. For each assay 
50 pl of diluted antiserum was mixed with 100 .il of radio-active protein 
sample (in PBS). The samples and antiserum were incubated overnight at 
4C with gentle mixing. After the incubation, 100 l of a 1:2 dilution 
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(in RIP) of either donkey anti-rabbit serum or goat anti-human serum 
(Scottish Diagnostics Laboratories) (depending on the antiserum used, 
either rabbit or human/chimpanzee respectively) was added and the 
samples incubated overnight at 4C. After the incubation, 1 ml of RIP 
buffer, containing 0•1% (w/v) starch, was added and the imniuno-
precipitate/starch was isolated by centrifugation in a microcentrifuge 
for 10 minutes. The pellet was washed with 1 ml of RIP buffer and 
reisolated by centrifugation. 
The irnmuno-precipitate was subjected to electrophoresis using SDS-PAGE. 
For 125 I-labelled proteins the gels were dried on a slab gel drier and 
the gels exposed to X-ray film using indirect autoradiography at -70C 
using two intensifying screens and pre-flashed film. For 35 S-labelled 
proteins the gels were impregnated with sodium salicylate and used for 
fluorography at -70C with intensifying screens and pre-flashed X-ray 
film. The method used for impregnating the gel with sodium salicylate 
was that of Chamberlain, (1979). Coomassie blue stained gels were 
presoaked for 30 minutes in water to remove acetic acid. The gel was 
immersed in 1 ?j (16% w/v) sodium salicylate for 30 minutes. The gel 
was removed from the sodium salicylate and dried on blotting paper 
using a slab gel drier. 
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Chapter Three 
Results and Discussion 
Cloning and Analysis of Integrated IIBV Sequences 
3.1 Construction and ScreeninE of Genomic DNA Libraries 
3.1.1 Characterisation of Integrated HBV DNA and Cloning Vectors 
The cell lines used in this study were those constructed by Gough and 
Murray, (1982). The cell lines L11304/TK154 and Rat2/1304/TK4 were 
constructed by co-transfection of mouse L (tk) and Rat2 (tk) cells 
respectively, with the plasmid pHBV130.4 (fig. 3.1) and the thymidfne 
klnase gene from the Herpes simplex virus, contained on the plasmid pFG5 
(Colbere-Garapin at al., 1979), as a selectable marker. The resultant 
cell lines were found to express HB5Ag, HBcAg/HBeAg and HBxAg (Gough 
and Murray, 1982; Pugh at al., 1986). 
Examination of the poly (A) RNA isolated from these cell lines showed 
that the cells express four viral specific mRNAs of 44, 39, 24 and 
1-0 kb in length, which hybridise to the minus strand of HBV, indicating 
that they were of the plus strand polarity (Gough, 1983). The 24 kb 
mRNA hybridised to the surface and X genes and was designated the 
surface mRNA in agreement with Chakraborty at al., (1980) and Pourcel at 
al., (1982). The 1'0 kb mRNA specifically hybridised to the X region of 
the HBV genome and therefore was designated the X mRNA. The 39 and 
4•4 kb mRNAs are both greater than genomic length of HBV and were only 
present in cells that expressed HBcAg/HBeAg. It was proposed that one 
of these mRNAs codes for the core protein. The 3•9 kb mRNA is of the 
same order of size as the core mRNA observed in infected liver (Cattaneo 
et al., 1984) and is probably the same HBV transcript. The 1-0 and 
4.4 kb mRNAs have not been observed In infected tissues and may 
possibly be peculiarities of the expression system. However, transcripts 
have been observed to be expressed in hepatoma derived cells originating 
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Figure 3.1. Restriction endonuclease cleavage maps of A) pHBV130 and 
B) pHBV130•4. The heavy lines represent HBV sequences and the thin 
lines represent pBR322 sequences. The location and direction of the 
open translational reading frames are shown on the inner arcs. The 
polymerase and surface genes of pHBV130 are interrupted by pBR322 
sequences. The larger arrow heads on the pHBV1304 map represent the 
four head-to-tail genomic length Bst Eli fragments of HBV ligated 
together to form pHBV1304. Abbreviations: B, Barn HI; Bg, Bgl II; 
Bs, Bst Eli; E, Eco RI; Ps, Pst I; Xh, Xho I. Open reading frames: 
C, core gene; P, polymerase gene; S, surface gene; preSl and preS2, preS 














immediately upstream of the X gene (Trenin and Laub, 1987; Siddiqui et 
al., 1987). These transcripts probably correspond to the X mRNA observed 
by Gough, (1983). It is worth noting that the size difference between 
the 4'4 and 3•9 kb RNA species corresponds to the difference in the 
distance of the mapped positions of the observed initiation sites of the 
core mRNA (Will et al., 1987; Yaginuma et al., 1987b) and the X mRNA 
(Trenin and Laub, 1987; Siddiqui at al., 1987). Therefore, the 44 kb 
mRNA probably corresponds to transcripts from the X gene promoter which 
are polyadenylated upon transcription of a complete HBV genome, 
generating a mRNA with a terminal redundancy of approximately 600 
nucleotides. 
Examination of the integrated HBV DNA contained within these cell lines 
(fig. 3.2), indicates that both cell lines contain multiple copies of 
integrated HBV DNA. The integrated HBV copy number contained in these 
cell lines was determined by Gough and Murray, (1982). The cell line 
Rat2/1304/TK4 contains approximately ten copies of the HBV genome per 
haploid rat genome, whereas, the L/130'4/TK154 cells contain 
approximately one intact HBV genome per haploid genome. The mouse L 
cell line is partially tetraploid and therefore the number of intact HBV 
genornes per cell is probably two to three (Gough and Murray, 1982). 
This estimate of integrated HBV copy number contained in the mouse L 
cell line is probably an underestimate of the true copy number, since 
one of the clones isolated, XLTK154-H7 (see below), contains a complete 
HBV genonle. However, the corresponding fragment on the Southern blot of 
Hind III digested L/130 .4/TK154 DNA is not one of the major hybridising 
bands, indicating that the cells probably contain more than two or three 
integrated copies of HBV. 
Since the pattern of integration of the mouse L cell line L/1304/TK154 
is less complex than the corresponding pattern of Rat2/130•4/TK4, the 
mouse L cell line was chosen for this study. Both cell lines express 
the }iBsAg and HBcAg/HBeAg at equivalent levels (Gough and Murray, 1982). 
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Figure 3.2. Detection of HBV sequences in genomic DNA. The samples 
were separated on 07% (w/v) agarose gels and hybridised to genomic 
length HBV DNA. A) DNA from L/1304/TK154 (10 jig), digested with Eco RI 
(track 1), Hind III (track 2) or Eco RI & Hind III (track 3). To provide 
size markers, bacteriophage Xc1857 DNA was digested with Hind III, sizes 
are given (in W. B) DNA from Rat 2/1304/TK4 (10 J.Lg), digested with 
Eco RI. Molecular size markers used were Xc1857 DNA digested with 
Eco RI & Hind III, sizes are given (in kb). C) Southern blot examination 
of genomic clones, DNA from L/130.4/TK154 (10 jig), digested with Eco RI 
& Hind III (track 1); DNA from )LTK154-H7 digested with Eco RI & Hind III 
(track 2); DNA from XLTK154-R3 digested with Eco RI & Hind III (track 3). 
Molecular size markers used were Xc1857 DNA digested with Hind [II, 
sizes are given (in W. The L/13041TK154 Eco RI & Hind III DNA band 
co-migrating with the XLTK154-R3 fragment is a doublet, the XLTK154-R3 
fragment does not contain a Hind III restriction site. 
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The HBV subtype cloned in pHBV130 and pHBV1304 does not contain either 
Eco RI or Hind III restriction endonuclease cleavage sites. Therefore, 
these enzymes were used for generation of the genomic libraries. 
Digestion of the genomic DNA from the cell line L/1304/TK14 with 
either, or both, of these enzymes results In a complex pattern of HBV 
hybridising bands when analysed by Southern blotting (fig. 3.2). The two 
most strongly hybridising Eco RI fragments are too large to be 
conveniently cloned into the vector XEMBL4. However, digestion with 
Hind III or double digestion Hind III and Eco RI and Southern blot 
analysis indicates that the HBV sequences contained within the two 
largest Eco RI fragments are contained within the two largest Hind III 
fragments which are of clonable size. Therefore, genomic libraries were 
constructed by digestion of the genomic DNA with either Eco RI or 
Hind III and cloning the resultant DNA fragments into the lambda vectors 
XEMBL4 and XCh34 respectively. 
The lambda vectors XEMBL4 and XCh34 can both accommodate DNA inserts of 
approximately 9 to 20 kb. Both vectors were constructed with inverted 
polylinker sequences between the lambda arms and the stuffer fragments 
(Frischauf et al., 1983; Loenen and Blattner, 1983). By using double 
restriction endonuclease digestions it is possible to generate lambda 
arms and stuffer DNA fragments with different ends, thus preventing the 
stuffer fragments from religating to the vector arms. Digestion of 
XEMBL4 with Eco RI and Barn HI or XCh34 with Hind III and Barn HI 
followed by isopropanol precipitation of the nucleic acids, leaves the 
short cohesive linker fragments in the supernatant, thereby eliminating 
the possibility of religation of the middle fragment to the lambda arms 
Frischauf et al., 1983). Using this procedure it is possible to 
selectively enrich for recombinants by ligation of DNA fragments 
containing the same cohesive ends to the lambda arms. The vector 
XEMBL4 was also constructed such that only recombinants will grow on a 
P2 lysogen (Frischauf et al., 1983). The middle fragment of XEMBL4 
contains the lambda red and gam genes which provides a genetic 
selection. Growth of the Sp.t' vector is selected against when plated on 
a E. coli P2 lysogen. Chimeric constructions, which contain a foreign 
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Insert, are effectively red- and gam , therefore the Spt recombinants 
will grow on the P2 lysogen. 
3.1 .2 Construction of the Genomic Libraries 
The L/1304/TK154 chromosomal DNA used for the library constructions 
was obtained from laboratory stocks. Fifty micrograms of chromosomal 
DNA was digested with either Eco RI or Hind III and size fractionated on 
a 10% to 40% (w/v) sucrose gradient. The fractions were analysed by 
agarose gel electrophoresis and 	those containing DNA fragments, from 
6 kb to less 	than 20 kb, were pooled,- dialysed against 10 mM. Tris-HC1 
pH 75, 1 mj EDTA to remove the sucrose and then ethanol precipitated 
(data not shown). 
The genomic libraries were constructed by ligation ca. 0•5 jig of 
digested chromosomal DNA and 1•5 jig of doubly digested, heat inactivated 
(65 *C for 20 minutes) and isopropanol precipitated lambda vector DNA in 
a total volume of 20 jil. The Eco RI generated genomic library using the 
vector XEMBL4 was tested for the efficiency of generation of 
recombinants by in vitro packaging the equivalent of = 0.1 jig of vector 
DNA and plating on E. coil 5K (hsdR) and Q359 (hsoR, P2 lysogen). Only 
recombinants should plate on Q359, whereas, both vector and recombinants 
will grow on 5K. One hundred plaques were picked at random from the 
bacteriophages grown on 5K and replica plated onto separate lawns of 5K 
and Q359. Routinely, 70 to 80% of the phage grown on strain 5K grew on 
Q359, indicating that 70 to 80% of the packaged lambda DNA consisted of 
recombinant molecules. Although the E. coil strain Q359 specifically 
selects for Spt recombinants, it was observed that the efficiency of 
plating in vitro packaged recombinant phage molecules was reduced 
approximately two fold when plated on Q359, relative to plating on 5K 
(data not shown). Therefore, both the Eco RI and Hind III generated 
genomic libraries were in vitro packaged and plated onto E. coil strain 
5K. 
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The Eco RI and Hind III genomic libraries were screened by plaque 
hybridisation using 32 P-labelled pHBV130.4. After screening 
approximately 106 recombinant plaques from each library, one recombinant 
from each library was isolated that hybridised to the probe. The 
positive clones were purified and lambda DNA prepared. The clones were 
found to contain restriction fragments corresponding to the third 
largest HBV Eco RI fragment and seventh largest HBV Hind III fragment of 
L/130•4/TK154. These clones were designated XL1K154-R3 and XLTK154-}17 
respectively. Double digestion of the clones and L/1304/TK154 DNA with 
Eco RI and Hind III and analysis by southern blotting (fig. 3.2), 
indicates that the cloned fragments do correspond to genuine 
integrations contained in L/1304/TK154 and that the clones represent 
separate integrations. 
Further attempts to construct genomic libraries using L/1304/TK154 DNA 
were not possible due to exhaustion of the laboratory stocks of the 
chromosomal DNA, and attempts to recover the L/1304/TK154 cell line 
from frozen stocks were unsuccessful, therefore it was not possible to 
isolate chromosomal DNA from this cell line. The cell line 
Rat2/1304/TK4 was the only readily available, viable cell line of those 
constructed by Gough and Murray, (1982). Geriomic DNA was prepared 
from the Ra t2 / 130 4 /TK4 cell line and used to construct Eco RI genomic 
libraries, as described above, using the vector XEMBL4. After screening 
approximately 5x10 6 recombinants, 5 positive signals (from the same 
ligation reaction) were observed when probing the genomic library with 
32 P-labelled pHBV130.4. Further analysis of these recombinants (XTK4-1 
to >..TK4-5) indicated that the two isolates XTK4-3 and XTK4-4 contained 
only pBR322 derived sequences and were not studied any further (data 
not shown). Southern blot analysis of the remaining clones and Eco RI 
digested Rat2/130•4/TK4 DNA, using 32 P-labelled gel purified HBV DNA as 
a probe, showed that the cloned DNA fragments contained In SK4-1, 
XTK4-2 and XTK4-5 did not correspond to restriction fragments of 
Rat2/1304/TK4 (data not shown). This indicates that these clones arose 
by a cloning artifact. Further analysis by Southern blotting using 
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32 P-labelled XEMBL4 indicated that the central Eco RI fragment of the 
clones hybridises to lambda DNA (data not shown). 
It is evident that the cloning efficiency of the HBV containing fragments 
corresponding to genoniic integrations of the cell lines L/1304/TK154 
and Rat2/1304/TK4 was very low. Screening of the number of 
recombinants isolated should have resulted in the identification of a 
number of HBV positive clones, particularly from the Rat2/1304/TK4 cell 
line. It is possible that the genomic libraries were not completely 
representative due to the preferential ligation of concatemers of small 
DNA fragments into the lambda arms. Alternatively, the HBV integrations 
contained on the restriction fragments, when ligated to the lambda 
vectors, could be unstable when propagated on the E. coil 5K host, due 
to repeated HBV-pBR322 or cellular flanking sequences and were therefore 
lost from the genomic libraries. Several cases have been reported where 
the presence of tandemly-repeated sequences in cloned eukaryotic DNA has 
led to deletion by recombination during phage propagation on certain 
E. coil hosts (Arnheim et al., 1979; Fritsch et al., 1980; Lauer et al., 
1980). 
If the constructions of the genomic libraries were to be repeated, the 
libraries could be propagated on a strain deficient in both exonuclease I 
and V, such as, E. coil CES200 (recBC, sbcB, hsdR) (Nader et al.. 1985). 
Nader et al., (1985) have reported that the strain E. coil CES200 can be 
used for the propagation of XEMBL3 Spt recombinants, which are unstable 
when propagated on other E. coil strains. The strain E. coil CES200 was 
not available when the genomic libraries were constructed and screened 
for the presence of integrated HBV DNA sequences. 
3,2 Analysis of the Genomic Clones 
The DNA fragments cloned into the lambda vectors were analysed by 
heteroduplex electron microscopy, using Eco RI digested pKBV130 
(fig. 3.1) as a probe, and by restriction mapping/Southern blot 
hybridisation, to determine the structure of integrated HBV DNA. 
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The Junctions of the viral and cellular sequences were determined by 
cloning restriction fragments containing the integration sites into M13 
based vectors and determining the nucleotide sequence, as described in 
materials and methods. 
3.2.1 XLTK154-H7 
The structure of the Hind III fragment cloned into XLTK154-H7 was 
determined by heteroduplex hybridisation (fig. 3.3). The heteroduplex 
analysis indicates that the clone contains approximately 114% of HBV 
sequences, from position Ca. 1000 ± 100 through one HBV genome 
equivalent, to the original oligoGC tail Pst I cloning site (ca. 1460 ± 
50), plus approximately 1.5 kb of the pBR322 vector sequences integrated 
into mouse DNA sequences, The structure of XLTK154-H7 was confirmed by 
restriction endonuclease mapping (fig. 3.4). 
The vector XCh34 has the capacity to accommodate DNA fragments of 9 to 
20 kb. It is evident that the Hind III fragment cloned into XLTK154-H7 
is of the order of 56 kb, which would result in the clone being below 
the optimum packaging size. The Hind III digestion of XLTK154-H7 also 
generates a fragment of approximately 225 kb, which corresponds to the 
size of one of the vector stuffer Hind III fragments. At least two of 
these fragments were co-ligated with the REV containing fragment to 
generate XLTK154-H7. The stuffer fragments obviously still contain the 
polylinker attached to their ends, which indicates that the Barn HI 
restriction reaction did not digest to completion. 
The REV Barn HI site at position 1004 was determined to be contained in 
the clone with the corresponding terminal Hind Ill/Barn HI fragment being 
approximately 250 base pairs. The position of the viral-cellular 
Junction was confirmed by gel purifying the H7-Hind III fragment and re-
digesting with Barn HI; the resultant restriction fragments were cloned 
into appropriately digested mp18 and mp19 vectors. The nucleotide 
sequence of the 277 base pair Hind Ill/Barn HI fragment was determined, 
118 
Figure 3.3 Mapping of the HBV sequences In the clone XLTK154-H7 by 
heteroduplex analysis. A) Electron micrograph of a heteroduplex between 
clone XLTK154-H7 and pHBV130 (Eco RI). B) Interpretive drawing of the 
electron micrograph. Thin and thick lines represent single-stranded and 
double-stranded DNA, respectively. C) A schematic representation of the 
heteroduplex structure. Approximate sizes of single-stranded and 
double-stranded regions are given (in W. The HBV-cellular junction is 
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Figure 3.4 	Restriction endonuclease cleavage patterns of >..LTK154-H7. 
Approximately 0•5 	g  of DNA was digested with Hind III (track 1), Hind 
III & Eco RI (track 2), Hind III & Xho I (track 3), Hind III & Bst Eli 
(track 4), Hind III & Barn HI (partial digestion) (track 5), Hind Eli & 
Bg1 II (track 6) and Hind III & Pst I (partial digestion) (track 7). 
A) The DNA fragments were separated on a 07% (w/v) agarose gel. Size 
markers were Rind III digested Xc1857 DNA (track M), sizes are given (in 
W. B) The DNA fragments probed with a radioactively labelled Xho I HBV 
DNA fragment of pHBV130. C) The DNA fragments probed with radioactively 


















indicating that the viral-cellular Junction is positioned at nucleotide 
994 on the HBV130 map (fig. 3.5). 
The XLTK154-H7 Hind III fragment (fig 3.12) contains the complete coding 
sequences for the preS2/surface gene, the X ORF and the preC/core gene. 
Cattaneo et al., (1983b) have postulated that the major surface promoter 
is contained between HBV nucleotides 1188 and 1260, therefore, the H7 
DNA fragment should be capable of directing transcription of the surface 
gene, with the mRNAs being processed at the polyadenylation signal at 
position 16 (Gough, 1983). Also contained on the fragment is the 
complete putative transcriptional unit for the X mRNA (Gough, 1983). 
Although the fragment contains the HBV enhancer, core promoter and the 
complete preC/core gene, it is unlikely to direct synthesis of the core 
protein, due to the lack of an appropriately placed polyadenylation 
signal (Cattaneo et al., 1984). Synthesis of the core mRNAs would 
require co-transcription into pBR322 and also possibly mouse sequence, 
until a suitable polyadenylation signal was transcribed. 
3.2.2 XLTK154-R3 
The pattern of heteroduplexes obtained for the clone XLTK154-R3 was 
very complex due to directly repeating HBV and pBR322 sequences 
contained on the integration. One of the heteroduplexes obtained is 
shown in fig. 3.6 . The pHBV130 molecule hybridised to the XLTK154-R3 
molecule shown in fig. 3.6, is deleted by approximately 1-6 kb from the 
end of the molecule due to fragmentation, possibly resulting from a 
single strand break. The presence of the = 0.5 to 1.0 kb single strand 
end of the Eco RI digested pHBV130 probe, indicates that the cloned 
sequences contain non-homologous sequences to this region, resulting 
from either deletion or inversion of the pBR322 sequences (see below). 
One of the two possible orientations of hybridisation is shown In 
fig. 3.6. The structure shown was confirmed by restriction mapping and 
Southern blot hybridisation. 
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XLTK154-H7 JUNCTION SEQUENCE 
	








mousel 994 HBV Barn HI 
CACACCAAATTTACCACCAGTTGOATCCAGCCTTCAGACAAACACCAACA 
XLTK154-R3 JUNCTION SEQUENCE 






HBV 16551 mouse 	. 	. 	. Xho I 
TGTGTCAAGGTACCAGAAAAATGAAGTCCCTGTCCTCCTCGAG 
figure 3.5 Nucleotide sequence (HBV plus strand) of the HBV-
cellular Junctions of a) XLTK154-H7 and b) XLTK154-R3. Shown are 
relevant restriction endonuclease sites. Integration sites are 
indicated by a vertical bar above the sequence corresponding to the 
terminal HBV nucleotide. 
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Figure 3.6 Mapping of the HEy sequences in the clone XLTK154-R3 by 
heteroduplex analysis. A) Electron micrograph of a heteroduplex between 
clone XLTK154-R3 and pHBV130 (Eco RI). B) Interpretive drawing of the 
electron micrograph. Thin and thick lines represent single-stranded and 
double-stranded DNA, respectively. C) A schematic representation of the 
heteroduplex structure. Approximate sizes os single-stranded and 
double-stranded regions are given (in W. The discontinuities with the 
pHBV130 probe are indicated by approximate HEy co-ordinates (below). 
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The restriction mapping and blot hybridisation of the clone XLTK154-R3 
(fig. 3.7) was more informative than the heteroduplex analysis. The 
presence of the 075 kb Eco RI/Pst I fragment, which specifically 
hybridises to 32 P-labelled pBR322 DNA, corresponds to the size of the 
pBR322 restriction fragment (pBR322 co-ordinates 3608-4361), Indicating 
that the Eco RI cloning site is derived from integrated pBR322 
sequences. The 056 kb Pst I fragment, which specifically hybridises to 
32 	 HBV DNA, corresponds to the expected size of the HBV insert 
present between the two pBR322 vector fragments of pHBV130.4. The 
presence of the 1-3 kb (Eco RI/Xho I) and 0-85 kb (Eco RI/Barn HI) 
fragments, which hybridise to both 32 P-labelled pBR322 and HBV DNAs, is 
consistent with the pBR322 Eco RI cloning site. The failure of the 
075 kb (Eco RI/Bst Eli) fragment to hybridise to HBV DNA is consistent 
with the original oligoG.0 tailing cloning site of pHBV130, being 
immediately upstream of the Bst ElI (915). Using a higher specific 
activity 32 P-labelled HBV probe, this fragment was shown to weakly 
hybridise to HBV sequences (data not shown). The Internal Pst I 
fragment of 38 kb, which hybridised strongly to pBR322 DNA, is smaller 
than the expected length of pBR322 (4.3 kb), indicating that the pBR322 
sequences contain a ca. 05 kb deletion. The presence of the 44 kb 
fragment In the digestions with Xho I, Bst Eli and Barn HI, which 
hybridises to both probes, is also consistent with the pBR322 sequences 
containing a ca. 0.5 kb deletion. 
If the Pst I fragments of this clone were representative of fragments of 
pHBV130.4, it would be expected that the fragments should specifically 
hybridise to either HBV or pBR322 DNA. The 3•8 kb and 195 kb Pst I 
fragments., shown in fig. 3.7, hybridise with both HBV and pBR322 DNA. 
Hybridisation of HBV DNA to the 3•8 kb fragment is not an artifact due 
to vector contamination of the HBV probe, since strand specific 
32 P-labelled HBV DNA (the Xho I genomic length HBV fragment cloned in 
M13mp18) also weakly hybridised to this band (data not shown). The 
hybridisation pattern is consistent with a small inversion of the pBR322 
and HBV sequences surrounding the Pst I site. Since the overlapping 
4.4 kb Bst Eli, Barn HI and Xho I fragments are all of the same size, this 
indicates that the inversion occurred between the Bst Eli and Pst I 
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Figure 3.7 Restriction endonuclease cleavage patterns of )J..TK154-R3. 
Approximately 0.5 g of DNA was digested with Eco RI (track 1), Eco RI & 
Hind III (track 2), Eco RI & Xho I (track 3), Eco RI & Bst Eli (track 4), 
Eco RI & Barn HI (partial digestion) (track 5), Eco RI & Bgl II (track 6), 
Eco RI & Pst I (track 7). A) The DNA fragments were separated on a 0•7% 
(w/v> agarose gel. Size markers were Hind III digested Xc1857 DNA 
(track M), sizes are given (in W. B) The DNA fragments probed with a 
radioactively labelled Xho I HBV DNA fragment of pHBV130. C) The DNA 
fragments probed with radioactively labelled pBR322 DNA. 
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sites. It should be noted that the Eco RI, Hind III and Barn HI sites are 
deleted from the Internal pBR322 sequences. The non-homologous region 
observed in the heteroduplex analysis probably corresponds to the 
Inverted sequences, or both the inverted and deleted sequences. 
The Xho I fragment (a 0'3 kb) which hybridises to HBV DNA, does not 
correspond to a restriction fragment of pHBV130 4, therefore, a viral-
cellular junction probably occurs within this fragment. The 195 kb 
Pst I fragment was gel purified and digested with Xho I. The resultant 
fragments were ligated to Sal I digested mp18 DNA and the nucleotide 
sequence of the 294 base pair Xho I fragment determined (fig 3.5). The 
nucleotide sequence of the small Xho I fragment indicates that the 
viral-cellular junction occurs at HBV position 1655. The restriction map 
of XLTK154-R3 is shown in fig. 3.12. 
3.2.3 XTK4-1 and XTK4-2 
As indicated above, the Rat2/130•4/TK4 genomic clones isolated are the 
result of a cloning artifact. No heteroduplexes were obtained for either 
of the clones XTK4-1 or XTK4-2, possibly due to the limited sequence 
homology between these clones and pHBV130. The structure of these two 
clones was determined by restriction mapping and Southern blotting 
(fig. 3.8, XTK4-1; fig. 3.9, XTK4-2). As with XLTK154-R3, the Eco RI 
cloning site of XTK4-1/2 corresponds to the pBR322 Eco RI site, with the 
cloned sequences being discontinuous with HBV downstream of the Barn HI 
(1004) site (fig. 3.12). The 22 kb Bst ElI fragments from both clones, 
which hybridise to 32 P-labelled HBV DNA, were gel purified. The ends of 
the fragments were "filled in" using the Kienow fragment DNA polymerase 
and ligated to Sma I digested mp18. The nucleotide sequences of the 
Bst ElI fragments are consistent with the HBV DNA being digested with 
Barn HI and ligated to the Barn HI site of the polylinker sequence of 
XEMBL4; with the Barn HI site being immediately followed by a Sal I site 
and vector sequences (data not shown). It is evident that the ligation 
reaction used to generate the genomic library contained a residual 
Barn HI activity that was ineffectively inactivated by heat treatment. 
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Figure 3.8 Restriction endonuclease patterns of XTK4-1. 	Approximately 
0•5 jig of DNA was digested with Eco RI (track 1), Eco RI & Hind III 
(track 2), Eco RI & Xho I (track 3), Eco RI & Bst ElI (track 4), Eco RI & 
Barn HI (track 5), Eco RI & Bgl II (track 6), Eco RI & Pst I (track 7). 
A) The DNA fragments were separated on a 0•7% (w/v) agarose gel. Size 
markers were Hind III digested Xc1857 DNA (track P), sizes are given (in 
kb). B) The DNA fragments probed with a radioactively labelled Xho I HBV 
DNA fragment of pHBV130. C) The DNA fragments probed with radioactively 
labelled pBR322 DNA. 
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Figure 3.9 Restriction endonuclease patterns of XTK4-2. Approximately 
05 pg of DNA was digested with Eco RI (track 1), Eco RI & Hind III 
(track 2), Eco RI & Xho I (track 3), Eco RI & Bst Eli (track 4), Eco RI & 
Barn HI (track 5), Eco RI & Bg.Z II 	(track 6), Eco RI & Pst I (track 7). 
A) The DNA fragments were separated on a 07% (w/v) agarose gel. 	Size 
markers used were Hind III digested Xc1857 DNA (track M), sizes are 
given (in kb). 	B) The DNA fragments probed with a radioactively labelled 
Xho I HBV DNA fragment of pHBV130. C) The DNA fragments probed with 
radioactively labelled pBR322 DNA. 
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The clone XTK4-5 was analysed by heteroduplex analysis (fig. 3.10). The 
heteroduplex analysis indicates that the clone contains approximately 
1.9 kb of homology with pHBV130. One possible heteroduplex orientation 
is shown in fig. 3.10, which indicates that the cloned sequences show 
discontinuities with the HBV sequences at positions 1000 ± 100 and 
2300 ± 100. The structure was confirmed by restriction mapping and 
Southern blot hybridisation (fig 3.11). The 32 P-labelled pBR322 probe 
failed to hybridise to the restriction fragments of this clone, 
indicating that the cloned fragment does not contain pBR322 sequences 
(data not shown). The restriction map of XTK4-5 is shown in fig. 3.12. 
The 2•2 kb Bst Eli fragment from XTK4-5 was gel purified, the ends 
"filled in", cloned into Sma I digested mp18 and the nucleotide sequence 
determined. Like the clones >.TK4-1 and XTK4-2, the sequences 
downstream of the HBV Barn HI (1004) site of XTK4-5, correspond to 
vector sequences (data not shown). The integration site, at the left end 
of the clone, Is not represented by a Barn HI site and therefore, probably 
is a true integration site. Attempts to determine the sequence of the 
integration site were unsuccessful. The integration site is contained on 
the 1.0 kb Eco RI/Barn HI (HBV position 2682) fragment. This fragment 
was Isolated and digested with Stu I (2251, 2396) and the resultant 
fragments cloned into Sma I/Barn HI digested mpl9, Sma I/Eco RI and Sma I 
digested mpl8. The ligated molecules were used to transform E. coli 
NM522 and the resultant plaques screened by plaque hybridisation to 
32 P-labelled HBV DNA. The plaques giving positive signals upon 
hybridisation were sequenced. Only fragments corresponding to HBV 
sequences 2396 to 2682 were identified and sequenced. Repeating the 
sub-cloning obtained the same result. No recombinants corresponding to 
internal Stu I or terminal Eco RI/Stu I fragments were identified. This 
could possibly indicate that the HBV-cellular Junction occurred 
immediately upstream of the Stu I (2396) site, with the number of 
nucleotides being homologous to the probe being limited, reducing the 
efficiency of hybridisation. The results of the heteroduplex analysis 
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Figure 3.10 Mapping of the HBV sequences in the clone XTK4-5 by 
heteroduplex analysis. A) Electron micrograph of a heteroduplex between 
clone XTK4-5 and pHBV130 (Eco RI). B) Interpretive drawing of the 
electron micrograph. Thin and thick lines represent single-stranded and 
double-stranded DNA, respectively. C) A schematic representation of the 
heteroduplex structure. Approximate sizes of single-stranded and 
double-stranded regions are given (in W. The discontinuities with the 
pHBV130 probe are indicated by approximate HBV co-ordinates (below). 
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Figure 3.11 Restriction endonuclease patterns of XTK4-5. Approximately 
0.5 g of DNA was digested with Eco RI (track 1), Eco RI & Hind III 
(track 2), Eco RI & Xho I (track 3), Eco RI & Bst Eli (track 4), Eco RI & 
Barn HI (partial digestion) (track 5), Eco RI & Bgl II (track 6), Eco RI & 
Pst I (track 7). A) The DNA fragments were separated on a 07% (wfv) 
agarose gel. Size markers used were Hind III digested Xc1857 DNA 
(track M), sizes are given (in W. B) The DNA fragments probed with a 
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Figure 3.12 Restriction endonuclease maps of the genomic clones 
isolated from the cell lines L/130•4/TK154 and Rat2/1304/TK4. 
The shaded blocks represent HBV sequences, the open blocks represent 
pBR322 sequences, solid thin lines represent eukaryotic sequences and 
dashed horizontal lines represent lambda sequences. a) XLTK154-H7, 
showing the HBV-cellular integration site at position 994. Shown above 
the map are the HBV transcriptional regulatory signals: SRI, preSi gene 
promoter; SPIt, preS2/surface gene promoter; En/XP, HBV Enhancer regionfX 
gene promoter region; CR, core promoter region; poly(A), polyadenylation 
signal. Shown below the map are the relative positions of the viral 
open reading frames: C, core gene; P, polymerase gene; preS/S, 
preS/surface gene, X, X gene. b) XLTK154-R3, showing the HBV-cellular 
integration site at position 1655. Also shown is the HBV-pBR322 
inversion surrounding the Pst I site, above the map is shown the 
approximate position of the ca. 05 kb pBR322 deletion. c) XTK4-1, 
showing the position of the ligation of the HBV sequences (position 
1004, Barn HI) to bacteriophage lambda (X) sequences (dashed line). 
XTK4-2, showing the position of the ligation of HBV sequences 
(position 1004, Barn HI) to bacteriophage X sequences (dashed line). 
XTK4-5, showing the approximate position of the HBV-cellular 
integration at HBV position 2300 ± 100. Also shown is the position of 
ligation of HBV sequences (position 1004, Barn HI) to bacteriophage X 
sequences (dashed line). Shown below the map is the relative positions 
of the viral open reading frames contained on this clone 
(see fig. 3.12a). Restriction endonuclease abbreviations: B, Barn HI; Bg, 
Bgl II; Bs, Bst Eli; E, Eco RI; H, Hind III; Ps, Pst I and Xh, Xho I. 
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are consistent with this hypothesis, suggesting that the integration site 
is at approximate HBV position 2300 ± 100. 
!I Uii- 
A model of HBV integration has been proposed by Koshy et al., (1983) and 
Koch et al, (1984b). These authors observed that three HBV Integrations 
Isolated from the PLC/PRF/5 cell line contained the HBV-cellular 
integration events within the single stranded region present in the Dane 
particle HBV genome. Their hypothesis assumes that replicative 
intermediates within the nucleus of the infected cell contain regions of 
single stranded DNA analogous to the Dane particle DNA. The model 
proposes that the integrative process interacts with cellular DNA 
replication. Interaction between the HBV genome and cellular sequences 
could possibly be facilitated by transient alignment of short stretches 
of nucleotide homology between the HBV and cellular sequences (Koch et 
al., 1984b). DNA polymerases using the cellular template are proposed to 
switch to the single stranded gap region of the HBV genome close to the 
5' end of the short strand. A recombination event then joins the long 
strand with the cellular sequences, which was previously the template 
for DNA polymerase. Finally, the single-stranded regions are filled and 
ligated to yield an integrated HBV DNA molecule. The authors propose It 
is possible that this mechanism also uses other single-stranded regions 
of the viral genome; either the naturally occurring "nick" or randomly 
generated nicks. If this model is correct, HBV integration would take 
place preferentially via the large single strand gap. 
A more extensive analysis of integrated HBV DNA present in the Alexander 
cell line (Shaul et al., 1984; Ziemer et al., 1985), indicates that the 
viral-cellular junctions are essentially dispersed over the entire HBV 
genome, with some preference for integration to occur within the double-
stranded region of the genome. Therefore, these results are 
inconsistent with the above model. The results obtained in this study 
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are consistent with this observation of random integration with no 
specific viral sequences required for integration; with integration sites 
at HBV nucleotides 994, 1655 and 2300 ± 100. However, it is probably 
not a reasonable assumption that the integration pattern observed in 
this study represents natural integration events, due to structural 
differences between the transforming DNA used to construct L/130 4/TK154 
and Rat2/I304/TK4 and the native HBV genome. Gough and Murray (1982) 
used pHBV1304, which consists of four fully double-stranded head-to-
tail copies of HBV DNA cloned between two copies of pBR322, to transform 
mouse L and Rat2 cells using the calcium-phosphate procedure. The 
naturally occurring intracellular HBV DNA exists in two forms: i) the 
nuclear monomeric covalently closed double stranded DNA which is used as 
transcriptional templates, and ii) the cytoplasmic replicative forms with 
structures reminiscent of the Dane particle DNA. The observations of 
Dejean at al., (1984), Hino at al., (1986) and Yaginuma at el., (1987a), 
indicate that semi-specific integration can occur via the DR sequences, 
which probably represents a recombination event via the free ends of 
replicative intermediates. The DNA molecules used by Gough and Murray 
(1982) did not contain these free ends, therefore recombination in this 
manner would not have occurred. 
The strongest impression obtained from the several detailed descriptions 
of integrated DNA from primary tumours (Dejean at al., 1984, 1986; Rogler 
at al., 1985; Fowler at al., 1986; Hino at al. 1986; Yaglnuma at al., 
1987a) and hepatoma derived cell lines (Dejean at al., 1983; Koike at al., 
1983; Koshy at al., 1983; Koch at al., 1984b; Shaul at al., 1984,1986b; 
Mizusawa, at al., 1985; Yeginuma at al., 1985; Zeimer, 1985; Berger and 
Shaul, 1987), is one of irregularity. The integrated viral DNA may be 
co-linear with the genome or rearranged with one or more deletions or 
inversions. The cellular sequences that serve as integration sites show 
no obvious relationship to each other, nor to the recombination sites 
within the viral DNA. The host integration sites may be located on any 
of several chromosomes, with the chromosomes exhibiting deletions, 
inversion, duplication and trans-locations. All of these features are 
reminiscent of nonhomologous events that mediate integration of 
experimentally transfected DNA into cellular chromosomes. Therefore, the 
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study of experimentally integrated DNA may exemplify the integration 
mechanisms of HBV DNA. 
The microinjection studies of Folger et al., (1982) indicate that linear 
DNA molecules have an integration efficiency 40-fold greater than 
circular molecules. Examination of integrated sequences indicates that 
recombination events occur at random when using circular molecules. 
However, linear molecules tend to integrate at the ends of the fragments 
with very little loss of terminal sequences, however, the original 
restriction endonuc].ease sites are deleted. These results suggest that 
linear molecules are the preferred substrate for illegitimate 
recombination of exogenous DNA in the mammalian genome and that such 
molecules are integrated via their ends. In support of this model, it 
has been shown that mammalian cells can introduce double-strand breaks 
in exogenous DNA (Wake et al., 1984) and that free ends of DNA are 
efficiently ligated (Folger et al., 1982; Wilson et al., 1982; Wake et al,, 
1984). It has been proposed that the principal mechanism of 
nonhomologous recombination in transfected DNA is end-to-end ligation 
(Wilson et al., 1982; Wake et al., 1984). Wake et al., (1984) propose 
that integration of foreign DNA into host chromosomes, may possibly 
occur by ligation of the foreign DNA into transient chromosomal breaks. 
Bullock et al., (1985) have proposed that eukaryotic topoisomerase type I 
may be involved in illegitimate recombination. Topoisomerase I reactions 
involve double-stranded DNA substrates which are nicked at discrete loci, 
with the enzyme remaining bound to the DNA by a covalent linkage to the 
3'-phosphate at the site of the break. The closing of the nick Is 
mediated by topoisomerase I by ligation of the 3 1-phosphate to the 
5 1-hydroxyl. Bullock et al., (1985) propose that the religation reaction 
may not always be proficient and that free 3' ends containing bound 
topoisomerase I could be capable of ligation to other DNA strands 
containing a free 5'-hydroxyl. Nicking by topoisomerase I of DNA, near a 
pre-existing nick or gap on the opposite strand, could generate a double 
strand break if the number of complementary nucleotides between the 
strand breaks were insufficient to hold the double stranded structure 
together. Ligation utilising the topoisomerase I activity of the double 
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strand breaks to chromosomal nicks, possibly also generated by 
topoisomerase I, could facilitate illegitimate recombination. The 
ligation of exogenous DNA into the chromosomal DNA need only account for 
one strand of the junction sequence. The single strand could give rise 
to complementary sequences by serving as a template for subsequent 
rounds of DNA replication or DNA repair. This model of Bullock et al., 
(1985) is essentially consistent with the proposed models of Folger et 
al., (1982) and Wake et al., (1984). 
If the above models do represent the mechanism of HBV DNA integration, 
it is conceivable that random double stranded breaks are introduced into 
the nuclear covalently closed HBV DNA, which then recombine, by ligation 
mechanisms, with cellular sequences via transient breaks in the genomic 
DNA. The observation that HBV DNA integrates via the DR sequences is 
also consistent with the above hypothesis. Tuttleman et el., (1986) have 
shown that the nuclear supercoiled HBV DNA is generated by de novo 
synthesis in the cytoplasm and not by semi-conservative replication. 
Therefore, it is possible that open circular replicative forms are 
transiently present in the nucleus. The open circular molecules would 
need to be processed to remove the protein and RNA primers and the 
terminal redundancy Er] before ligation of the viral strands. Therefore, 
replicative intermediates will contain free DNA ends which could 
integrate via the above proposed model. It is possible that single 
strand breaks, in either the gap region or opposite the "nick" of 
replicative intermediates, would also generate linear substrates for 
integration which is consistent with the observation of integration 
occurring within the cohesive end region (Nagaya et al., 1987). 
Yaginuma et al., (1987a) have observed that one isolated HBV integration 
from a tumour appears to have Integrated via the terminal redundancy 
present on the 5' and 3' ends of the minus strand of a replicative 
intermediate. The integration event resulted in the loss of two-three 
nucleotides from the 3' end of the minus strand, with a concomitant loss 
of 16 base-pairs from the chromosomal DNA at the site of integration. 
Dejean et al., (1984) have suggested that homologous recombination 
events may be involved in HBV integration, with a specific recombination 
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event occurring within the direct repeat sequences and chromosomal DNA. 
The chromosomal clone of Yaginuma et al., (1987a), corresponding to the 
integration site of the above HBV integration, showed no significant 
sequence homology between viral and chromosomal DNA sequences, 
therefore, homologous recombination is probably not a general mechanism 
involved in HBV integration. 
If semi-specific integration does occur via the free ends of replicative 
intermediates, the DR2 integration event observed by Dejean et al., 
(1984,1986) would require transient formation of a covalent RNA-DNA 
hybrid to produce the observed Junction, since the site of Integration 
corresponds to the putative RNA primer sequence. Therefore, it is 
possible that this integration site does not represent an event mediated 
by the free DNA end of a replicative intermediate, but that it could 
represent, a random integration site which is fortuitously placed within 
the DR2 sequence. 
The majority of the observed patterns of HBV integration are consistent 
with random integration events. Therefore, it is possible that the 
initial stages of integration may involve the generation of random, 
single or double strand breaks Into the HBV genomic DNA, which then 
recombine with the cellular genome via single strand ligations to 
genomic "nicks", rather than template switches during chromosomal 
replication as proposed by Koshy et al., <1983) and Kock et al., (1984b). 
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Chapter Four 
Results and Discussion 
Transcriptional Control of the Major -Surface Promoter 
4.1 Analysis of HBsAg Expression Directed by Chromosomally Integrated. 
MBV DNA, 
4.1.1 Transfection of Eukaryotic Cells with XLTK154-H7 
Analysis of the genomic clones isolated in bacteriophage lambda vectors, 
indicated that only the clone %LTK154-H7 contains a complete HBV 
integration capable of expressing native HBV transcripts. The viral/cell 
DNA junction at position 994 on the HBV map is situated between the 
preSl "TATA box promoter (position 876-882) (Rall et al., 1983) and the 
Putative preS2 /surface "SV4O-late-like" promoter (positions 1188-1260) 
(Cattaneo et al., 1983b). Therefore, if the results of Standring et al., 
(1984) are correct, in that the preS2/surface promoter can act 
Independently of the preSl promoter, the clone X/LTK154/H7 should be 
capable of directing transcription of the major surface mRNA from the 
preS2/surface promoter. To confirm the results of Standring et al., 
(1984), the clone XLTK154-H7 was used to transfect the HPRT deficient 
cell line RJK88 by co-transfection of XLTK154-H7 DNA with the mouse 
HPRT mini-gene contained on the plasmid pDWM1 (Melton et al., 1986). 
The mouse HPRT mini-gene consists of a chimeric HPRT gene, constructed 
by ligation of restriction fragments from genomic and cDNA clones to 
remove most of the introns. The 33 kb mouse HPRT gene was reduced in 
size to a 3 kb mini-gene containing the mouse HPRT promoter, the entire 
5' and 3' untranslated regions and the coding sequence interrupted by 
the last two introns (Melton et al., 1986). 
Calcium phosphate transformations were conducted in duplicate as 
described in materials and methods; 5 pg of XLTK154-H7 DNA was digested 
with Hind III and mixed with 50 ng of Eco RI digested pDWM1 (ie. at an 
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approximate ratio of the linear Hind III H7 fragment (- 5-6 kb) to Eco RI 
digested pDWMI (- 5•9 kb) of 10:1 molar ratio). As a positive control 
for transformation efficiency 50 ng of Eco RI digested pDWM1 was mixed 
with 5 jig of sonicated calf thymus DNA (sCTD). Both DNA preparations 
were used to transform the cell line R1K88. The transformed cells were 
selected by growth in DMEM/HAT medium. The duplicate XLTK154-H7 
co-transformations yielded 4 and 3 HAT resistant colonies each (60 to 80 
HAT resistant colonies/jg of pDWM1); the cell cultures were designated 
RJK88/H7-1 and R3K88/H7-2 repectivly. The control pDWM1/sCTD 
transformation yielded 31 HAT resistant colonies (620 HAT resistant 
colonies/jig of pDWM1); a negative control culture from this 
transformation was maintained and designated R1K88/HPRT. 
It is evident that the presence of the Hind III digested XLTK154-H7 DNA 
in the transformation mixture reduced the efficiency of transformation. 
It was observed that during the transformation procedure, the samples 
containing XLTK154-H7 DNA formed large aggregated calcium phosphate 
precipitates on the surface of the cells. Whereas, with the samples 
containing pDWMI/sCTD the precipitates were smaller and evenly dispersed 
over the surface of the cells •. It is possible that the presence of the 
bacteriophage X arms of 20 and 9 kb (approximately 29 kb when joined by 
annealing of the cos ends) being large DNA molecules could cause 
aggregation of the calcium phosphate precipitates preventing even 
dispersion of the precipitate, and therefore, reducing the transformation 
efficiency by limiting the number of cells exposed to the transforming 
DNA. 
4.1.2 Analysis of Integrated DNA in the Transformed Cells 
Total chromosomal DNA was prepared from the R31(88/H7-1 and RYK88/H7-2 
cultures; 10 pig of DNA was digested with Barn HI and the DNA fragments 
separated by agarose gel electrophoresis. The DNA was transferred to 
nitrocellulose filters and probed with 32 P-labelled Xho I digested 
genomic length HBV DNA. After one weeks exposure, very faint signals 
corresponding to HBV Barn HI fragments of 1-5 and 1-7 kb were visible on 
148 
the autoradiograph, indicating that cell line R1K881H7-1 contained 
integrated HBV DNA. DNA from the cell line RJK88/H7-2 showed no 
hybridisation to the probe (data not shown). The southern blot was 
repeated using 100 j.ig of RJ1(88/H7-1 DNA per lane; the DNA was digested 
with restriction enzymes that would give diagnostic restriction patterns 
for the H7 DNA fragment (fig. 4.1a). The southern blot shows that 
digestion of R1K88/H7-1 DNA with the restriction enzymes generated the 
corresponding major HBV hybridising fragments of 3'2 kb (Xho D, 1'5 and 
1-7 kb (Barn HI) and 2-8 kb (Pst I). All these fragments correspond to 
internal restriction fragments of the H7 clone indicating that at least 
one complete copy of the HBV H7 sequences between positions 
1004-3182/1-(-1460 ± 50) is integrated into the genome of the cell line. 
The presence of the 56 kb Hind III fragment, which hybridises to HBV 
DNA is suggestive that an uncut XLTK154-H7 molecule may have integrated 
into the genome of the cells. Another possibility is that the Hind III 
digested fragments formed concatemers by end-to-end ligation prior to 
the integration event (Wilson et al., 1982; Folger et al., 1982), thus 
preserving the Hind III restriction sites. 
4.1.3 Analysis of HBV mRNA Directed by the Integrated HBV Sequences 
Poly (A) RNA was prepared at the same time as the genomic DNA. The 
poly(A) RNA, from the equivalent of 10 Petri dishes (10 cm diameter), 
was separated on a 1-3% agarose/formaldehyde gel. Poly (A) RNA from one 
dish of the cell line Rat2/130'4/TK4 was separated on the same gel as a 
positive control. The RNA was transferred to a Hybond-N membrane and 
probed with 32 P-labelled genomic length HBV DNA (fig. 4.1b). The 
autoradiograph shows that the cell line Rat2/130'4/TK4 produces a HBV 
mRNA of the expected size for the HBsAg mRNA (2'3 kb; fig. 4.1b, lane 2) 
(Gough, 1983). In the adjacent lane (RJK88/H7-1; fig. 4.1b, lane 3) is a 
very faint signal corresponding to a mRNA migrating slightly slower than 
the Rat21130'4/TK4 surface mRNA. It is possible that this mRNA also 
corresponds to the surface mRNA. The slower rate of migration may be 
due to an artifact of the electrophoresis system since at least 10-fold 
as much RNA was loaded onto this lane, with the large quantity of RNA 
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Figure 4.1 Examination of HBV nucleic acids contained In the cell line 
RJK88/H7-1. 
Southern blot of R1K88/H7-1 chromosomal DNA (100 pig/track) digested 
with Hind III (track 1), Xho I (track 2), Barn HI (track 3) and Pst I 
(track 4). The DNA digestions were separated on a 0'7% (w/v) agarose 
gel, transferred to nitrocellulose and probed with a 32 P-labelled Xho I 
digested unit length HBV fragment from pHBV130. Size markers used were 
Eco RI & Hind III digested Xc1857 DNA, sizes are given (in kb). 
Northern blot of poly(A) RNA isolated from tissue culture cells 
containing integrated HBV DNA. Poly(A) RNA from the equivalent of a 
confluent culture of one x 10 cm diameter Petri dish, Rat2 cells 
(track 1), Rat2/1304/TK4 cells (track 2); from ten x 10 cm diameter 
Petri dishes, Rfl(88/H7-1 (track 3), R5K88/HPRT (track 4). The RNA was 
separated on a 1.3% (w/v) agarose/formaldehyde gel, transferred to 
Hybond-N membrane (Amersham) and probed with a 32 P-labelled Xho I 
digested unit length HBV fragment from pHBV130. The position of the 
arrow indicates the position of a faintly hybridising signal in track 3. 
Size markers used were mammalian 28 and 18S rRNA (ca. 4700 and 1800 
nucleotides). 
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inhibiting migration. Two other possibilities may account for the slower 
rate of migration: 1) the mRNA could be a co-transcript of hamster/mouse 
sequences and HBV sequences and is therefore, slightly larger than the 
native HBV surface mRNA or ii) that the signal corresponds to a local 
area of high background and does not represent hybridisation to MBV 
rnRNA. The result obtained from the northern blot is suggestive that the 
SPII promoter is transcriptionally active if taken in conjunction with 
the radio immunoassays (RIA) for the presence of HBV surface antigen In 
the medium (see below). 
4.1.4 HBsAg Expression Directed by Integrated HBV Sequences 
The medium from the cells used to isolate DNA and RNA was pooled; 
200 p1 samples were tested in duplicate for the presence of secreted 
HBsAg by RIA using the Abbott AUSRIA-II assay for HEsAg. A positive to 
negative signal ratio (P/N) of 2•1, or greater, is considered statiticèJ1y 
positive for the presence of HBsAg. The signals obtained for the 
radioimmunoassay conducted using neat culture medium indicated that the 
cell line R1K88/H7-1 was not producing significant amounts of HBsAg. 
The figures obtained for the P/N ratios were below 21 and were of the 
same order as the signals obtained for the negative control RJ1(88/HPRT 
(Table 4.1). The cell line R1K88/H7-1 definitely contains integrated HBV 
DNA and the results of the northern blot were suggestive that the 
surface gene was being transcribed. It is possible that the level of 
secreted HBsAg in the medium was below the level of detection of the 
radioimmunoassay. 
The volume of culture medium obtained from the DNA and RNA preparations 
was in the order of 300 ml. Since the HBSAg is usually present as 
22 nm particles, it was reasoned that it may be possible to recover the 
liBsAg particles from the medium by high speed centrifugation. Two 
hundred millilitres of the pooled medium were clarified by centrifugation 
at 5,000 rpm for 10 minutes in a Sorval]. GSA rotor to remove cellular 
debris. The clarified medium was subjected to high speed centrifugation 
for 12 hours at 23,000 rpm in a MSE lOxlOO ml rotor and the pellets 
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P/N P/N Total protein 
neat (x200) conc. 	of 
medium medium (x200) medium 
mg/ml 
RJK88/H7-1 	1•2 2•3,2•4 21•5 
RJK88/HPRT 	1.2 1•4,1•4 210 
Radioimmunoassay results for HBsA8 present in the culture medium of 
RJK88 cells containing chromosomally integrated REV DNA. Duplicate 
assays were conducted with 200 jd sample volumes using the AUSRIA 
11-125 (Abbott) HBsAg radioimmunoassay, the figures given are the 
average of the duplicate assays. (x200) samples were prepared by ultra-
centrifugation of the culture medium samples and resuspending the 
pellets in 1/200 of the initial volume of phosphate buffered saline. 
Total protein concentrations of the (x200) concentrated samples were 
determined by the method of Lowry et al., (1951). 
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resuspended in 1 ml of phosphate buffered saline (ie 1/200 of the 
initial volume) at 4C for 24 hours. It was not possible to resuspend 
all the pellet due to the presence of some Insoluble material. The 
concentrated samples were clarified by centrifugation for 15 minutes in 
a microcentrifuge to remove the insoluble material, and the supernatants 
transferred to a fresh 1-5 ml microcentrifuge tube. The protein 
concentration of the resuspended pellets was determined by the Lowry 
assay as described in materials and methods. The samples were then 
tested by RIA for the presence of HBsAg, in duplicate, on two separate 
occasions. The results of these assays are presented in table 4.1. The 
concentrated sample from the cell line R1K88/H7-1 consistently gave a 
P/N ratio in the order of 2'3-2'4 which is just above the level of 
statistical significance for the presence of HBsAg. The level of P/N 
ratio obtained for RJK88/H7-1 is probably not an artifact due to high 
levels of protein in the solutions since, the protein concentration of 
the negative control R31(88/HPRT and RJK88/}i7-1 were not significantly 
different. This most probably indicates that the H7 transformed cell 
line does express HBsAg at very low levels. 
In an attempt to confirm that the signals obtained from the RIAs were 
indicative of the presence of HBsAg, analysis of the HBsAg proteins was 
attempted by SDS polyacrylamide gel electrophoresis (SDS-PAGE) and 
western blotting. Aliquots of the above concentrated protein samples 
(50 l) were immunoprecipitated using the double antibody precipitation 
procedure, as described in materials and methods, using a high titre 
chimpanzee anti-HBs serum, raised against yeast derived HBsAg (Murray et 
al., 1984). The immunoprecipitates and 50 1.1 of non- immunoprecipitated 
samples were separated by SDS polyacrylamide gel electrophoresis and 
transferred to nitrocellulose filters. The filters were probed with 
rabbit anti-HBs, raised against SDS denatured yeast derived HBsAg 
P. Wingfield, personal communication), and then incubated with 
1 25 Ilabelled protein A and exposed to X-ray film, No signals were 
obtained corresponding to the expected migration position of the major 
HBsAg proteins, p25 and gp28 (data not shown). The concentrated protein 
samples (see above) from RJK88/HPRT and R3X88/H7-1 were labelled in 
vitro with 1. 25 lodine using lodogen, with approximately 85% incorporation. 
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The 125 I-labelled  proteins were immunoprecipitated as described above 
and separated by SDS-PAGE. The polyacrylamide gel was dried and exposed 
to X-ray film; again no HBsAg proteins were observed. As a final 
attempt to identify the HBsAg proteins, the cellular proteins were 
labelled in vivo in the presence of L-[ 3 5 S]Methionine. Concentrated 
HBsA8 samples were prepared from the medium by ultra-centrifugation, 
immunoprecipitated and separated by SDS-PAGE as described above; again 
no labelled HBsAg proteins were observed. The inability to detect the 
HB5Ag proteins using the methods described above is most likely due to 
the very low abundance of HBsAg in the preparations, being below the 
detection limits of the procedures. 
Due to the very low expression levels of HBsAg the cell line RflC88/H7-1 
was not studied any further. It is evident from the Southern blot 
experiment that the cell line RJK88/H7-1 is a heterogeneous culture with 
only a minority of cells containing integrated HBV DNA. Attempts to 
clonally purify the cells containing the HBV integration(s) were 
unsuccessful. Attempts to repeat the transformation procedure to obtain 
further cell lines containing the integrated H7 fragment were also 
unsuccessful. Since the weak signals obtained from the northern blot 
analysis and HBsAg RIAs could.be artifacts of the system, it is not 
say 
possible to"conclusively 	- that the SPII promoter is transcriptionally 
active In the system studied here. However, the overall results obtained 
for HBsAg expression by the cell line R1K88/H7-1 are suggestive that the 
cloned Hind III fragment contained in XLTK154-H7 is capable of directing 
transcription/expression of the HEsAg, indicating that the SPII promoter 
is transcriptionally active in the absence of the SPI promoter. This 
result was confirmed using an in vivo transient expression assay system 
described in section 4.5. 
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4.2.1 Nucleotide Comparisons 
Cattaneo et al., (1983b) originally proposed that sequences between HBV 
nucleotides 1188 to 1260 as the major promoter region for the HBsAg 
mRNA. This was based on the observation that these sequences, 
positioned immediately upstream of the mRNA initiation site, share 
extensive DNA nucleotide homology with sequences shown to regulate the 
transcription of the SV40 major late mRNA (Brady et al., 1982; Contreras 
at al., 1982; Cattsneo at al,, 1983a). Examination of the transcriptional 
and genetic maps of all the sequenced Hepadnaviruses (see Chapter One, 
fig. 1.3 to 1.6 inclusive) indicates that all the hepatitis B like viruses 
encode a major surface antigen transcript in relatively the same 
position on their respective sequences. Therefore, it is possible that 
sequences important in regulation of transcription of the surface mRNAs 
could have been conserved throughout the evolution of the viruses. 
The major HBV surface antigen promoter region and flanking sequences 
(from the unique Bst Eli site to the end of the preS2 region, HBV130 
positions 915-1436) were compared to the corresponding sequences of the 
other subtypes of HBV, GSHV and WHV sequences. Nucleotide comparisons 
were performed using the University of Wisconin Genetics Group software 
package (v.4), gap and pretty programs. The output of these programs 
was -- manually edited to optimise alignment of the nucleotide sequences 
(fig. 4.2). It was not possible to conveniently align the surface 
promoter region of the DHBV sequence, due to its divergence from the 
sequences of the mammalian viruses. 
The nucleotide comparisons indicate that there are blocks of conserved 
nucleotide sequence among the mammalian viruses. These blocks of 
nucleotide homology are shown on fig. 4.2 (a to d). Conserved DNA 
sequences may not necessarily represent transcriptional regulatory 
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Figure 4.2 Nucleotide comparison of the major surface promoter regions 
of the mammalian hepatitis B like viruses. The consensus sequence was 
generated by a plurality of 8 homology (ie. 8/10 matching nucleotides), 
presented below the sequences. Regions of conserved nucleotide homology 
are indicated (a to d). The initiation methionine codons for the preSi 
and preS2 regions are Indicated, the nucleotide positions of the mapped 
transcriptional Initiation sites are indicated with a + above the 
repective sequence. The positions of relevant restriction eridonuclease 
sites present in the HBV130 nucleotide sequence are shown. 
(References: Galibert at al,, 1979,1982; Valenzuela et al,, 1980; Fujiyama 
et al., 1983; Ono et al., 1983; Mandart et al., 1984; Seeger et al., 1984; 
Buscher et al., 1985; Enders at al., 1985; Kodema et al., 1985; Moroy et 




a 	 ------- PreSi 
HBV130 	915 GGTcA . CCATATTCTTGGGAACA . AGA. . GCTAcA ............... 
HBVadr 915 GGTcA.CCATATTCTTGGGAACA.AGA. .GCTAcAGCAtgggaggttggt 
HBVadr4 915 GGTcA.CCATATTCTTGGGAACA.AGA. .GCTAcAGCAtgggaggttggt 
HBVadw 921 GGTcA . CCATATTCTTGGGAACA . AGA. . GCTAcAGCAt ........... 
HBVadw2 921 GGTcA.CCATATTCTTGGGAACA.AGA. .GCTAcAGCAtgggaggttggt 
HBVayr 915 GGTcA.CCATATTCTTGGGAACA.AGA. .GCTAcAGCAtgggaggttggt 
HBVayw 	915 GGTcA. CCATATTCTTGGGAACA.AGA. . tCTAcA ............... 
GSHV 926 GGTaAaCCATATTCTTGGGAACAcAGAcaGCTAgAGcAacataatgggca 
WHy 	929 GGTaAaCCATATTCTTGGGAACACAGACaGCTAgtGCAaCataatgg9Ca 
WHV2 925 GGTaAaCCATATTCTTGGGAACAcAGAcaGCTAgtGCAacataatgggca 
Consensus 	GGT-A-CCATATTCTTGGGAACA-AGA--GCTA-AGCA------------ 
DHBV 	1121 GGTcAgCCtTATaaTTGGGAACA 1143 
HBV13O 
HBVadr 	961 	cttccaaacc ........................................ 
HBVadr4 961 	cttccaaacc ........................................ 
HBVadw 
HBVadw2 	967 	catcaaaacc ........................................ 
HBVayr 961 	cttccaaacc ........................................ 
HBVayw 
GSHV 	976 acaacataaaagtaacattcgatcccaacaaattagctgcatggtggcca 
WHV 979 acaacataaaagtcaccttcaatccagacaaaatagcagcgtggtggcct 
WHV2 	975 acaacataaaagtcaccttcaatccagacaaaatagcagcatggtggcct 
Consensus 
HBV13O 
HBVadr 	971 	............................................. tcgac 
HBVadr4 971 .............................................. tcgac 
HBVadw 	956 	............................................. tcgca 
HBVadw2 977 ............................................. tcgca 
HBVayr 	971 	............................................. tcgac 
HBVayw 
GSHV 	1026 acagtgggaacttattatacacccactaccaccgtgacaaatccag.caa 
WHV 1029 gcagtgggcacttattacacaaccacttaccctcag ....aaccagtcag 
WHV2 	1025 gcagtgggcacttattacacaaccacttatcctcag .... aatcagtcag 
Consensus 
PreSi 
HBV130 	946 .. .gcatggggcaGAATcTtTCcaccagCAatcCTctgggATtC. tttcC 
HBVadr 976 aaggcatggggAcGAATcTtTCtgttccCAatcCTctgggATtC.tttcC 
HBVadr4 976 aaggcatggggAcGAATcTtTCtgttccCAatcCTctgggATtC. tttcC 
HBVadw 961 aaggcatggggAcGAATcTtTCtgttccCAaccCTctgggATtC. cttcC 
HBVadw2 982 aaggcatggggAcGAATcTtTCtgttccCAatcCTctgggATtc. tttcC 
HBVayr 	976 aaggcatggggAcGAATcTtTCtgttccCAatcCTctgggATtC. tttcC 
HBVayw 946 . . . gcatggggcaGAATcTtTCcaccagCAatcCTctgggATtC. tttcC 
GSHV 	1075 ta. ttcaaaccAgGAATtTaTCagacaaCgtcttTaaaaaATcCaaagaa 
WHV 1075 tgtttc . aaccAgGAATtTaTCaaacaaCAtcttTggtaaATcCcaaaac 
WHV2 	1071 tgtttc . aaccAgGAATtTaTCaaacaaCAtctCTgataaATcccaaaaa 
Consensus 	----------- A-GAAT-T-TC ------ CA --- CT ----- AT-C ----- C 
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BamHI 
HEV1 30 992 cgAcCAccAGTTGGAtcCaGcctTCagAgCaAacaccAAcaAtccAGATT 
HBSladr 1025 cgAtCAccAGTTGGAccCTGcgtTCggAgCcAacTcaAAcaAtccAGATT 
HBVadr4 1025 cgAtCAccAGTTGGAccCTGcgtTCggAgCcAacTcacAcaAtcccGATT 
HBVadw 1010 cgAtCAtcAGTTGCAccCTGcatTCggAgCcAacTcaAcaaAtccAGATT 
HBVadw2 1031 cgAtCAtcAGTTGGAccCTGcatTCggAgCcAacTcaAAcaAtccAGATT 
HBVayr 1025 cgAtCAccAGTTGGAccCTGcgtTCggAgCcAacTcaAAcaAtccAGATT 
HBVayw 992 cgAcCAccAGTTGGAtcCaGcctTCagAgCaAacaccgcaaAtccAGATT 
GSHV 	1124 tcAaCAagAGTTaGAtgCTatacTtatgaCaAgaTacAAagAaatAGAPT 
WHV 1124 tcAaCAagAacTGcActCTGttcTCatAaacAgaTacAAacAgatAGAPT 
WHV2 	1120 tcAaCAagAacTcGActCTGttcTtatAaacAgaTacAAacAgatAGAcT 
Consensus 	--A-CA--AGTTGGA--CTC --- TC--A-C-A--T--AA--A --- AGATT 
I 	 , 	NF-1 
HBVI30 1042 CCGACttcAatccCAA ........... CAAggAcaccTggCCAGacGccA 
HBVadr 1075 GCGACttcAacccCAA ........... CAAggAtcaaTggCCAGagGcaA 
HBVadr4 1075 CGGACttcAacccCAA ........... CAAggAtcatTggCCAGagGcaA 
HBVadw 1060 GCGACttcAacccCAt ...........CAAggAccacTggCCAGcaGccA 
HBVadw2 1081 GccACttcAacccCgt ...........CAAggAcgacTggCCAGcaGccA 
HBVayr 1075 GCGACttcAacccCAA ........... CAAggAtcacTggCCAGagGcaA 
HBVayw 1042 GCGACttcAatccCAA ........... CAAggAcaccTggCCAGacGccA 
GSHV 	1174 GCGAC .aAttggCAAggattccctgtgAAtcAaaggctcCCAGtgagcA 
WHV 1174 GCaAC .acttggCAAggatttcctgtCgAtcAaaaactaCCAttgGtcA 
WHV2 	1170 GGaAC .acttggCAAggatttcctgtggAtcAaaaaTtttCATTgctcA 
Consensus 	GGGAC --- A ---- CAA ----------- CAA--A ---- T--CCAG--G--A 
-I 	
Bsml 
HBV130 1081 AcaAGGtaggagCtggAgcAttcgggctAgGgttcACccCaCcgcacgga 
HBVadr 1114 AtcACGtaggagCgggAgcAttcgggccAgGgttcACccCaCcacacggc 
HBVadr4 1114 AtcAGGtaggagCgggAgcAttcgggccAgGgttcACccCaCcacacggc 
HBVadw 1099 AccAGGtaggagtgggAgcAt tcgggccAgGgctcACccCtCcacacggc 
HBVadw2 1120 AccAaGtaggagtgggAgcAttcgggccAaGgctcACccCtCcacacggc 
HBVayr 1114 AtcAcctaggagCgggAgcAtttggtccAgGgttcACccCaCcacacgga 
HBVayw 1081 AcaAGGtaggagCtggAgcAttcgggctggGt t tcACccCaCcgcacgga 
GSHV 	1222 AcaAcaatcctcCctc ............AgctcaaAgggCagagactttc 
WHV 1222 AcagccatcctcCcccA ........... Aaatca .... gCtCaaactttc 
WHV2 	1218 gcagGGatcctcCcccAaaAccttatatAaatcaatCagCtCaaactttc 
Consenus 	- A--AGG ------ C --- A--A -------- A-G ---- AC--C-C -------- 
Saul 
HBV130 1131 GgccTtttggggTGGaGCCctcA. .gGcTCagGGcATAatGcaaAccttg 
HBVadr 1164 GgtcTtttggggTGcacCCctcA. . gGcTCagGGcATAttGacaAcagtg 
HBVadr4 1164 GgtcTtttggggTGGaGCCcgcA. .gGcTCagGGcgTAttGacaAccgtg 
HBVadw 1149 GgtaTtttggggTGGacCCctcA. . gGcTCagcccATAttGaccAcagtg 
HBVadw2 1170 GgtaTtttggggTGGaGCCctcA. .gGcTCagGGcATAttGaccAcagtg 
HBVayr 1164 GgccTtttggggTGGaGCCctcA. .gGcTCagGGcATAttGacaAcactg 
HBVayw 1131 GgccTtttggggTGGaGCCctcA. . gGcTCagGGcATActacaaActttg 
GSHV 	1260 GaaaPcaaa. tccaG .GCCtatAataGtTCcaGGaATAagGgatAtacca 
WHV 1257 GaaaTcaaa . cTGG .GCCtatAataGtTCctGGaATtcgGgacAtacca 
WHV2 	1268 GaaaPcaaa . ccTGG .GCCtatAataGtTCccGGaATtcgGgacAtacca 
Consensus 	G---T ------- TGG-GCC --- A --- G-TC--GG-ATA--G --- A ----- 
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I 	 C- 
HBV13O 1179 CcaG. . . cAaatCCgCCTCctgCctCtACCAATCGcCAgtCAGGAcGgcP. 
HBVadr 1212 CcaG... CAgCaCCtCCTCCtgCCtCCACCAAPCGgCAgtCAGGAAGaCA 
HBVadr4 1212 CcaG... tAgCaCCtCCTCCtgCCtCCACCAATCGgCAgtCAGGAAGaCA 
HBVadw 1244 tcaa... cAattCCtCCTCctgCctCcAccAATCGgcAgtcAGcpJcgcp. 
HBVadw2 1265 tcaa... cAat tCCtCCTCCtgCCtCCACCAATCGgCAgtCACGAAGgCA 
HBVayr 1212 CcaG. . . cAgcaCCtCCTCctgCctCcACCAAPCGgcAgtcAGGGacA 
HBVayw 1179 CcaG... cAaatCCgCCTCctgCctCcACcAATCGccAgtcAcG)GgcA 
GSHV 	1308 CgtGgcatAgtaCCaCCTCagaCtcCatCCAApcGggAtcaAacpjcaaA 
WHV 1305 CgtcgtttAgt tCCgCCTCaaaCtcCaACaAATCGagAtCaAGGgAGaaA 
WHV2 	1316 CgtGgt ttAgttCCgCCTCaaaCtcCaACaAATCGagAtcaAccgAcaap. 
Consensus 	C--G ---- A --- CC -CCTC --- C--C-ACCAATCG--A --- AGGAAG--A 
Saul 
C 	 i 	PreS2 
HBV1 30 1226 GCCTACcCCgcTg tCTCCACCTCTgAGAacCAcTCAtCCTCAggccc 
HBVadr 1259 GCCTACtCCcaTctCTCCACCTCTaAGAGACAgTCAtCcTCAggccc 
HBVadr4 1259 GCCTACtCCCaTCtCTCCACCTCTaAGAGACAgTCAtCCTCAggCCC 
HBVadw 1244 GCCTAC tCCcaTc tCTCCACCTCTaAGAGACAgTCAtCCTCAggccc 
HBVadw2 1265 GCCTACtCCCaTCtCTCCACCTCTaAGAGACAgTCAtCCTCAggCCC 
HBVayr 1259 GCCTACtCCCaTCtCTCCACCTCTaAGAGACAgTCAtCCTCAggCCC 
HBVayw 1226 GCCTACcCCgcTg tCTCCACCTtTgAGAaACACTCAtCCTCAggCC9C 
GSHV 	1358 aCCCACaCCtCTaaCTCCtCCTtTgAGAGACACaCACCTCAtttgACaa 
WIHV 1355 GCCTACtCCtCCaaCTCCACCTCTaAGAGAtACTCACCCCCACttaACta 
WHV2 	1366 GCCTACtCCtCCaaCTCCACCTCTaAGACAtACTCACCCCCACttaACta 
Consensus 	GCCTAC-CC--T--CTCCACCTcT-AGAGACA-TCA-CCTCA ---- A-- - 
HBV130 1276 aGtggAActccACaaccttcCaCC ............AaactCTGCaAGAt 
HBVadr 1309 aGtggAAttccACaacattcCaCC............AagctCTGCtAGAt 
HBVadr4 1309 aGtggAActccACaacattcCacc ............ AagctCTGCtAGAc 
HBVadw 1294 aGtggAAttccACtgccttgCaCC............AagctCTGCagGAt 
HBVadw2 1315 aGtggAAttccACtgccttcCaCC............AaactCTGCagGAt 
HBVayr 1309 aGtggAActccACaacattcCacc ............ AagctCTGCtAGAt 
HBVayw 1276 aGtggAAttccACaaccttcCaCC............AaactCTGCaAGAt 
GSHV 1408 aaaAAtcagACaggtcacCtgCagggat t tgcagAgggaCTGagAGct 
WHV 	1405 tGaaaAAtcagACtt t tcatCtCCagggtttcgtggAcggaTaagAGAc 
WHV2 1416 tGaaaAAtcagACttttcatCtCCaggggttcgtagAcggatTaCgAGAc 
Consensus 	-G --- AA ---- AC ------- C-CC ------------ A ---- CTGC-AGA- 
HBV13O 1314 CccAgAgtgAgaGgcCtgtAtttccCTGctggTcGctccagTTcagggAc 
HBVadr 1347 CccAgAgtgAggGgcCtatAttttcCTGCtggTGGctccagTTccggaAc 
HBVadr4 1347 CccAgAgtgAgycgcCtatActttcCTGCtggTcGctccagTTccggaAC 
HBVadw 1332 CccAgAgtcAggGgtCtgtAtcttcCTGCtggTGcctccagTrrcaggaAc 
HBVadw2 1353 CccAgAgtcAggcgtCtgtAtcttcCTGCtggTcGctccagTTcaggaAc 
HBSlayr 1347 CccAgAgtgAggGgcCtatAt t t tcCTGCtggTGGctccagTTccggaAC 
HBVayw 1314 CccAgAgtgAgaGgcCtgtAtttccCTGCtggTcGctccagTTcaggaAc 
GSHV 	1458 CtaAccacctcaGatCatcAcaactCTGCctaTGGagatccTTt tactAC 
WHV 1455 ttgAcAacaAcgcaaCgccAacacaaTGCctaTGGagatccTTttacgAc 
WHV2 	1466 ttgAcAacaAcgGaaCgccAacacaaTGCctaTcGagatccTTttacaAc 
Consensus 	C--A-A --- A--G--C --- A ----- CTGC --- TGG ------ TT ----- AC 
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d 
HBV130 1364 AgTAAaCCCTGttccgaCTACTGcCTCtcCCATATcGTCaatcttCTCGA 
HBVadr 1397 AgTAAaCCCTGttccgaCTACTGcCTCacCCATATcGTCaatcttCTCCA 
HBVadr4 1397 AgTAAaCCCTGttccgaCTACTGcCTCacCCATATcGTCaatctcCTCGA 
HBVadw 1382 AgTAAaCCCTGctccgaaTAtTGcCTCtcaCATcTcGTCaatctcCgCGA 
HBVadw2 1403 AqTAAaCCCTGCtCCgaaTAtTGCCTCtCaCATCTCGTCaatCtCCgCGA 
HBVayr 1397 AgTAAaCCCTGttccgaCTACTGcCTCacCCATATcGTCaatcttCTCGA 
HBVayw 1364 AgTAAaCCCTGt tctgaCTACTGcCTCtcCCtTATcGTCaatcttCTCGA 
GSHV 	1508 AcTAAgCCCTGtggtacCTACTGtCTCcaCCAcATtGTCtcctccaTtGA 
WHV 1505 AcTAAgCCCTGtggttcCTACTGtaTCcaCCATATtGTCtcctccaTCGA 


























sequences. The nucleotide sequences studied here covers not only the 
preS coding sequences but also the overlapping polymerase gene. Blocks 
of conserved nucleotide sequences may also represent conserved coding 
sequences for functionally important overlapping amino acid translations. 
The nucleotide sequence may be conserved due to the coding pressure for 
the overlapping reading frames limiting sequence divergence. 
Region (a) is very highly conserved among all the sequenced hepatitis B 
like viruses including DHBV. This block of conserved nucleotides is 
found within the polymerase coding sequence. It is possible that this 
nucleotide sequence could code for a functionally important amino acid 
sequence of the polymerase protein and therefore has been conserved. 
This region is situated at position -340 to -313 relative to the start 
of the major surface mRNA (Cattaneo et al., 1983b) and +8 to +35 
relative to the start of the preSi mRNA (Rail et al., 1983; Ou and 
Rutter, 1985). Region (a) is outside the region defined by Siddiqui et 
al., (1986), to contain the promoter sequences for the major surface 
mRNA, which correspond to HBV130 positions 993 to 1310. Therefore, it 
is possible, that since this region is close to the initiation point of 
the preSi mRNA, that it may be involved in the regulation of the preSi 
mRNA transcription. No preSi mRNA initiation sites have been mapped for 
GSHV and WHV. However, Buscher et al., (1985) have mapped an initiation 
site for a preS mRNA of DHBV, at positions 1107 and 1115 on the DHBV 
map. Therefore the DHBV conserved region (a) is situated at position 
+14 to +36 and +6 to +28 relative to the start of the DHBV preS mRNAs, 
in a similar position of HBV region (a), relative to the HBV preSl mRNA 
initiation site. 
A 10 base sequence found between HBV nucleotides 1036 to 1046 is highly 
conserved among the mammalian hepatitis B like viruses, region (b). The 
central nucleotides 1039-1043 (ATTOG) found in all sequences, except 
WHV2 (AcTGG), is a potential consensus sequence for an inverted CTF 
(CCAAT transcription factor) binding site. Such an inverted sequence has 
been found to be important for transcription of the Herpes simplex 
thymidine kinase gene at position -86 to -82 relative to the start of 
HSV tk gene transcription. This indicates that transcriptional activity 
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of the CTF binding site (CCAAT) is Independent of orientation (Jones et 
81., 1985; Graves at al., 1986). The pentanucleotide 5 1-CCAAT-3' occurs 
In the -80 region of many eukaryotic mRNA-coding genes (Benoist et al., 
1980; Efstratiadis et al., 1980), therefore, the position of the distal 
ATTGG sequence (-216 to -212) is in an unusual position relative to the 
I{BV major surface mRNA start site, possibly casting doubt on its 
involvement in HBV transcription. The sequences of the other mammalian 
hepatitis B "like" viruses also contain additional consensus sequences 
for an inverted CTF binding site at positions 1180-1184 for GSHV and 
1214-1218 for WHy. This means that all the mammalian viruses contain a 
potential inverted CTF binding site at approximately position -215 to 
-220 relative to the mapped mRNA initiation sites (Enders et al., 1985; 
Moroy et al., 1985). The DHBV also contains a inverted CTF consensus 
sequence at position 1134-1138, within region (a), at -224 relative to 
the surface mRNA initiation site mapped by Buscher et al., (1985). Since 
all the viruses contain an inverted CTF consensus sequence at 
approximately the same position relative to the major surface mRNA 
initiation sites, it is suggestive that this sequence could be involved 
in regulation of the surface mRNA transcription. An additional potential 
CTF consensus sequence is conserved among the HBV and GSHV viruses at 
HBV position 1204-1208 (CCAAT), within region (c), -51 relative to the 
mapped mRNA initiation site. The corresponding WHV sequence contains ---- 
a single mismatch (CaAAT). This sequence is placed in a more usual 
position of CTF binding sites observed by Benoist et al., (1980) and 
Efstratiadis at al., (1980). 
The sequences proposed by Cattaneo et al., (1983b) as being the promoter 
for the major surface mRNA, is highly conserved among the viruses, 
region (C), possibly indicating conservation of important promoter 
elements. An interesting feature of the nucleotide sequence immediately 
upstream of the preS2 initiation codon is the alternating blocks of 
pyrimidine and purine rich sequences. The semi-conservered -sequence 
motif TC (C/A)NCCTC is repeated three times within region (C), once within 
the region with homology to the SV40 origin and twice within the 
alternating pyrimidine, purine blocks. It is possible that these 
sequences could represent multiple binding sequences for a 
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transcriptional regulatory factor similar to the multiple 5pi binding 
sites found in the SV40 early promoter region (reviewed by Kadonaga et 
al., 1986). 
Region (d) covers a large number of small blocks of conserved nucleotide 
sequences. However this region is at the beginning of a large stretch 
of highly conserved nucleotide sequences covering the surface gene 
coding sequence and may represent important conserved coding sequences 
of the preS2 reading frame. The highly conserved region (d') shows a 
high degree of nucleotide homology to part of the SV40 72 base pair 
repeat enhancer. Mutations within the first repeated TC motif 
(5 '-TCCCCAG-3') in the SV40 enhancer have been shown to reduce enhancer 
function (Zenke et al., 1986). The SV40 repeated TC motif has the 
overall sequence 5 '-GTCCCCAGGCTCCCCAG--3' (complementary sequence 
5 '-CT0GGAGccI.GGGAC-3'). The HBV sequence between nucleotides 1418- 
1428 (5 '-TGGGGACCCTG-3'), shares the underlined nucleotide homology to 
the repeated SV40 TC motif. Since this HBV sequence shares homology to 
part of a known enhancer element, it is possible that this sequence 
could be involved in the regulation of surface mRNA synthesis. However, 
it could also be a coincidence that this sequence shares homology to the 
SV40 enhancer, conservation of this sequence may simply represent the 
conservation of functionally important amino acid sequences of the preS2 
protein. 
4,2.2 The Nuclear Factor-i Binding Site 
While the above nucleotide comparisons were being conducted Shaul et al., 
(1986a) published that nuclear factor-i NF-1), isolated from a WISH cell 
nuclear extract, binds to the HBVadw2 surface promoter region and 
protects nucleotides 1103-1122 of HBVadw2 (1064-1083 of HBV130) from 
in vitro DNase I digestion. Shaul et al., (1986a) propose that the NF-1 
protein binds to the HBV sequence TGGN)6GCCAA (HBV130 positions 1068-
1081) (fig. 4.2). Shaul at al., (1986a) have compared the relative in 
vitro binding affinities of the HBVadw and HBVayw sequences for the NF-i 
protein. Their results indicate that the HBVayw binding site is five 
163 
fold less efficient at binding NF-1 than the corresponding HBVadw2 NP-i 
binding site. Shaul et al., (1986a) attribute the lower binding affinity 
to an intrinsic property of the HBVayw sequence. A CC dinucleotide 
immediately 5' to the NF-1 binding consensus sequence in the HBVayw 
sequence could reduce the binding affinity of the sequence for NF-1- 
This phenomenon was also observed for deletion mutants of the 
Adenovirus 2 NF-1 binding site (Leegwater et al., 1985). Another 
possible explanation could be that the lower binding affinity of the 
sequence 5 I_CC*TGQ (N )6GCCAA-3' (complementary sequence 
3 '-GGACC (N)GCGGTT-5') could be the result of steric hindrance due to 
overlapping dcm methylation (dcm methylation consensus sequence 
CC(T/A)GG underlined with the internal C residue being methylated), as a 
result of amplification of the cloned viral DNA in E. coli. De Vries et 
al., (1987) have shown that partial in vitro methylation of the guanine 
residues in the Ad2 NF-1 consensus binding site reduces the NF-1 binding 
affinity of the sequence. Therefore it is possible that the lower NP-i 
binding affinity of the HBVayw sequence could be due to overlapping dan 
methylation. Unfortunately, Shaul et al., (1986a) did not discuss the 
strain of E. coli used to amplify the cloned HBV sequences, therefore, 
the effect of overlapping d=11, inethylation on the binding affinity of 
NF-1 to the HBVayw binding site is only speculative. However, Leegwater 
et al., (1985) used E. coil HB101 as a host for their constructions. 
E. coli 118101 is dcm' (see below) and this could account for the low 
NF-1 binding affinity of the sequence CCTGG(N) 6GCCAA used in their 
studies. Shaul et al., (1986a) did not test the in vitro binding affinity 
of the HBV subtypes HBVadr and HBVayr sequences for the NF-1 protein; 
both these sequences contain a single mismatch to the NP-i consensus 
sequence (TGG(N)eGCAA). Therefore, it is not possible to say wether the 
single mismatch to the NF-i consensus sequence will be tolerated or 
impair the affinity of NF-1 binding to the surface promoter regions of 
these }IBV subtypes. 
The report of Jones et al., (1987) indicates that the NP-i and CTF are 
possibly the same, or closely related nuclear proteins. Therefore, all 
the putative HBV NF-1 binding sites contain a single mismatch to the CTF 
consensus sequence in the 3' portion of the "consensus" NP-i binding 
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site (adw and ayw CCAAc; adr and ayr CaAAT). The 5' portions of the 
HBV NF-1 consensus sequences also contain potential inverted CTF binding 
sites, with the adr (AaTGG) and adw/ayw (AcTGG) sequences containing a 
single mismatch to the inverted Cl? consensus sequence. The subtype 
adr4 (ATTGG) contains a perfect inverted CIF consensus sequence while 
the ayw/HBV130 (ccTGG) sequence contains two mismatches. If NF-1 and 
CTF are the same nuclear protein, the CC dinucleotide, immediately 5' to 
the HBVayw NF-1 consensus sequence, may as Shaul et al., (1986a) propose 
result in a decreased binding affinity of NF-1/CTF to the sequence, due 
to two mismatches to the consensus motif, reducing/preventing the 
nuclear protein from binding to the DNA. If this is the case the 
observed in vitro binding affinity of NF-1 to the HBVayw sequence may 
be an intrinsic property of the nucleotide sequence and not an artifact 
due to dcm methylation. The WHV and GSHV promoter regions contain 
additional potential inverted CTF binding sites ATTGG, in approximately 
the same position as the HBV NF-1/CTF binding site relative to the 
conserved SPII promoter sequences (see above). Conservation of at least 
two potential distal binding sites for the CTF protein in all the 
mammalian hepadnaviruses suggests that these sequences could be 
involved in the regulation of transcription of the major surface mRNAs. 
The results of Gronostajski, (1987) indicate that the CTF motif (CCAAT) 
is not sufficient for strong binding of purified NF-1 to sequences 
containing this motif, suggesting that NF-1 and CTF may be closely 
related proteins but not identical. It is possible that CTF may bind to 
NF-1 sites but the reciprocal may not always be the case. This 
hypothesis was supported by Miksicek et al., (1987) who have shown that 
the NF-1 protein failed to show significant binding to the CTF binding 
site of the Herpes simplex virus tk promoter which lacks the full NF-1 
consensus sequence, indicating that NF-1 and CIF are probably not the 
same nuclear protein. 
The results of Shaul et al., (1986a) indicate that the HBVadw2 NF-1 
binding site is involved in the regulation of the SPII promoter. Their 
constructions contained the HBV sequences corresponding to HBV130 
positions 973 to 1310 inserted upstream of the bacterial chloramphenicol 
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ace tyl trans ferase gene (CAT gene). Deletion of the the 5' sequences to 
the corresponding HBV130 position 1065 reduced CAT expression by 
approximately 40% relative to maximal expression directed by the 
sequences 973-1310. Deletion to this position removed the potential 
inverted CTF binding sequence (1039-1043) observed in the nucleotide 
comparisons (see above), possibly indicating that the inverted CTF 
binding site is active in regulation of RBsAg mRNA transcription. 
Although it is possible that deletion to this position also removed 
important 5' flanking sequences necessary for optimal NF-1 binding. 
Deletion to position 1071 (within the NP-i binding site) reduced 
expression by approximately 90%, indicating that HBsAg ntRNA 
transcription is dependent upon the NF-1 binding site. Both deletion 
mutants Indicate that the sequences between the corresponding HBV130 
positions 973 to 1071 contain distal transcriptional regulatory 
sequences for the major HBV surface antigen promoter. 
4.3 E. coil Methylation of HBV Sequences 
The HBV130 NF-1 sequence has the same 5' flanking sequences as the 
HBVayw NF-1 binding site. One possible explanation for the low binding 
affinity of the HBVayw sequence for NF-1, could be the result of steric 
hindrance due to overlapping dciii methylation. Therefore, it may be 
possible to modulate HBV surface mRNA transcription both in vitro and in 
vivo by using cloned HBV DNA amplified in both dcnr and dcm E. coil 
hosts. This hypothesis would only be correct if the relative level of 
transcription/expression is proportional to the level of NP-i binding to 
the promoter sequences. Leegwater et al., (1985) used E. coil ff8101 as a 
host for their Ad2 NF-1 deletion mutants, therefore the two E. coil 
strains HB101 (dcnr') and GM48 (dc,r) were chosen as hosts to amplify 
cloned HBV DNA sequences for use in in vitro run off transcription and 
in vivo transient expression assays. 
The E. coil strains HBI01 and GM48 were tested for expression of the 
dciv methylase by bacteriophage X plating efficiency assays using an 
E. coil strain expressing Eco Ru. The restriction endonuclease Eco Ru 
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(5 1-4CC(A/T)GG-3 1 ) is very sensitive to methylation and will not cleave 
DNA at its recognition sequence when the internal C residue is 
methylated and therefore, DNA isolated from a E. coil (dcrt') host is 
partially resistant to digestion with Eco Rh (Bigger et al., 1973). 
Since E. coil HB101 contains the mutation hs&O, the DNA isolated from 
this strain will not be methylated at either Eco B or Eco K sites, 
therefore, it was necessary to construct a E. coil (r,r) host containing 
the plasmid R245. Plasmid DNA was isolated from E.coil NM145 (R245, Tc', 
mK, r,, Eco RIP'), by the alkaline-SDS method. The plasmid DNA was 
used to transform E. coil 6K; one tetracycline resistant transformant was 
designated 5K/R245 and was used for the bacteriophage X plating assays. 
Efficiency of plating experiments using bacteriophage X..gr grows on 
HB101 (%,1 ...}iB101) and GM48 (X 1 ..GM48) were conducted on E. coil 5K and 
5K/R245. The results of these plating assays are presented in table 4.2. 
The results Indicate that E. coil HB101 codes for a functional dcm 
methylese; X..ir.HB101 was partially protected from restriction by Eco Ru 
when plated on 5K/R245. Whereas X,.gr.GM48 was restricted when plated 
on strain 5K/R245 confirming that GM48 (dam3, dcm6) does not code for 
the dcm methylase. These results were confirmed In vitro using pHBV130 
DNA isolated from HB101 and GM48 backgrounds. The restriction 
endonuclease Bst NI (5'-CC4 (A/T)GG-3') is an isoschizomer of Eco RII but 
cleaves dcm methylated DNA (fig. 4.3). P].asmid DNA isolated from HB101 
was partially resistant to cleavage with Eco RII but sensitive to 
restriction with Bst NI, while DNA isolated from a GM48 background was 
sensitive to both restriction endonucleases indicating that the dcm sites 
were not methylated. DNA isolated from a GM48 background was also 
sensitive to Bci I digestion (data not shown) indicating that the strain 
GM48 is also deficient for the E. coil dam methylase. The strain E. coil 
GM48 codes for an active Eco K restriction system; it is unlikely that 
methy].ation of DNA by the Eco K methylase would affect HBV transcription 
since the HBV sequence contained in pHBV130 is devoid of Eco K (and 
Eco B) recognition sequences. 
The clone XLTK154-H7 grew very poorly on Gt448 with very low titres and 
no significant amounts of X DNA was obtained when propagating this 
clone on GM48. Therefore, the 5'6 kb Hind III insert contained in 
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Table 4.2 Efficiency of Plating Assays 
Titre on 	Titre on 	EOP of X,. on 
5K 	 5K/R245 E. coil 5K/R245 
relative to 
pfu/ml 	pf u/mi 	5K1.0 
),i r..HB101 	24x10 8 	12x10 7 	50x10 2 
Xi,ir .GM48 	20x10 9 	19x104 	9•5x10 6 
Bacteriophage X.,. stocks were prepared on E. coil HB10 1 and GM48. 
Plating efficiencies were determined by titre on H. coil 5K and 5K/R245 








Figure 4.3 Restriction endonuclease digestion of dcm methylated and 
non-methylated pHBV 130 DNA isolated from E. coil HB101 and GM48 
respectively. pHBV130.GM48 (1 g) plus 3 units of Eco Ru (track 1), 
pHBV130.HB101 (1 j.g) plus 3 units of Eco Ru (track 2), pHBV130.GM48 
(1 g) & pHBV130.HB101 (1 j.g) plus 6 units of Eco Ru (track 3), 
pHBV130.GM48 (1 g) plus 1. unit Bst NI (track 4), pHBV130. HBI01 (1 g) 
plus 1 unit Bst NI (track 5), pHBV130.GM48 (1 g) & pHBV130.HB101 (1 g) 
plus 2 units of Bst NI (track 6). All restriction endonuclease digestions 
were performed as recommended by the manufacturer, for 60 minutes. 
Size markers used were the 1 kb ladder (BRL) (track M), sizes are shown 
(in kb) 
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XLTK154-H7 was gel purified and ligated into the Hind III site of the 
vector XNM1 149. The ligated DNA was used to transform H. coil NM154. A 
recombinant clone was isolated and found to contain the 5-6 kb insert; 
this clone, X1149-H7, was used for all further assays of the HBV surface 
promoter. 
4.4 In Vitro Transcription Assays 
The original studies conducted to investigate the transcriptional 
regulatory sequences of the HB'J surface antigen promoter(s) were those 
of Rall et al., (1983). Rail et al., (1983) conducted. in vitro run off 
transcription assays using a HeLa whole cell extract (Manley et al., 
1980). They observed transcription of the preS/surface open reading 
frame initiating at position 907±10, 25 nucleotides downstream of a 
"TATA" like sequence. Rail et al., (1983) failed to observe the major 
transcription initiation site(s) observed by 5' end mapping of in vivo 
surface mRNAs (Cattaneo et al,, 1983b; Standring et al., 1984; Ou and 
Rutter 1985; Yaginuma et al., 1987b). The possible reason for the lack 
of observation of the major transcripts by Rail et al., (1983) is most 
likely due to the templates used for the run off transcription assays. 
These templates were discontinuous downstream of the Eco RI (1280) and 
the Barn HI (1310) sites, therefore, if the templates directed 
transcription from the major SF11 promoter, the largest oligoribo-
nucleotides generated would have been ca. 25 and 55 nucleotides 
respectively and possibly would not have been resolved on the gel 
electrophoresis system used. 
The results obtained studying HBsAg production by the cell line 
RJK88/H7-1 were suggestive of transcription and expression of the HBsAg 
directed by the SF11 promoter. However, the results obtained were not 
substantial enough to unequivocally 	that the putative SF11 promoter 
was responsible for expression of the surface mRNAs. Therefore, in 
vitro transcription experiments using HeLa whole cell extracts (Manley 
et al., 1980) were conducted in an attempt to show that the DNA fragment 
cloned in the recombinant X1149-H7 (and XLTK154-H7) has the potential 
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to transcribe and express HBsAg. Plasmid (pHBV130) and bacteriophage X 
0\1149-H7) DNA was prepared from H. coli HB101 (dcm) and GM48 (dcm) 
backgrounds, to test the effect of dcm methylation of the sequence CCTGG 
(1066-1070) on the in vitro binding of NF-1 to the surface promoter 
region, in an attempt to modulate in vitro transcription. 
The Hind III to Pst I (1800) fragment from the left hand end of the 
clone X1149-H7 was gel purified. This DNA fragment contains the HBV 
sequences from 994 to 1800 and contains the sequences found by Siddiqul 
et al., (1986) (positions 993-1310) to encode for SPII promoter activity 
In transient expression studies conducted using CV-1 cells. A Bst Eli 
(915) to Pst I (1800) fragment of pHBV130 was also gel purified as a 
additional control. Half the DNA (a 1.5 g) present In the samples was 
digested with Bsm I (1098) to delete the NF-1 binding site (1068-1081) 
from the SPII sequences (1188-1260). 
Both sets of methylated and unmethylated DNA fragments (H7: 994-1800 
and 1098-1800; pHBV130: 915-1800 and 1098-1800) were used for in vitro 
run off transcription assays, as described in materials and methods. As 
an additional control, Pst I digested SV40 DNA (BRL, supplied with the 
HeLa cell extracts) was used to show that the in vitro transcription 
system was functioning as expected. The expected run off transcripts 
directed by the HBV DNA fragments should have approximate lengths of 
545, 524 and 513 nucleotides, based on the map positions of the 5' ends 
of in vivo transcripts (Yaglnuma et al., 1987b). The products of the in 
vitro transcription reactions were separated on a 3•5% (wfv) 
polyacrlamide/1 •0% (w/v) agarose formaldehyde gel system. The gels were 
dried and exposed to Kodak XAR-5 X-ray film at -70C. After one week 
exposure no signals corresponding to the expected HBV run off 
transcripts could be observed on the autoradiograph (data not shown). 
The expected four SV40 directed run off transcripts (separated on a 1.3% 
(w/v) agarose/formaldehyde gel) of ca. 2•0, 1'9, 1'75 and 1-6 kb 
(measured against 5' end labelled DNA molecular weight standards) gave 
strong signals on a overnight exposure using the less sensitive Cronex 4 
X-ray film (data not shown). The sizes of the observed SV40 run off 
transcripts correspond to the size of the SV40 (Pst I) run off 
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transcripts observed by Handa at al., (1981). This result indicates that 
the in vitro transcription system was functioning as expected. The HBV 
In vitro transcription experiments were repeated with the same result. 
Since no in vitro run off transcripts were observed, it is not possible 
to determine if overlapping dcin methylation of the NF-1 binding site 
affects the in vitro transcription efficiency. 
Possible explanations for the lack of transcriptional activity of the 
linear isolated SPII promoter sequences could be i) trace amounts of 
contaminates present in the gel purified DNA solutions may have 
inhibited the in vitro RNA polymerase II transcription system, ii) the 
HeLa whole cell extract may be lacking certain transcription factors 
necessary for transcriptional activity of the unusual non-TATA SPII 
promoter, or, that such factors if present may be in the incorrect ratios 
to promote transcription, or iii) the SPII promoter sequences contained 
on the linear fragments between nucleotides 994 and 1800 are not 
transcriptionally active in the in vitro transcription system. 
The only other reported in vitro transcription analysis of the SPII 
promoter is that of Cattaneo et al., (1983b). They observed HBV directed 
transcripts initiating at HBV position 1255. The in vitro transcription 
reactions of Cattaneo et al., (1983b) differed in two respects to those 
reported here and by Rall et al., (1983). The cell free extracts used by 
Cattaneo et al., (1983b) were not prepared in accordance to the 
procedure of Manley at al., (1980) but using a modified procedure of 
Weigaertner and Keller (1981), in which in vitro transcriptional activity 
depends upon the addition of a cytoplasmic fraction to a nuclear extract. 
The second difference in the method of Catte.neo et al., (1983b) is that 
they did not generate run off transcripts from linear templates, but 
transcribed cloned HBV DNA present in an uncut plasmid and mapped the 
start of transcription by SI protection mapping. The plasmid used by 
Cattaneo et al., (1983b) was pSH26, which contains 111% of the HBV 
genome from nucleotides (Rae II) 899-3182/1-1280 (Eco RI) inserted in a 
SV40 based vector, containing SV40 sequences (5157-5243/1-832) with the 
surface gene in sense with the SV40 late promoter. Therefore, the 
plasmid pSH2 •6 contains not only the HBV enhancer element but also the 
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SV40 enhancer, both of which could effect transcription from the SPII 
promoter. 
The SV40 enhancer element is known to stimulate in vitro transcription 
of heterologous promoter/enhancer systems (Sassone-Corsi et al., 
1984,1985). However, the SV40 enhancer is unlikely to be totally 
responsible for expression of the in vitro transcripts directed by 
pSH2•6, since Cattaneo et al., (1983b) report that cleavage of pSH2•6 
with Barn HI (1004, 2682), which separates the SPII promoter from the 
SV40 enhancer, did not disrupt transcription from the SPII promoter. 
This Barn HI fragment contains the sri promoter, the surface antigen 
gene and the HBV enhancer element. The results of Chang et al., (1987b) 
indicate that the HBV enhancer element has the potential to stimulate 
surface gene transcription in vivo. The results of Shaul et al., (1985) 
also indicate that, although, the HBV enhancer shows a semi-tissue 
specificity, it can function in non-hepatocyte derived cells. Since the 
SV40 enhancer is active in vitro, the HBV enhancer may also be active in 
HeLa cell extracts. HeLa cell nuclear extracts are known to contain an 
E "like" binding factor, which binds to the HBV enhancer region at 
position 2460-2486 (E binding site), that has been postulated to be 
involved in HBV enhancer function (Shaul and Ben-Levy, 1987). Therefore, 
it is likely that the HeLa cell extracts used for in vitro transcription 
assays also contain the E "like" binding factor. The difference in the 
results obtained in this study and those of Cattaneo et al., (1983b), 
could be due to the fact that the templates used here were devoid of 
the HBV enhancer element and contained only the SPII promoter. All the 
DNA templates used by Cattaneo et al., (1983b), for in vitro 
transcription experiments, contain the HBV enhancer element in cis with 
the SPII promoter. Therefore, in vitro transcription of the SF11 
promoter may be highly dependent upon the cis acting enhancer sequences. 
If this hypothesis is correct, the Barn HI fragment (1004-2682), from 
either X1149-H7 or pHBV130, should direct a run off transcript of 
Ca. 1-4 kb, while the same DNA fragments digested with Pst I will not 
generate run off transcripts due to separation of the SPII promoter 
sequences from the HBV enhancer. 
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4.5 Transient Assay Expression of HBsAg Using Mouse L Cells 
4.5.1 Preliminary Transient Assay Experiments 
Preliminary transient assay experiments were conducted according to the 
combined procedures of Sompayrac and Danna, (1981) and Luthman and 
Magnusson, (1983). Mouse L cells (3x10 5 cells per dish) were plated 
onto 5x35 cm diameter dishes and allowed to grow overnight at 37C in 
a CO,2 incubator, to be slightly sub-confluent at time of transfection. 
The gel purified Hind III DNA fragment from X1149-H7, and pHBV130 DNA 
(02 j.g DNA per lOS plating cells) was mixed with a total volume of 
0.7 ml of 200 pg/ml DEAE-dextran (molecular weight, 5x10 5 ), 005 Ii 
Tris-HC1 pH 7•3 in DMEM (serum free). The cells were incubated with the 
DNA mixture for 6 hours at 37C in a CO2 incubator. Chloroquine was 
added to a final concentration of 100 j4j and the incubation continued 
for 2 hours. The medium was replaced with DMEM (7% (v/v) FCS) and the 
cell allowed to grow at 37°C/CO2 . The medium and cells were harvested 
24 hours post transfection (ca. 70-80% confluence) and total nucleic 
acids isolated from the cells. The medium was assayed for the presence 
of HBsAg using an AUSRIA-II radioimmunoassay (Abbott laboratories). No 
HBsAg could be detected using either neat medium or concentrated 
samples (160,000 g for 12 hours, pellet resuspended in 1/30 initial, 
volume of PBS) (data not shown). Separation of the total nucleic acids 
on a 1.3% (w/v) agarose/formaldehyde gel, transfer to hybond-N filters 
and probing with 32 labelled genomic length HBV DNA, showed the 
presence of a DNAase sensitive nucleic acid homologous to HBV within the 
cells (data not shown). This indicated that the transformation procedure 
was successful, in that the cells had taken up the transforming DNA, 
however, no detectable HBsAg was produced. 
Gough and Murray, (1982) have shown that the cell line Rat2/130.4/TK4 
only secreted significant levels of HBsA8 into the medium when the cells 
were above 80% confluence and showed maximal expression when the cells 
reached 100% confluence. Therefore, the transfection procedure was 
repeated and the cells allowed to grow to confluence before the medium 
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was harvested. The results of the radioimmunoassay for HB5Ag are 
presented in table 4.3. The results indicate that HB5Ag is produced and 
secreted from the cells at a low level and that the DNA sequences 
contained on the Hind III fragment cloned in X1149-H7 are capable of 
directing transcription of the HBV surface antigen gene, thus confirming 
the results obtained studying HBsAg expression by the cell line 
RJK88/H7-1. The transient assay was repeated as described in materials 
and methods, using 10 cm diameter dishes, with pHBV130 DNA digested 
with Bst Eli. The results of the radioimmunoassay (table 4.3), indicate 
that by using the larger dishes for the transient assays the relative 
level of expression of HEsAg was increased by more than 30-fold. 
4 .5 .2 Transient assays for the Expression of HBsAg: Analysis of the 
Transcriptional Regulatory Signals 
a) Construction of pHBV1004 
As a control for the transient assays the plasmid pHBV 1004 was 
constructed; pHBV1004 contains HBV sequences between the Barn HI (1004) 
restriction site and the Bgi II (84) restriction site ligated into the 
Barn HI site of the cloning vector pLJC8. The subtype of HBV cloned into 
pHBV130 contains two Barn HI sites at position 1004 and 2682. Therefore, 
to construct the plasmid pHBV1004; 10 pg of the plasmid pHBV130 was 
digested to completion with 20 units of Bgi II, in 20 ii of a buffer 
consisting of 50 mK NaCl, 10 niti Tris-HC1 pH 74, 6 mM.  M8C12 , 6 mM. 
-mercaptoethanol, at 37C for 60 minutes. The Bgi II digested DNA was 
further partially digested with 1 unit of Barn HI in the same buffer at 
room temperature for 30 minutes. The digestion reactions were 
terminated by phenol extraction and the DNA fragments separated on a 1% 
(w/v) low melting temperature agarose gel. The 226 kb partial 
Barn HI/complete Bgi II DNA restricted fragment, spanning HBV nucleotides 
(Barn HI) 1004-3182/1-84 (Bgi ID, was isolated and ligated into the 
Barn HI site of pUC8. The ligated DNA was used to transform E. coil 
JM83; one of the resultant recombinant p].asmids isolated was designated 
pHBV1004 (fig. 4,4). The plasmid pHBV1004 contains the complete 
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DNA  PIN  P/N* 
fragment neat conc. 
used medium (x30) 
A 
H7 (Hind III) 	14 	 91 
pHBV130 uncut 	10 	 18 
pHBV130 (Bst Eli) 	1.0 	 1•5 
B 
pHBV130 (Bst Eli) 	41 	 352 
t DNA samples were originally amplified in E. coil GM48 (dci'ir) 
prior to the transient assays. 
B P/N ratios calculated against neat medium from a mock transformed 
mouse L cell negative control (P/N=10). 
* P/N ratios calculated against x30 concentrated negative control 
samples prepared in the same manner as the test samples. 
Radloimmunoassays were conducted in duplicate (200 l) using the 
Abbott AUSRIA-II radloimmunoassey for KBSAg. Concentrated samples 
were prepared by ultra-centrifugation, 12 ml samples were 
centrifuged at 35,000 rpm for 12 hours in a MSE 6x14 ml rotor, the 
pellets were resuspended in 400 pl of phosphate buffered saline. A) 
preliminary transformation according to the modified procedures of 
Sompayrac and Danna, (1981) and Luthman and Magnusson, (1983) using 
5x3•5 cm diameter dishes. B) repeated assay using the procedure 
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Figure 4.4 Restriction endonuclease cleavage map of of pHBV1004. The 
heavy lines represent HBV sequences and thin lines represent pUC8 
sequences. pHBV1004 contains the HBV sequences from 1004 (Barn HI) to 
84 (Bgl II) cloned into the Barn HI site of pUC8. The location and 
direction of the surface and X open translational reading frames are 
shown as the thick inner arcs, the thin inner arcs represent the HBV 
specific mRNAs. The nucleotide positions of restriction endonuclease 
sites unique to the HBV sequences are shown relative to the viral genes 
and transcriptional regulatory signals (shaded blocks). 
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transcriptional unit for the major surface mRNA, including the 11SV40-
late-like" (SPII) promoter, the preS2/surface open reading frame, the HBV 
enhancer, the X open reading frame and the polyadenylation signals 
(Simonsen and Levinson, 1983; Siddiqui et al., 1986; Shaul et al., 1985). 
b) Transformation of mouse L cells 
Methylated pHBV1004 and unmethylated pHBV1004, X1149-H7 DNA samples 
were prepared using B. coil 118101 and GM48 hosts respectively. The 
Hind III fragment from X1149-H7 was gel purified. The purified H7 
fragment and pHBV1004 DNA were digested with the following enzymes: 117, 
Eco RI (mouse sequences), Bsm I (1098); pHBV1004 Eco RI (pUC8), Bsm I and 
Sau I (Mst II; 1150, 1264). The purified 117 fragment was digested with 
Eco RI to remove most of the 5' mouse flanking sequences. An Eco RI 
restriction site is situated 34 bp upstream of the integration site (HBV 
position 994); digestion at this site will remove any potential mouse 
promoters thereby eliminating possible co-transcriprtion of mouse and 
HBV sequences. The pHBV1004 DNA was digested with Eco RI to separate 
the HBV surface gene from any potential 5' cryptic promoters contained 
on the vector sequences. The restriction enzyme Bsm I digests HBV DNA 
at position 1098, thereby, separating the NF-1 binding site and the SPII 
promoter sequences. Sau I (Mst II) digests HBV DNA at positions 1150 
and 1264, either side of the SF11 promoter sequence (Cattaneo et al., 
1983b). Therefore, digestion of HBV DNA with Sau I separates the 
surface gene from the putative SF11 promoter, and was used to show 
there are no transcriptionally active promoter sequences downstream of 
the sequence postulated by Cattaneo et al., (1983b). 
The uncut plasmid and linear DNA fragments were used for duplicate 
transient expression assays by transfection of mouse L cells using DEAE-
dextran as described in materials and methods. The transformed cells 
from the duplicate transient assays were pooled and total nucleic acids 
isolated. The medium from the transfected cells was assayed for 
production of HBsAg using the Abbott AUSRIA 11-125 radiolmmunoassay 
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(table 4.4). The level of HB5Ag expression was quantified by comparison 
to standards prepared from a HBV carrier sample (HBVayw 5•8x10 3 ng 
HBsAg/ml) diluted in medium from the mock transfected mouse L cell 
negative control. 
The RIA results obtained for HBsAg expression levels from mouse L cell 
transfections conducted using Sau I digested DNA, as expected, indicate 
that all the transcriptional regulatory sequences are contained at, or 
upstream, of the Sau I site at position 1264, supporting the results of 
Cattaneo et al., (1983b). The RIA results, for HBsAg expression by cells 
transfected with Bsm I digested DNA are suggestive that separation of 
the NF-1 site from the SPIt promoter sequences, does reduce the level of 
expression of HBsAg. However, examination of the HBV DNA (RNAase 
digested) present within the transformed cells by Southern blot 
hybridisation (fig 4.5) indicates that the level of intra-cellular Bsm I 
digested HB%J DNA was less, relative to the level of the other restriction 
digested DNAs. Examination of the relative levels of hybridisation by 
densitometric scanning of the autoradiograph (data not shown) indicated 
that the relative levels of hybridisation of linear Eco RI and Bsm I 
digested DNA fragments is approximately proportional to the relative 
difference in HB5Ag expression. Therefore, the only possible conclusion 
that can be drawn from the results of this experiment, is that when HBV 
sequences between position 1310-84 are present downstream of the SPII 
promoter element, separation of the distal upstream NF-1 binding site 
does not inhibit expression of the HBsAg and, therefore, it is possible 
that NF-1 binding to the distal transcriptional element, observed by 
Shaul et al., (1986a) is not obligatory for transcription of the surface 
gene when using transfected mouse L cells. 
The restriction enzyme Bsm I is one of the few known type II restriction 
enzymes that recognises a nonpalindromic sequence (5 '-NG4CATTC-3' 
complementary sequence 3 1-tNCGTAAG-5 1 ) generating a two base 3' 
protruding end. It is possible that a minor proportion of the Bsm I 
digested transforming DNA could have recircularised or formed 
concatemers in vivo due to annealing/ligation of the protruding 3' ends 
reconstituting a functional promoter sequence (Folger at al., 1982; 
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Table 4.4 Radioimmunoassay of transient assay medium 
DNA fragment P/N (neat) concentration Average 
digestion relative to HBsAg ng/ml HBsAg ng/m]. 
mouse L celll 
Mouse L cell 1•0 0 
H7 A 77 1•6 
(Hind III) B 7'8 1'6 1.6 
H7 A 6•5 13 
(Eco RI) B 7•0 1'4 135 
}(7t A 2'5 0'4 
(Bsm I) B 22 0'4 0'4 
pHBV1004t A 18•2 5.4 
B 20'1 6'3 5•85 
pHBVlO04t A 14•0 3•4 
(Eco RI) B 13•3 3'2 3•3 
pHBV1004t A 5•3 1•0 
(BsmI) B 5•4 11 1•05 
pHBV1004t A 0.9 (-ye) 0 
(Sau I) B 1•0 (-ye) 0 
pHBV1004 A 207 6'6 
B 19'7 6'1 6•35 
pNBV1004 A 164 44 
(EcoRI) B 15'1 3•8 41 
pHBV10049 A 125 2'9 
(BsmI) B 125 29 2'9 
pHBV10046 A 1•2 (-ye) 0 
(Saul) B 1'1 (-ye) 0 
t unmethylated DNA prepared from a E.coli GM48 background 
methylated DNA prepared from a E. coli HB101 background 
Transient assay transformations were performed in duplicate (A & B), 
the medium from each transformation was assayed for the presence of 
HBsAg in duplicate using the Abbott AUSRIA 11-125 radio immunoassay 
for HBsAg. The P/N ratios are expressed as an average of the 
obtained cpm values from each assay relative to the mock transfected 
mouse L cell negative control. The concentration of HBsAg was 
determined from a standard curve constructed from MBVayw carrier 
serum (5'8x10 3 ng HBsAg/ml) diluted in medium from the negative 
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Figure 4.5 Examination of extra-chromosomal HBV DNA isolated from 
transfected mouse L cells. Total nucleic acids were isolated from 
transfected mouse L cells, digested with RNAase (heat treated), separated 
on a 07% (w/v) agarose gel, transferred to nitrocellulose and probed 
with a 32 P-labelled Bst ElI (915) to Bg1 II (84) HBV restriction fragment 
of pHBV130 covering the surface transcriptional unit. Mock transfected 
mouse L cells (track 1), mouse L cells transfected with the gel purified 
Hind III H7 DNA fragment (track 2), H7 DNA digested with Eco RI 
(track 3), H7 DNA digested with Bsm I (track 4), pHBV1004 (non-
methylated) (track 5), pHBV1004 (non-methylated) digested with Eco RI 
(track 6), pHBV1004 (non-methylated) digested with Bsm I (track 7), 
pHBV1004 (non-methylated) digested with Eau I (track 8), pHBV1004 
(methylated) (track 9), pRBV1004 (methylated) digested with Eco RI 
(track 10), pHBVI004 (methylated) digested with Bsro I (track 11), 
pHBV1004 (methylated) digested with Eau I (track 12). Size markers used 
were the 1 kb ladder (BRL), sizes are shown (in kb). 
181 
Wilson et al., 1982; Wake at al., 1984). No recfrcu].arised molecules 
could be observed on the southern blot (fig. 4.5), although such 
molecules may be present in amounts below detection levels. 
Recircul8risation of the Sau I digested DNA would not reconstitute a 
promoter sequence since this enzyme digests at positions 1150 and 1264, 
any recircularised molecules would be deleted for the SPII promoter 
sequences. Since the level of HBsAg expression is proportional to the 
observed level of 32 P-labelled HBV DNA hybridisation to linear DNA 
isolated from the cells, this is suggestive that the linear templates 
were used for transcription of the surface mRNAs. Although, the 
possibility that transcription from recircularised Bsm I digested 
molecules accounts for the observed HBsAg expression can not be 
excluded. If recircularised Bsm I digested DNA fragments were used as 
transcriptional templates this would mean that the majority of the uncut 
and linear, Eco RI digested, pHBV1004 DNA molecules were 
transcriptionally inactive. 
If in vivo recircularisation is an artifact of the expression system this 
could be tested by repeating the transformation assay using pHBV1004 
DNA digested at the unique Xho I site (1409). Xho I cuts HBV DNA 
between the SPII promoter and the coding sequence for the surface open 
reading frame. If mouse L cells express significant levels of HBsAg 
when transformed with Xho I digested pHBV1004, this would indicate that 
the molecules have recircularised. 
It is evident that the presence of the restriction endonuclease Bsm I in 
the transformation solution, inhibited the efficiency of transformation. 
A similar phenomenon has also been observed by Gusew et al., (1987); 
using the calcium-phosphate transformation procedure to transform FR3T3 
rat cells, they observed that certain restriction endonucleases, used to 
linearise DNA, inhibit transformation/integration by 10-50 fold and that 
removal of such enzymes by phenol extraction, prior to transformation, 
restored transformation efficiency. Gusew et al., (1987) propose that 
restriction enzyme proteins remain attached to the ends of the linear 
DNA following digestion and inhibit the integration of the DNA 
molecules into the chromosomes of the cells. Their results indicate that 
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the presence of the proteins did not effect DNA uptake into the cells, 
but decreased the efficiency of integration. 
The DEAE-dextran tranafection procedure used here does not rely upon 
integration of the linear DNA molecules therefore, the observed lower 
level of Bsm I digested DNA within the cells can only be due to either 
1) the presence of the DNA bound protein inhibiting DNA uptake into the 
cells or ii) the presence of the attached protein promotes preferential 
DNA degradation. The difference in the possible mechanisms of decreased 
transformation efficiencies observed by Gusew et al., (1987) and this 
study, could be due to the different transformation procedures used and 
that the observed effects could be due to two separate phenomena 
resulting from the presence of the DNA bound protein. 
One-third of the total nucleic acid preparation (equivalent to 2/3 of a 
culture grown on a 10 cm diameter dish) was separated by 
electrophoresis on a 13% (w/v) agarose/formaldehyde gel. Analysis by 
northern blotting, using a 32 P-labelled genomic length HBV probe, showed 
the presence of a smear of nucleic acids hybridising to HBV DNA. The 
smear began at the expected molecular size of the linear transforming 
DNA molecules (data not shown). Digestion of the total nucleic acid with 
DNAase (RNAase free), prior to electrophoresis, removed the smear 
confirming that it was due to the presence of HBV DNA, however no 
surface mRNA could be detected (data not shown). It is possible that 
the RNA present within the samples was degraded during the isolation 
procedure, however, mouse rRNA bands were clearly visible upon ethidium 
bromide staining of the gels. It is possible that the amount of HBV 
surface mRNA was below detection levels. 
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The above experiments were originally designed to generate results in 
support of those of Shaul et al., (1986a), in that one or more distal 
transcription elements (between HBV nucleotides 994-1098) are required 
for efficient transcription of the major HBV surface mRNAs. However, the 
results obtained In this study indicate that the distal NF-1 binding site 
(1068-1081) and the potential inverted CTF binding site (1039-1043) are 
not required for efficient expression of the HBsA8. All DNA sequences 
necessary for transcription of the surface mRNA are located downstream 
of the Bsm I site at position 1098. Therefore, overlapping dcjn 
methylation of the NF-1 binding site will have no effect on HBsAg 
production, as indicated by the HBsAg RIA results obtained by analysis of 
the culture medium after transformation of mouse L cells with 
methylated and unmethylated pHBV1004 DNA. Deletion of the sequences 5' 
to the Sau I site at position 1264, resulted in the complete abolition 
of HBsA8 expression most probably resulting from the deletion of the 
"SV4O-late-like" promoter sequences postulated by Cattaneo et al., 
(1983b). Therefore, the major surface antigen promoter is contained 
between nucleotides 1098 and 1264, covering the region of nucleotide 
conservation found in the promoter regions of the mammalian 
hepadnaviruses. 
Cattaneo et al., (1983b) originally proposed that sequences between HBV 
cc-respoA4 to 	 This wa 
nucleotides 1188-1260's  the major promoter for the HBsAg mRNAs.'due to obsetveL 
sequence homologies between these HBV sequences and regions of the SV40 
genome known to regulate late transcription Brady et al, 1982; 
Contreras et al., 1982; Cattaneo et al., 1983a). The postulation that the 
HBV sequences correspond to the surface promoter is based on the 
assumption that these sequences represent the same, or closely related 
transcriptional regulatory sequences as the SV40 late promoter. 
Therefore, to take the analogy further, it would be reasonable to assume 
that the putative major surface promoter interacts with the cellular 
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transcriptional machinery in the same, or closely related manner, as the 
SV40 late promoter. 
May and co-workers have conducted an extensive analysis of the 
sequences immediately upstream of the major SV40 late mRNA initiation 
site, positions -53 to +7 relative to the major late initiation site. 
This sequence contains the promoter sequences defined by Brady et al., 
(1982). Ernoult-Lange et al., (1984) constructed a series of SV40 based 
plasmids deleted for the SV40 early promoter region, the origin of 
replication, the G-C rich 21 base pair repeats (Spi binding sites) and 
the 72 base pair enhancer repeats. Their constructions contained the 
-53 to +7 late region inserted in the sense orientation upstream of the 
T antigen gene (le. in the opposite orientation to the native 
configuration). Transfection of HeLa cells with the construction 
resulted in no expression of the T antigen. Only when one or both of 
the 72 bp repeats were inserted in the native conformation relative to 
the -53 to +7 region, was significant T antigen expression observed. 
These results indicate that the -53 to +7 late region, in the absence of 
the enhancer sequences, does not display any intrinsic promoter activity. 
Omilli et al., (1987) have shown that deletion of the -53 to +7 region 
reduces SV40 late transcription 5-fold, with the 5' initiation sites 
becoming more heterogeneous with respect to the native pattern of 
transcription sites. Inversion of the -53 to +7 region restores the 
native level of expression, however, only one 5' initiation site was 
observed. Examination of the sequence indicated that inversion of the 
region resulted in the generation of a "TATA" box like sequence in sense 
with the enhancer elements, with the 5' mRNA initiation beginning 21-26 
bases downstream of the "TATA" like sequence. Omilli et al., (1987) 
propose that the -53 to +7 late region may not be an absolute 
requirement for late promoter activity driven by the enhancer elements. They .svcj'sl 
th+ -the -13 to -t7 r€'on act5 b correctly fixing the initiation sites and therefor } 
limits the heterogeneity of the late initiation sites. 
The results of Shaul et al., (1986a) also indicate that the HBV "SV40-
late-like" surface promoter requires cis acting elements for efficient 
transcription. Shaul et al., (1986a) inserted a HBVadW2 surface promoter 
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fragment (HBV130 positions 978-1310) upstream of the CAT gene. The 
fragment contains the putative NF-1 binding site, the major surface 
promoter and the cap sites of the HBsA8 xnRNA. Transfection of HeLa 
cells with their constructions, resulted In CAT expression. Complete 
isolation of the SPII promoter sequences, by deletion of the distal NF-1 
binding site, reduced expression by 90% (from 29% to 03-04% 
conversion of chioramphenicol; or from 32 to 0•33-0.44 relative to 
pSV2CAT=100 190% conversion]). The plasmid pSV2CAT contains the SV40 
72 bp repeat enhancer, the SV40 early region promoter and the start site 
for transcription (Gorman at al., 1982). The relative level of CAT 
expression directed by the isolated surface promoter indicates that the 
isolated SPII promoter is transcriptionally weak when compared to 
expression directed by the SV40 early promoter contained on the plasmid 
pSVCAT, when assayed under the same conditions. 
It should be noted that, in a previous report, Shaul et al., (1985) cloned 
a Barn HI fragment of HBVad (corresponding to nucleotides 
2682-3182/1-1310 of HBV130), into the Bgl II site of pSVOCAT to 
generate pHB2.00AT with the SPII promoter in sense with the CAT gene. 
Transfection of Alexander cells with this construction resulted in no 
significant expression of the CAT gene (<01 relative to pSV 2CAT=100). 
The construction of Shaul et al., (1986a) contains the same HBVad' SPII 
sequences (corresponding to HBV130 sequences 978-1310) in sense with 
the CAT gene. In this case transfection of HeLa cells with this 
a 
construction resulted in'low, but significant level of CAT expression 
(see above). If all the SPII promoter regulatory sequences are contained 
upstream of position 1310 it would-be expected that both constructions 
used by Shaul et al., (1985) and Shaul et al., (1986a) should show SPII 
directed CAT expression. A possible explanation for the lack of SPII 
directed expression of the CAT gene in Alexander cells could be that the 
SPII promoter is not functional In these cells. This is clearly not the. 
case; the Alexander cells are known to express the HBsAg particles and 
examination of the surface promoter directed HBV mRNA isolated from the 
cells indicates that ca. 98% of the surface mRNAs are directed by the 
SPII promoter (Ou and Rutter, 1985). Therefore the SF11 promoter 
contained on pHB2.00AT, should have directed CAT expression in Alexander 
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cells if all the transcriptional regulatory sequences are contained 5' to 
position 1310. This is, unless the SF11 promoter contained on the 
plasmid is being repressed by unknown HBV or cellular directed factors 
or that the SPII promoter contained on pHB2.00AT was non-functional due 
to deletion or mutation. 
Chang at al., (1987b) using a similar construction, containing HBVadw 
sequences (corresponding to HBV130 positions 523-1280) inserted 5' to 
the CAT gene (pSpCAT), conducted transfections of the hepatoma cell line 
HuH-7. Again, SF11 promoter directed expression of the CAT gene was 
observed. In their assays the levels of conversion of chioramphenicol to 
its acetylated products, using the pSpCAT transformed HuH-7 cell lysates, 
was 4.06% conversion of chioramphenicol. Chang at al., (1987b) also 
inserted the HBV enhancer region 2245-2682 upstream of the surface 
promoter fragment to generate pEnSpCAT ((Hinc II) 2245-2682 (Barn HI)/ 
(Bgl II) 523-1280 (Eco RI)]. Transfection of the hepatoma cell line with 
pEnSpCAT resulted in approximately 20-fold increase of the surface 
promoter directed CAT expression (90-54% conversion of chloramphenicol 
for pEnSpCAT transfected HuH-7 cell lysates). The level of CAT 
expression using constructions containing the HBV enhancer and the 
surface promoters, was of approximately the same order of magnitude as 
the level of CAT expression using the plasmid pSVaCAT (9793%) assayed 
under identical conditions. 
The isolated surface promoters have been studied by Shaul at al., 
(1986a), Siddiqui at al., (1986) and Chang at al., (1987b) by inserting 
HBVadw (HBVad) fragments containing the surface promoters into 
pSVOCAT or pSP6-CAT (Shaul at al., 1986a) based plasmids. In all cases, 
transfection of mammalian cells with the constructions containing the 
isolated surface promoter (a), resulted in CAT expression. The 
combination of these result indicates that transcriptionally weak SF11 
promoter regulatory sequences are found between HRV nucleotides 993 and 
1310. It should be noted that all these investigations were carried out 
using subtype }IBVadw sequences. It is possible that the weak 
transcriptional activity observed using these constructions may be 
unique to the HBVadw subtype. Shaul at al., (1986a) have shown that the 
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SPII promoter is highly dependent upon the HBVadw2 NP-i binding site. 
They have also shown that the subtype. HBVayw has a lower in vitro 
binding affinity for NF-1 relative to HBVadw2 and as Shaul et al., 
(1986a) propose, this could be an intrinsic property of the DNA sequence. 
The remaining subtypes of HBV all have a single mismatch to the NP-i 
consensus sequence and it is possible that NP-i will not bind to these 
degenerate sequences. Therefore, all HBV subtypes, other than HSVadw, 
may not contain independent transcriptionally active promoter elements 
on the isolated sequences between the corresponding HBV130 sequences 
993 and 1310. The above expression studies need to be repeated using 
DNA sequences from subtypes HBVadr or HBVayr before the observed 
promoter activities of HBVadw can be generalised to include all subtypes 
of HBV. 
Siddiqui et al., (1986) have constructed HBV-pSVOCAT recombinants 
containing the isolated "TATA" box promoter (SPI) or the SPII promoter. 
Transfection of human, non-human, hepatoma derived and non-hepatoma 
tissue culture cells with both sets of constructions, resulted in CAT 
expression. An interesting point made by Siddiqui et al., (1986) Is that 
both the SPI and SPII promoters contained In their pSVOCAT derived 
plasmids, appear to have similar promoter strengths. This is In contrast 
to the actual relative promoter strengths found in Alexander cells, HBV 
infected liver tissue or hepatoma derived cell cultures supporting viral 
replication, in which the SPI directed inRNA accounts for only a minor 
proportion (approximately 2%) of the total surface antigen mRNA (Ou and 
Rutter, 1985; Will et al., 1987; Yaginuma et al., 1987b). 
Summation of the above published results suggests that while the HBV 
sequences 993-1310 do contain elements of the SPII promoter, which 
under certain conditions are capable of independent transcriptional 
activity, they also suggest that not all the transcriptional regulatory 
elements are contained upstream of position 1310. The results of Chang 
et al., (1987b) indicate that the HBV enhancer may also regulate the 
expression of the SF11 promoter. Siddiqui et al., (1986) suggest (based 
on unpublished results) that the HBV enhancer element, in its native 
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position relative to the surface gene, may also be involved in regulation 
of the SPII promoter in hepatocellular carcinoma derived cell lines. 
It is possible that the difference in the results obtained by Shaul et 
al., (1986a) and the results obtained in this study, could simply be due 
to the different HBV sequences contained in the plasmid constructions 
and the interaction of these sequences, or HBV protein products coded by 
these sequences, with the SPII promoter. The constructions of Shaul et 
al., (1986a) did not contain the HBV enhancer or X gene sequences. The 
promoter activity observed by Shaul et al., (1986a) was highly dependent 
upon the upstream distal transcriptional elements contained on their 
constructions. Deletion of the potential inverted CCAAT box and the 
NF-1 binding site, both of which resulted in a decrease in promoter 
activity, resulted in the isolation of the "SV4O-late-like" promoter 
sequences and like the actual SV40 late region (-53 to +7) these 
sequences contain no or very little intrinsic promoter activity in the 
absence of other cis acting elements. The constructions used in this 
study contained the complete transcriptional unit for the native major 
surface mRNAs (assuming no distal elements are contained upstream of 
position 1004) as well as the complete potential transcriptional unit for 
the X gene mRNAs. It is possible that the HBV enhancer element 
contained on the constructions used here has the ability to interact in 
cis with the SF11 promoter sequences, having a much stronger influence 
on the SF11 promoter than the upstream distal transcriptional element 
observed by Shaul et al., (1986a). The physical separation of the 5' 
distal elements from the SF11 sequences by restriction endonuclease 
digestion (assuming that the DNA fragments did not recircularise in 
vivo), had very little, if any, affect on the overall expression of the 
HBsAg. However, the methods used to detect HBsAg expression do not 
differentiate between the relative levels of expression of the preS2 and 
major surface proteins. It is possible, that during natural HBV 
infection, the distal promoter region may be involved in regulation of 
transcription of the relative ratios of the preS2 and surface mRNAs, 
thereby regulating viral morphogenesis. 
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It is possible that the HBV "SV40-late-like" SPII promoter, like the 
actual SV40 late promoter, is highly dependent upon the influence of the 
viral enhancer sequences for full transcriptional activity. The HBV 
enhancer has been shown to be semi-tissue specific in its ability to 
stimulate core promoter activity, in that its stimulative effect was 50 
fold higher in Alexander cells as compared to its activity in CV-1 cells 
(Shaul et al., 1985). It could be argued that due to this tissue 
specificity, the possible enhancer augmentation of the SPII promoter 
would be minimal in mouse L cells. However, Shaul et al., (1985) have 
also shown that In an heterologous system, the HBV enhancer element is 
capable of stimulating the SV40 early promoter activity, in the absence 
of the 72 bp repeat, 105-fold in COS cells, relative to the vector 
plasmid, pA1OCAT3, containing only the SV40 early promoter and the CAT 
gene. These results indicate that while the enhancer element may have 
maximal activity in hepatocyte derived cells, the enhancer has the 
potential to have a very significant stimulative effect on promoters in 
non-hepatocyte derived cells. Therefore, it is probable that the HBV 
enhancer may also have a significant stimulative effect on the SPII 
promoter In mouse L cells. 
The results of Wollershiem and Hofschneider (1987) indicate that the X 
gene product may act as a trans-activating protein. The constructions 
used in the transient transformation assays also contain the potential 
complete X gene transcriptional unit. Therefore, it is possible that the 
X protein could have been expressed in the transformed cells either by 
translation from its own mRNA or by internal Initiation of translation of 
the surface mRNA. If the X protein was translated, it could also have a 
trans-activating stimulative effect on the HBV SPII promoter. 
4.8 Future Prospects 
The sequences necessary for the regulation of transcription of the major 
surface mRNAs require.. further investigation. Although the results in 
this study indicate that the upstream distal element(s) proposed by 
Shaul et al., (1986a) are not required for transcription, when the 
sequences downstream of position 1310 are present, the results obtained 
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could be artifacts of the system due to possible recfrcularisation of 
the linear DNA fragments used, reconstituting a functional promoter 
sequence. Unfortunately, time did not permit further Investigation of 
the sequences necessary for expression of the HBsA8. However, using the 
transient expression system described in this report with a series of 
deletion derivatives of the plasmid pHBV1004, it should be possible to 
determine whether the HBV enhancer element or the X protein influence 
the promoter activity of the SPII promoter. A series of deletion 
derivatives of the plasmid pHBV1004 could be constructed using unique 
restriction endonuc].ease sites present in the HBV sequences, but not in 
the pUC8 vector. An out line of the proposed construction procedure is 
presented in fig. 4.6. 
The proposed constructions would be deleted for the following sequences 
from the surface transcriptional unit: pHBV1004NF-1 (Sina I (pUC8) to 
HBV position 1098, Bsm I), pHBV10046SPII (Sau I, 1150 to 1264), 
pHBV1004En (Dr-a III, 2318 to 2654, Nco I), pHBV1004X (F/co I, 2654 to 
3164, Sty I), and pHBV1004En-X (Dr-a III, 2318 to 3164, Sty I). The HF-1 
binding site could also be removed from the constructions containing 
deletions of the enhancer and X gene by removing the Sma I to Bsm I 
fragment in the same way as creating the pHBV1004MF-1 plasmid, to 
generate double deletion mutants. Transient assays could be performed 
In mouse L cells and possibly also in the HBV negative human hepatoma 
cell line HuH-7 (Nakabayashi et al., 1982), which has been shown to be a 
good host for both HBsA8 expression and viral replication (Chang et al., 
1987b, Yaginuma et al., 1987b). The results of the transient assays 
should indicate the interaction of the NF-1 binding site, the enhancer 
element and possibly the X protein with the SF11 promoter and therefore 
Increase our understanding of viral gene expression. 
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Figure 4.6 Proposed procedure for construction of deletion derivatives 
of pHBV1004: pHBV1004NF-1; pHBV1O04SPII; pMBV1004En; pHBV1004AX; 
pHBV1004En-X. Thick lines represent HBV sequences, thin lines 
represent pUC8 sequences. Restriction endonuclease abbreviations: B, 
Barn MI; D, Dra III; E, Eco RI; N, Nco I; S, Sau I; Sm, Sma I; St, Sty I. 
For nucleotide positions of the restriction endonucleese sites relative 
to the translational open reading frames and transcriptional regulatory 
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Appendix I 
Nucleotide Sequence of HBV130 
The nucleotide sequence presented In this appendix is that contained in 
the clone pHBV130 (Pasek et al., 1979; Gough and Murray, 1982; Pugh et 
al., 1986). The nucleotide sequence shown is the sequence of the 
complete plus strand (3182 nucleotides) numbered using the convention of 
Pasek et al., (1979). Shown below the sequence is the amino acid 
translation of the major open translational reading frames found in the 
three forward reading frames, the positions of the methionine initiation 
codons for the viral genes are indicated. The mapped transcriptional 
initiation sites are indicated by + above the sequence (Treinin and Laub, 
1987; Yaglnuma et al., 1987b). Also shown are the positions of the 
polyadenylation signal and the direct repeats DR1 and DR2. 
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Nucleotide Sequence of HBV130 
1 Core 	. 	Poly(A) 	. 	 . 50 
APCGACATTGACCCTTATAGAATTTGGAGCTACTGTGGAGTTACTCTC 
MetAspI 1eAspProTyrLysG1uPheG1yA1aThrVa1G1uLeureuSe 
51 . 	 . 100 
GTTTTTGCCTTCTGACTTCTTTCCTTCCGTACGAGATCTTCTAGATACCG 
rPheLeuProSerAspPhePheProSe rValArgAspLeuLeuAspThrA 
101 . 	 . 	 . 	 . 150 
CCGCAGCTCTGTATCGGGATGCCTTAGAGTCTCCTGAGCATTGTTCACCT 
laAlaAlaLeuTyrArgAspAlaLeuGluSerProGluHiscysserpro 
151 . 	 . 200 
CACCATACTGCACTCAGGCAAGCAATTCTTTGCTGGGGAGACTTAATGAC 
HisHisThrAlaLeuArgGlnAlalleLeuCysTrpGlyAspLeuMetTh 
201 . 250 
TCTAGCTACCTGGGTGGGTACTAATTTAGAAGATCCAGCATCTAGGGACC 
rLeuAlaThrTrpVa lGlyThrAsnLeuGluAspProAlaSerArgAspL 
251 . 	 . 	 . 	 . 300 
TAGTAGTCAGTTATGTCAACACTAATGTGGGCCTAAAGTTCAGACAATTA 
euValValSe rTyrValAsnThrAsnValGlvLeuLysPheArgGlnLeu 
301 . 	 . 350 
TTGTGGTTTCACATTTCTTGTCTCACTTTTGGAAGAGAAACGGTTCTAGA 
LeuTrpPheHi SI leSerCysLeuThrPheGlyArgGluThrvalLeucl 
351 . 	 . 	 . 400 
GTATTTGGTGTCTTTTGGAGTGTGGATTCGCACTCCTCCAGCTTATAGAC 
uTyrLeuValSerPheGlyValTrplleArgThrProProAlaTyrArgp 
401 Pol. 	 . 	 . 	 . 	 . 450 
CACC AAATGC C CC TATCC T ATCAACAC TTCCGGAGAC TACTGT T C TT AGA 
roProAsnAlaProlleLeuSerThrLeuProcluThrThrvalvalArg 
MetProLeuSerTyrGlnHisPheAr9ArgLeuLeuLeuLeuAs 








551 . 	 . 	 . 	 . 	 . 600 
AGTATCCCTTGGACTCATAAGGTGGGAAATTTTACTGGGCTTTP.TTCTTC 
nd 
Ser IleProTrpThrHi sLysValCiyAsnPheThrGlyLeuTyrSerSe 
601 . 	 . 	 . 	 . 	 . 650 
TACTGTACCTGTCTTTAACCCTCATTGGAAAACGCCCTCTTTTCCTTA 
rThrValProValPheAsnProHisTrpLysThrProserpheproAsnl 




701 	 . 	 . 	 . 	 . 	750 
CTCACAGTCAATGAGAAAAGAAGGTTAAAATTGATCATGCCTGCTAGGTT 
LeuThrValAsnGluLysArgArgLeuLysLeu I leMe tProAlaArgPh 
751 	 . 	 . 	 . 	800 
TTATCCTAATTTTACCAAATATTTGCCCTTGGATAAGGGTATTAAACCTT 
eTyrProAsnPheThrLysTyrLeuProLeuAspLysGlylleLysProT 
801 . 	 . 850 
ATTATCCAGAACATCTAGTTAATCATTACTTCCAAACTAGACACTATTTA 
yrTyrProcluHisLeuValAsnHisTyrPheGlnThrArgHi sTyrLeu 
851 . 	 . 900 
CACACTCTATGGAAGGCGGGTGTTTTATATAAGAGAGTATCAACACATAG 
HisThrLeuTrpLysAlaGlyValLeuTyrLysArgValSerThrHisSe 


















1101 	 . 	1150 
TTCGGGCTAGGGTTCACCCCACCGCACGGAGGCCTTTTGGGGTGGAGCCC 
leArgAlaArgValHi sProThrAlaArgArgProPheGlyValGluPro 
PheGlyLeuGlyPheThrProProHi sGlyGlyL.euLeuGlyTrpSe rPr 







































1,601 	 . 	 . 	 . 	 1650 
CCCAATCTCCAATCACTCACCAACCTCCTGTCCTCCAACTTGTCCTGGTT 
ProAsnLeuGlnSerLeuThrAsnLeuLeuSe rSe rAsnLeuSerTrpLe 
rProlleSerAsnHisSerProThrSerCysProProThrCysProGlyT 













1801 	 . 	 . 	 . 	 1850 
GAACCTGCACGACTCCTGCTCAAGGAATCTCTATGTATCCCTCCTGTTGC 
nAsnLeuHi sAspSerCysSerArgAsnLeuTyrValSe rLeuLeuLeuL 
rgThrCysThrThrProAlaGlnGlylleSerMetTyrProSerCysCys 


























2151 	 . 	 2200 
TAAATTTCATGGGCTATGTCATTGGATGTTGGGGATCATTGCCACAAGAT 
euAsnPheMetGlyTyrVallleGlyCysTrpGlySerLeuProGlnAsp 
2201 	 . 	 . 	 2250 
CACATCATACACAAAATCAAAGAATGTTTTAGAAAACTCCCTGTTCACAG 
HisI lel leHisLysl leLysGluCysPheArgLysLeuProValHisAr 
2251 	 . 	 . 	 2300 
GCCTATTGATTGGAAAGTGTGTCAACGAATTGTGGGTCTTCTGGGTTTTG 
gProl leAspTrpLysValCysGlnArgl leVaiGlyLeuLeuGlyPheA 
198 





	 . 	 . 	2400 
TGTATTCAATCTAAGCAGGCTTTCACTTTTTCGCCAACTTACAAGGCCTT 
CyslleGlnSerLysGlnAlaPheThrPheSerProThr'ryrLysAlaph 
2401 	 . 	2450 
TCTGTGTAAACAATACCTGAACCTTTACCCCGTTGCCAGGCAACGGCCAG 
eLeuCysLysGlnTyrLeuAsnLeuTyrProvalAlaArqGlnArgproc 
2451 	 . 	 . 	 2500 
GTCTGTGCCAAGTGTTTGCTGATGCAACCCCCACTGGCTGGGGCTTGGTC 
lyLeuCysGlnValPheAlaAspAlaThrProThrGlyTrpclyLeuval 
2501 	 . 	 . 	 2550 
ATGGGCCATCAGCGCATGCGTGGAACCTTTCTGGCTCCTCTGCCGATCCA 
MetGlyHisGlnArgMetArgGlyThrpheLeuAlaproLeuprolleHj 
2551 	 . 	 + 	 2600 
TACTGCGGAACTCCTAGCCGCTTGTTTTCCTCGCAGCAGGTCTGGAGCAJ 
sThrAlaGluLeuLeuAlaAlaCysPheAlaArgserArgserclyAlaA 
2601 	 . + 	+ 	 . 	 . 	 . 	2650 
ACATTCTCGGAACTGACAACTCTGTTGTCCTCTCCCGCAAATATACATCG 
sf1 leLeuGlyThrAspAsnSerValValLeuSerArgLysTyrThrser 








2751 	 . 	 2800 
GCCGCTTGGGGCCCTGTCGTCCTCTTCTCTGCCTGCCGTTCCGGCCGCCC 
yProLeuGlyAlaLeuSe rSe rSe rSerLeuProAlaValProAlaAlaH 
lyArgLeuclyProCysArgProLeuLeucysLeupropheArgpropro 
2801 	 . 	 . 	 . 	 2850 
ACGGGGCGCACCTCTCTTTACGCGGCCTCCCCGTCTGTGCCTTCTCATCT 
i sGlyAlaHi sLeuSerLeuArgclyLeuProValCysAlapheserse 
ThrGlyArgThrSerLeuTyrAlaAlaserproservalproserHjsLe 









2951 	 • 	 . 	3000 
GACTCTCTGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGT 
lyLeuSerAlaMetserThrThrAspLeuGluAlaTyrpheLysAspcys 
3001 	 . 	 3050 
TTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGATTGGTCTT 
LeuPheLysAspTrpGluGluLeuGlyGluGlur leArgLeuLysValPh 
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